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Abstract 
DNA methylation (DNAm) is the covalent modification of DNA by addition of a 
methyl group primarily at the cytosine directly upstream of a guanine. DNAm level 
plays a central role in transcriptional regulation and is linked to disease. Therefore, 
understanding genetic and environmental influences on DNAm level in healthy 
tissue is an important step in the elucidation of trait and disease etiology. However, 
at present only a minority of easy to access human tissues and ethnicities have been 
investigated.  
Therefore, we studied DNAm level measured in five human tissues: cerebellum, 
frontal cortex, pons, temporal cortex and colon in either North American or South 
American samples. We applied a novel statistical approach to estimate the 
heritability attributable to genomic regions (regional heritability, ℎ!,!! ) for DNAm 
level at thousands of individual DNAm sites genome-wide.  
In all five tissues, DNAm level was significantly associated with the local genomic 
region for more DNAm sites than expected by chance. Moreover, DNAm level could 
be predicted from the local sequence variants with an accuracy that scaled with the 
estimated ℎ!,!! .  
Our results inform on molecular mechanisms regulating DNAm level and trait 
etiology in several ways. Firstly, DNAm level at DNAm sites located in genomic risk 
regions and measured in a tissue relevant to the disease can be influenced by the 
local genetic variants. Specifically, we found that genetic variation within a region 
associated with Fluid Intelligence was also associated with local DNAm level at the 
proline-rich coiled-coil 1 (PRRC1) gene in healthy temporal cortex tissue. 
Additionally, we replicated the finding of a Colorectal Cancer risk variant 
(rs4925386) associated with two DNAm sites in healthy colon tissue. More 
generally, we showed that DNAm sites located within a susceptibility region and 
measured in a relevant tissue exhibit a similar overall pattern of estimated ℎ!,!!  to 
DNAm sites outwith a susceptibility region. Secondly, the propensity for DNAm 
level to be associated with the local sequence variation differs with respect to CpG 
dinucleotide density and genic location. Most notably, DNAm sites located in CpG 
 ix 
dense regions of the genome are less likely to be heritable than DNAm sites located 
in CpG sparse regions of the genome. Additionally, within both CpG dense and CpG 
sparse regions of the genome intergenic DNAm sites are more likely to be heritable 
than intragenic DNAm sites. Overall, our study suggests that variation in DNAm 
level at some DNAm sites is at least partially controlled by nuclear genetic variation.  
Moreover, DNAm level in healthy tissue has the potential to act as an intermediary in 



















The DNA sequence encodes the instructions that give rise to life. Extensive research 
has shown that some differences in the DNA sequence between people can influence 
observable characteristics such as susceptibility to disease. Recently studies have 
revealed that there are DNA modifications, known as epigenetic marks, which do not 
alter the sequence but can affect the way in which it is decoded.  One such epigenetic 
mark is DNA methylation (DNAm). Differences in DNAm level between people 
within a tissue has also been linked to disease susceptibility. However, what is less 
known is the extent to which DNAm in healthy tissue is influenced by nature 
(inherited genetic variation) and by nurture (the environment).  
Therefore, we studied DNAm level measured in five human tissues: cerebellum, 
frontal cortex, pons, temporal cortex and colon in either North American or South 
American people. We used a novel statistical approach to determine the degree that 
DNAm level at thousands of individual locations in the DNA sequence is affected by 
genetic variation. 
We found that in all tissues studied, DNAm level at some locations is at least 
partially controlled by the surrounding genetic variation. Therefore, in some cases 
DNAm level can be inherited across generations. In addition we obtained specific 
examples where DNAm level in a relevant tissue is affected by the same genetic 
variation that influences disease. Together these results indicate that DNAm level in 
healthy tissue has the potential to act as an intermediary between genetic variation 
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Chapter 1 Introduction 
1.1 The Discovery of 5-methylcytosine 
5-methylcytosine is formed by the biochemical process of the addition of a methyl 
group (CH3) at the 5th position of the atom ring that constitutes the pyrimidine base, 
cytosine. At the turn of the twentieth century experiments in organic chemistry led to 
the synthesis of 5-methylcytosine in the laboratory [3]. Scientists seeking to 
understand the nature of nucleotide bases knew that hydrolysis of cytosine led to the 
removal of an amine group (deamination) and the formation of uracil, a constituent 
of nucleic acid. At this time, thymine had also been realized as a constituent of 
nucleic acid and chemists hypothesized that a pyrimidine base with that of the 
chemical formula of 5-methylcytosine could deaminate and lead to the formation of 
thymine. Despite success in synthesizing and exploring the chemical properties of 5-
methylcytosine a further 21 years passed before 5-methylcytosine was discovered in 
the nucleic acid of a living organism; Mycobacterium tuberculosis [4]. By adding 
picric acid to a filtrate containing cytosine obtained from the nucleic acid of 
Mycobacterium tuberculosis, 5-methycytosine could be separated from cytosine as 
salt crystals with observable differences [4].   
1.2 Current Techniques for Interrogation of 5-
methycytosine 
With the dawn of the 21st century came the development of assays that could 
interrogate cytosine for methylation at basepair resolution, genome-wide. These 
assays utilize traditional molecular techniques for assaying 5-methylcytosine such as 
immunoprecipitation, methyl-sensitive restriction enzymes or sodium bisulfite 
conversion, coupled with either the latest sequencing or microarray technology 
(reviewed in [5]). These methods, of which there are many variants, all treat DNA 






methylcytosine is not maintained throughout polymerase chain reaction and cannot 
be identified from hybridization alone due to the location of the methyl group with 
respect to the DNA structure (reviewed in [6]). Following treatment of the DNA, 
microarray based methods are efficient in assaying large numbers of samples while 
whole genome sequencing remains a more costly gold standard.  
The treatment of DNA with sodium bisulfite is a popular approach taken by 
researchers’ to interrogate cytosine for methylation, genome-wide. In 1992, a 
seminal paper revealed the utility of sodium bisulfite for measuring 5-methylcytosine 
[7]. In the presence of sodium bisulfite, unmethylated cytosine deaminated to uracil 
whereas methylated cytosine remained essentially unreactive. This changed the 
epigenetic modification into a genetic modification amenable to established assays 
for genetic polymorphism. However, both 5-methylcytosine and the oxidation 
product, 5-hydroxymethylcytosine, do not react to treatment with sodium bisulfite; 
therefore, this assay cannot distinguish between these two forms of methylated 
cytosine (reviewed in [8]). Methylation of cytosine is a binary outcome within a cell 
at a given genomic location on one strand of DNA. However, two double strands of 
DNA within a cell, input of multiple cells within a sample, and polymerase chain 
reaction following bisulphite treatment, means that the occurrence of 5-
methylcytosine is reported as a variable indicating a level of 5-methylcytosine. This 
variable is often the proportion of methylated to total cytosine bases at a genomic 
location (Beta-value) or a transformation of that proportion (M-value) [9].  
1.3 Biological Roles and Importance of 5-
methylcytosine 
5-methylcytosine is a reversible mark that can affect how the DNA sequence is 
decoded. DNA methyltransferases (Table 1) and agents that lead to demethylation of 
5-methylcytosine (Table 2) respectively add and remove 5-methylcytosine at sites 
across the genome. A DNA methyltransferase (DNMT) acts by covalently bonding 






donor, 5-adenosyl-L-methionine. After the CH3 bonds to the cytosine the DNMT is 
released [10]. The process of demethylation is less well characterized than the 
process of methylation; however, several mechanisms have been identified (Table 2).  
 
Table 1 DNA Methyltransferases 
 Function Reference 
DNMT1 Maintenance across mitosis  [11-13] 
DNMT2 Non CpG 5-methylcytosine Reviewed in [14] 
DNMT3A De novo (imprinting) 
De novo (development) 
[15-18] 
DNMT3B De novo (development) [15] 
DNMT3L De novo (Imprinting) [16-18] 
 
 
Table 2 Agents of Demethylation 
Mechanism Description Examples Reference 
Oxidation To 5-
hydroxymethylcytosine 
(and other products 
















oxidized product are 



























5-methylcytosine has a functional role in several crucial biological processes 
including regulation of gene expression level. As early as 1975 Holiday and Pugh 
hypothesized that 5-methylcytosine could be responsible for the changes in the 
expression of developmental genes in a time dependent manner that led to cell 
differentiation [21]. Since this hypothesis, experiments have confirmed that 5-
methylcytosine and chromatin modifications are associated with the transition of 
cells from a pluripotent to unipotent state [8,22]. For instance, a large increase in 
global 5-methylcytosine and methylation of H3K9me3 by G9a has been observed at 
the first differentiation event in embryogenesis when genes that maintain 
pluripotency are down regulated [8,22]. Additionally, 5-methylcytosine at imprinting 
control regions (ICR) has been shown to regulate gene expression level in a parent of 
origin manner. This means that 5-methylcytosine, which occurs on either the paternal 
or maternal haplotype at an ICR, leads to mono-allelic expression at the locus 
(reviewed in [23]). At fertilization the paternal and maternal DNA undergo extensive 
chromatin remodelling and epigenetic changes. These epigenetic changes include a 
global loss of 5-methylcytosine by embryonic day 4 (reviewed in [19]). However, at 
a minority of sites namely in imprinted loci, 5-methylcytosine escapes 
demethylation. In human germ cells, parental imprints are erased in a second wave of 
demethylation occurring between embryonic day 7 and embryonic day 13.5. 
Research showed that the reestablishment of methylation at imprinted loci in female 
mice germ cells occurred after birth and was dependent on the developmental stage 
of the oocyte [24]. In contrast, in male mice, reestablishment of methylation at 
imprinted loci began at embryonic day 14.5 and was almost complete by embryonic 
day 17.5 [25]. 
Despite the important changes in 5-methylcytosine that occur during development, 
after development 5-methylcytosine is stably inherited throughout mitotic cell 
divisions. Studies have assayed the human methylome in differentiated cells. These 
studies provided several results 1) 5-methylcytosine occurred almost exclusively at 
CpG dinucleotides in differentiated cells and on both the forward and reverse strand 






correlated for CpG sites located up to 1kb apart [27]. 3) Average level of 5-
methylcytosine within amplicons was bimodal with the majority of amplicons 
exhibiting either low or high levels of 5-methylcytosine [27,28]. 4) Level of 5-
methylcytosine varied across different genomic locations. Specifically, CpG sites 
within transcription start sites (TSS) showed lower levels of 5-methylcytosine than 
intragenic CpG sites [27,28] and centromeric CpG sites showed lower levels of 5-
methylcytosine than CpG sites located close to the telomeres [26]. 5) Different 
tissues exhibited a different pattern of level of 5-methylcytosine across the genome 
[26-29]. 6) In some cases, level of 5-methylcytosine associated with gene expression 
level [30,31]. Together these studies highlighted that the level of 5-methylcytosine is 
extensive and variable throughout the genome and across cell types. Moreover, level 
of 5-methylcytosine and level of gene expression are related at some loci in 
differentiated somatic cells.  
Aberrant 5-methylcytosine can be characteristic of disease. Several rare imprinting 
disorders can result from an unusual pattern of 5-methylcytosine. For instance, 
research showed that 2-5% of cases of Angelman syndrome and Prader-Willi 
syndrome resulted from aberrant 5-methylcytosine on the respective maternal and 
paternal allele at 15q11-13 (reviewed in [32]). In addition, defective 5-
methylcytosine at 11p15.5 led respectively to 40% and 40-60% of cases of Silver 
Russel Syndrome and Beckwith-Wiedemann syndrome (reviewed in [32]). Changes 
in 5-methylcytosine are linked to common disease such as cancer. Global 
hypomethylation in tumour cells has been associated with decreased genomic 
stability and changes in level of gene expression (reviewed in [33]). In contrast 
global hypermethylation has been linked to the silencing of genes that are important 
for normal cell maintenance and tumour suppression (reviewed in [33]). Moreover, 
level of 5-methylcytosine at a specific locus can be used as an indicator (biomarker) 
of cancer (reviewed in [34]). Epigenome-wide association studies (EWAS) are now a 
popular method for assessing how changes in 5-methylcytosine relate to variation in 
a common phenotype. An EWAS tests the association of a phenotype with level of 5-






EWASs have been conducted for a number of common diseases including systemic 
lupus, major psychosis and type 1 diabetes nephropathy. These studies identified 
small changes in 5-methylcytosine that were associated with changes in disease risk 
(reviewed in [35] ). The role of 5-methylcytosine in disease makes it of interest to 
clinical and human geneticists. Moreover, now that it is feasible to assay 5-
methylcytosine at hundreds of thousands of individual sites genome-wide, human 
quantitative geneticists can study phenotypic variation in 5-methylcytosine in healthy 
tissue.  
1.4 Quantitative Genetics 
Quantitative genetics is the measurement and classification of the inherited variation 
that comprises variation in complex phenotypes (or traits), which are phenotypes that 
are influenced by multiple genes [36]. Variance in a phenotype can be classified into 
genetic and environmental variance (Equation 1) [37]. The genetic variance is a 
measure of the deviation of genotypic effect from the population mean. The 
genotypic effect for an individual in the population is the total effect of their 
genotype on the phenotype. The genetic variance can be further decomposed into 
additive variance and non-additive variance (Equation 2) [37]. Additive genetic 
variance arises from variation in breeding value within a population. The breeding 
value of an individual within a population is a measure of their genetic effect that can 
be inherited by their offspring. The environmental variance can be further classified 
into general and special environmental variance (Equation 2) [37]. General 
environmental variance arises from variation in the effect of an environmental factor 
that is common to individuals within the population. Special environmental variance 
results from variation in environmental effects that arise from environmental factors 
unique to the individual.  The emergence of quantitative genetics can be traced back 
to the turn of the twentieth centenary. In 1918, building on the work of Darwin, 
Mendel, Galton and Pearson, Fisher hypothesized that many genes each of small 
effect and of Mendelian inheritance lead to the heritable variation observed for 







𝜎!! = 𝜎!! + 𝜎!! 
Equation 2 
𝜎!! = 𝜎!! + 𝜎!! + 𝜎!! + 𝜎!"! + 𝜎!"!  
 
Human quantitative genetics, as the name suggests, is the study of quantitative 
genetics in human populations. The development of sequencing and array 
technology, at the turn of the twenty first century, has enabled the discovery of a vast 
number of genetic variants (or Single Nucleotide Polymorphisms, SNPs) in human 
populations. For instance, in 1990 the landmark U.S Human Genome Project began 
[39]. The Human Genome Organization included over 20 groups worldwide that 
over a time period of 13 years, worked to develop efficient strategies to sequence the 
human genome. The draft sequence from the U.S Human Genome Project was 
published in 2001 [39], and the completed sequence (99% of the genome) 
uncovering more than 1.4 million SNPs followed in 2004 [40]. Following the U.S 
Human Genome Project came studies seeking to assess the extent of variation within 
multiple different human populations, such studies include the International HapMap 
project [41] and The 1000 Genomes Project [42]. These studies and smaller scale 
studies with similar goals (of which there are too many to reference) have generated 
large amounts of genetic data. This has led to the establishment of public on-line data 
repositories for storing genomic data. The ability to download genomic data and 
assay genetic variation in a high throughput manner has revolutionized human 
quantitative genetics. With genotypic data readily attainable human quantitative 







1.5 Understanding the Genetic Contribution 
to Variation in Complex Quantitative 
Traits 
One fundamental focus for human quantitative genetics is estimation of the 
heritability of a phenotype. The broad sense heritability is the proportion of the 
phenotypic variance that can be explained by variance in the total genetic effect 
(Equation 3) [37]. In contrast, the narrow sense heritability is the proportion of the 
phenotypic variance explained by variance in additive genetic effects (Equation 4) 
[37]. Several methods have been used to estimate the heritability and the method 
used can influence the estimation. Therefore, results from different study designs 
must be interpreted differently. Common and traditional methods involve using 
measurements of the phenotype and pedigree relationship among relatives to obtain 
an estimate of heritability due to the pedigree relationship (ℎ!"#! ). These pedigree 
based studies capture the full extent of the additive genetic heritability but can be 
biased by un-modelled sources of variation [37]. For instance, the offspring 
phenotypic value can be regressed on the phenotypic value of one of the parents to 
provide an estimate equal to half of the heritability [37]. However, general 
environmental effects can make parents and offspring appear more similar to one 
another than expected due to the sharing of alleles. This scenario would bias the 
heritability estimate upwards. As a second example, human studies often use 
monozygotic (MZ) and dizygotic (DZ) twins to estimate heritability. Twice the 
difference of correlation of MZ twin pairs minus the correlation of DZ twin pairs 
provides an estimate of heritability. However, this estimate of the heritability 
includes genetic variance arising from non-additive effects [37]. Moreover, it 
assumes that the general environmental variance is equal for MZ and DZ sib pairs. 
Un-modelled sources of environmental variance that result in MZ twins being more 
similar to one another than DZ twins will bias the heritability estimate upwards. 






methods to estimate the heritability can be thought of as providing an upper limit for 
the additive genetic heritability.  
Equation 3 









Within Human Quantitative Genetics a second question is to determine the causal 
effects acting on heritable phenotypes. One commonly used method to tackle this 
question, that has been enabled by the discovery and assay of abundant SNPs within 
the human genome, is a Genome-wide Association Study (GWAS, Single SNP 
Association Approach). A GWAS is a population-based method where SNPs across 
the genome are individually tested for correlation with a phenotype [43]. A SNP is 
used as a marker for causal variants with which it is in linkage disequilibrium (LD). 
This method estimates the effects of causal variation in LD with a marker SNP. 
GWAS have revealed important findings regarding the genetic architecture of 
common complex phenotypes. In some cases, such as with age related macular 
degeneration, several genetic variants have been discovered which have relatively 
large effects (reviewed in [44]). However, in most cases, common complex 
phenotypes appear to be influenced by many genetic variants of intermediate 
frequency and small effect. A classic example is human height where 423 causal loci 
have been identified [45] and together explain 0.16 of the phenotypic variance. 
Moreover, for the majority of traits, estimates of SNP effects from GWASs have 
fallen short of the heritability estimated from family based methods and this is called 
the “missing heritability” problem [46].  
Several explanations have been proposed for the elusive heritability. Firstly, it is 






heritability. As discussed above, this can occur when factors such as shared 
environmental effects and non-additive genetic effects, including dominance, 
epistasis and genetic by environment interactions, are not accounted for and lead to 
phenotypic covariance among relatives [46]. While this may be the case for some 
phenotypes, it has been shown that is unlikely to be the case for human height [47]. 
Secondly, small effect sizes may not be detected at stringent significance thresholds 
even if the causal variant is in LD with the marker SNP [46]. This hypothesis has 
spurred researchers’ to seek an increased sample size, as this will increase the power 
to detect variants of small effect. Thirdly, the effect of causal genetic variants not 
tagged by marker SNPs on genotyping arrays cannot be captured by GWAS [46]. 
This type of genetic variation includes both rare and common variants. The majority 
of marker SNPs on genotyping arrays are of intermediate frequency in the human 
population [48]. An allele of intermediate frequency cannot have a high correlation 
with an allele of low frequency. Thus a GWAS that uses markers of intermediate 
frequency does not effectively capture the phenotypic variance explained by rare 
genetic variants [46]. The effect of common variants can be missed due to sampling 
variation where by the causal variant is not tagged by a SNP on the genotyping array 
[49].  
In 2010 a pivotal study [49] used human height as an example and provided evidence 
for both the second and third of the above three hypotheses. At this time, GWAS had 
uncovered ~50 genetic variants associated with human height and together these 
variants explained 0.05 of the phenotypic variation. In the 2010 study [49], random 
effects of 294,831 SNPs on height were fit simultaneously within a restricted 
maximum likelihood (REML) framework. The most likely estimate of the variance 
in the phenotype due to additive SNP effects (ℎ!!) was 0.45. Fitting SNPs 
simultaneously led to a 9-fold increase in the proportion of the phenotypic variance 
explained compared to that explained by the individual effects of the known 
associated variants.  The authors’ [49] concluded that this result came from variants 
with small effect that individually would not surpass the significance threshold. 






effects were added together they explained a substantial proportion of the phenotypic 
variance. The total proportion of the phenotypic variance explained by the SNPs 
could be detected by fitting the effects of SNPs simultaneously. The authors’ [49] 
went on to show that even when fitting all SNPs simultaneously some causative 
variation could be missed. Firstly, positioning of the tagging SNPs with respect to the 
causative variants meant that some causative effects were missed and the magnitude 
of the discrepancy depended on the number of tagging SNPs. Secondly, the effects of 
causative variation with a minor allele frequency (MAF) < 0.1 were not captured as 
well as causative variation with a MAF < 0.5, when the tagging SNPs each have a 
MAF < 0.5. This indicated that if causative variants had a different allele frequency 
spectrum to that of tagging SNPs then their effects would not be captured. Indeed, 
when the authors’ adjusted for insufficient LD between causative variants with MAF 
< 0.1 and tagging variants with MAF < 0.5 they found ℎ!! of height to be 0.80 [49]. 
Overall, this study revealed that extensive common variation of small effect and rare 
variation could explain the missing heritability. Additionally, fitting the effects of 
SNPs simultaneously could capture common causative variation not identified by 
GWASs. However, the genomic heritability due to (common) tagging SNPs on an 
array may be lower than the additive genetic heritability. This is because the genomic 
heritability is unlikely to capture the effects of rare variants.   
1.6 Challenges and Prospects for Human 
Quantitative Genetics 
Current challenges for human quantitative genetics are finding the source of the 
missing heritability, identifying the genetic variants that underlie phenotypic 
variation and elucidating the relevant biological pathways. There are several 
prospects that could address the questions raised by these challenges. Firstly, insight 
could be gained from the development and application of novel statistical approaches 






phenotype, UP), a cellular phenotype (CP) measured in a tissue relevant to the UP 
and genetic variation could be explored (Figure 1).  
 
 
Figure 1 Possible Relationships Among Genetic Variation, A Cellular 
Phenotype and An Ultimate Phenotype.  




A relatively well-characterized CP is gene expression level and several approaches 
have been taken to implicate genes that may be involved in the aetiology of an UP. 
Firstly, level of gene expression can be tested for association with an UP. This can be 
done in a high throughput manner. For instance, the expression levels of 23,720 
genes measured in adipose tissue were tested for association with body mass index 
(BMI). A significant association was found for 72% of the genes tested and variation 
in gene expression level at 2,784 genes explained 0.10 of the variation in BMI. This 
suggested a relationship between a large number of genes in adipose tissue and BMI. 
Secondly, the comparison of SNPs associated with an UP (Quantitative Trait Loci, 
QTL) and SNPs associated with gene expression (expression Quantitative Trait Loci, 
eQTL) in a tissue relevant to the UP has been used to identify genes that may be 










childhood asthma were also associated in cis with expression levels of ORMDL3 in 
lymphoblastoid cells [50]. This result elucidated a potential mechanism by which the 
genetic variants could influence childhood asthma. Similarly, SNPs associated with 
the expression of genes in the macrophage-enriched metabolic pathway measured in 
adipose tissue associated with BMI, which suggested a link between the group of 
genes and obesity [51]. Overall, these studies have suggested a link between an UP, 
the expression level at genes measured in a relevant tissue and in some cases, genetic 
variation. The results indicted that it was possible that the CP, gene expression level, 
could mediate genetic effects on an UP. However, it should be noted that these 
studies have not proved a causal relationship between gene expression level and the 
UP.  
Information regarding the level of association between SNPs and a CP can be used to 
increase the power to detect the association of SNPs with an UP. In the case of gene 
expression levels, eQTLs have been used to prioritize SNPs to test for an association 
with an UP. For instance, eQTLs from a public database were used to select a subset, 
out of 500 SNPs most strongly associated with Crohn’s disease, for replication 
studies. Out of the 10 SNPs selected three were found significant in an independent 
study [52]. Using eQTLs to prioritize SNPs for association with an UP is predicated 
on the hypothesis that in comparison to the general pool of SNPs, trait associated 
SNPs are more likely to be eQTLs. Under this assumption, using eQTLs will provide 
an enrichment of significant associations between SNPs and a UP. Moreover, there 
may be increased power to detect a specified SNP effect on an CP than on the trait 
the CP influences [53]. This could occur if the CP resulted from a lower number of 
molecular interactions than the UP. The CP would be subject to less biological noise 
than the UP and the estimated SNP effect on the CP would be more precise 
compared the estimated SNP effect on the UP [53]. Therefore, overall genetic 
determination of CPs in a relevant tissue could be helpful in identifying SNPs that 






1.7 Genetic Variation Associated with Level of 
5-methylcytosine 
Level of 5-methylcytosine is a CP less well studied than level of gene expression. 
However, studies have begun to assess inter-individual variability in the level of 5-
methylcytosine and the relationship with genetic variability [2,54-58]. These studies 
have been of small sample size and have been conducted in a minority of tissues, 
typically tissues that are easy to access. In the tissues assayed, ℎ!"#!  has been 
calculated or individual SNPs genome-wide have been tested for association with 
level of 5-methylcytosine at basepair resolution across the genome to identify SNPs 
associated with 5-methylcytosine (methQTLs). In a minority of cases [57,58], ℎ!"#!  
have been compared for CpG sites located in different functional genomic contexts. 
Studies utilizing the pedigree information for MZ and DZ twins have suggested a 
wide range of ℎ!"#!  for 5-methylcytosine [56-58]. Additionally, these studies have 
suggested that the average ℎ!"#!  may be significantly different for different tissues 
[57] and for CpG sites located in different functional genomic contexts [56,58]. 
GWASs for 5-methylcytosine have revealed that a SNP can explain up to 88% of the 
phenotypic variation in level of 5-methylcytosine [2]. Moreover, SNPs local to the 5-
methylcytosine were enriched for higher effect sizes than SNPs distal to the 5-
methylcytosine [2] and the majority of associations detected for 5-methylcytosine 
resulted from local SNPs [54,55].  
1.8 The Aim of this Study 
The overall aim of this work was to explore the heritability of 5-methylcytosine, 
genome-wide in differentiated somatic cells. We used a newly established statistical 
methodology that we anticipated would have increased power over a GWAS 
approach to detect variants with a small effect. Moreover, unlike pedigree-based 
studies this methodology allowed us to determine the contribution of specific regions 






effect of local and distal genomic regions on level of 5-methylcytosine. We 
examined variation in the estimate of local genetic effects between CpG sites located 
within different genomic contexts. Finally, we assessed the extent to which genetic 
effects local to a CpG site differ among samples taken from different tissues. Our 
analyses informed on the basic mechanisms that lead to variation in the level of 5-
methylcytosine in differentiated somatic cells. 
 
1.9 Contributions 








Chapter 2 The Effect of Local Genetic 
Variation on DNA Methylation 
Level Measured in Four 
Regions of the Human Brain 
2.1 Introduction 
The occurrence of 5-methylcytosine, from here on defined as DNA methylation 
(DNAm), can be dependent on the genome sequence. A classic example is the 
random methylation of one of the two X chromosomes in females to silence genes 
and to compensate for the higher levels of gene expression that would otherwise 
occur in females relative to males. A second well noted example is DNAm at ICRs in 
a parent of origin manner. Furthermore, studies [2,54-61] have established that 
variation within the genome sequence can affect the binary outcome of DNAm. 
Family based studies [56-60] (Table 3) and GWASs [2,54,55,61] (Table 4) have been 
critical in establishing that genetic variation can influence DNAm level at individual 
CpG sites throughout the genome The results from different GWASs (Table 4) are 
not directly comparable because typically each study uses a different sample size, 
applies a different multiple testing correction, assays different DNAm sites and 
different tissues and defines local variation by a specific number of basepairs 
surrounding a DNAm site. Despite the difficulties in comparing findings from 
multiple GWASs, these studies (Table 4) and others [62,63] have suggested that a 
substantial proportion of the phenotypic variation for DNAm level can be explained 
by SNPs local to the DNAm site. However, currently, published results from 
GWASs (Table 4) are insufficient in providing an estimate of the local heritability 
for the DNAm sites studied. This is because while these studies have provided 






not taken into account the effects of rare variants, combinations of variants of small 




Table 3 Twin Studies Assessing Heritability of DNAm Level  
The table shows twin studies where the pedigree relationship was used to calculate 
ℎ!"#  ! for individual DNAm sites. The cell or tissue type in which DNAm level was 
measured is listed (column one) along with location of the DNAm sites assayed 
(column two). The ℎ!"#!  is the average for all the DNAm sites assayed (column 
three). The number of twin pairs provided (column 4) includes pairs of monozygotic 
(MZ) and dizygotic (DZ) twins.  
Cell or Tissue Type DNAm Sites Considered Average ℎ!"#!  Number of Pairs Reference 
Buccal Epithelial  Genome-wide 0.30 20 MZ, 20 DZ [57] 
White Blood  Genome-wide 0.01 20 MZ, 19 DZ [57] 
CD4+ MHC Complex CpG 
Islands 
0.07 49 MZ, 40 DZ [56] 
CD4+ MHC Complex 5 Prime 0.16 49 MZ, 40 DZ [56] 
CD4+ MHC Complex CNC 0.12 49 MZ, 40 DZ [56] 
CD4+ MHC Complex Random 0.02 49 MZ, 40 DZ [56] 
Peripheral Blood 
Lymphocytes 
Genome-wide 0.20 67 MZ [58] 
Whole Blood Genome-wide 0.22 23 MZ, 23 DZ [59] 
Cord Blood 
Mononuclear  
Genome-wide (n=19204) 0.12 18 MZ, 9 DZ [60] 
Human Umbilical 
Vascular Endothelial 
Genome-wide (n=19350) 0.07 14 MZ, 20 DZ [60] 










Table 4 GWAS Assessing Association of SNPs with DNAm level 
GWAS testing the association of SNPs with DNAm level at individual DNAm sites. 
The cell or tissue type in which DNAm level was measured is listed (column one) 
along with location of the DNAm sites assayed (column two) and the SNPs tested for 
association (column three). The proportion of the phenotypic variance explained by 
a SNP is reported (column four) and the number of DNAm sites with at least one 
significantly associated SNP (column five). 
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10 77 [55] 







69 148 [61] 

















0.22 – 0.76 657 108 [2] 




0.20 – 0.83 420 133 [2] 














0.19 – 0.76 774 125 [2] 




0.21 – 0.86 547 127 [2] 












Recently, the genomic heritability method (see 1.5) was adapted so that the effects of 
causal genetic variation could be partition into genomic regions (regional heritability, 
RH, ℎ!,!! ). The effects of SNPs within a genomic region of interest were 
simultaneously modelled as random effects. Simulation experiments revealed that the 
RH approach could capture an increased proportion of the genetic variance relative 
to a GWAS or gene based approaches that simultaneously estimated the effect of 
SNPs within a genomic region [64,65]. The RH approach outperformed a GWAS 
and gene based approaches except when the number of causal variants was extremely 
low [64,65], for instance, less than three within a 10 to 100 SNP window spanning 
between 103 and 1031 KB respectively [65]. In conjunction, the RH approach could 
capture the phenotypic variance explained by low MAF much more effectively than 
GWAS or gene based approaches [64,65].  Moreover, ℎ!,!!  obtained when the 
number of causal loci was not extremely small (less than three), were not 
dramatically affected by the number of causal variants, the variance contributed by 
individual causal variants, the size of the genomic window or the overall heritability 
of the trait [64,65]. Therefore, the RH approach can be used to obtain robust ℎ!,!!  that 
are likely to be more accurate estimates of the true additive heritability than those 
obtained from a GWAS.  
We used the RH approach to estimate the proportion of the phenotypic variance in 
DNAm level that can be explained by genetic variation +/- 1MB of a DNAm site. 
We chose a region of +/- 1MB surrounding a DNAm site in keeping with previous 
GWASs [2,54] that have investigated the effect of cis acting genetic variation on 
variation in DNAm level. We conducted this analysis using publically available data, 
on which others have conducted a GWAS for DNAm level [2]. This dataset, which 
we refer to as the brain dataset, was composed of DNAm level measured at 27,578 
DNAm sites in the cerebellum (CRBL), frontal cortex (FCTX), pons (PONS) and 
temporal cortex (TCTX) for a total of 148 unrelated individuals. We selected a 
subset of the total assayed DNAm sites for RH analysis, choosing the DNAm sites 






prioritized these DNAm sites for analysis because we were interested to establish if 
genetic variation that associated with disease also influenced a change in DNAm 
level measured in a tissue relevant to the disease. We conducted simulation 
experiments that validated the accuracy of the RH approach for obtaining ℎ!,!!  for 
DNAm level in our sample of unrelated individuals. Subsequently, we reported the 
RH results for the selected DNAm sites. Then we used the RH framework and all 
DNAm sites measured within the TCTX to show the extent to which local SNP 
effects could predict DNAm level for the TCTX in our population. Finally, from our 
work we have provided an example where genetic variation may mediate the 
outcome of a trait, fluid intelligence (FI), through changes in DNAm level.   
2.2 Materials and Methods 
2.2.1 Quality Control  
Obtaining accurate analytical results that reflect the true biological situation of study 
depend on the quality of the genotypic and phenotypic data. Technical factors and 
human error could increase variation in the data set, which if not accounted for could 
mask true biological signal. One ramification of this is false positive association, an 
association that falsely leads to the rejection of the null hypothesis of no association. 
A second and less identifiable consequence is false negative association, falsely 
accepting the null hypothesis of no association when in fact there was an association. 
Application of appropriate quality control procedures (Figure 2) can lead to reliable 
measurements of genetic markers and traits. This can reduce the probability of 










Figure 2 Schematic Diagram of the Quality Control Procedure  
The data obtained from the online repositories consisted of both phenotype and 





2.2.1.1 Genotype Quality Control 
Genotypes for 148 individuals at 561466 marker SNPs obtained from authorized 
access to dbGaP were made available to myself on September 12th 2011. These 
genotypes were subjected to the quality control procedures outlined below using 








































2.2.1.1.1 Genotyping Algorithms 
Genotype calling algorithms for SNP arrays determine a genotype at a given SNP by 
using the intensity measure from the probe binding the major allele (X) and the 
intensity measure from the probe binding the alternative allele (Y) and comparing the 
intensity measures (X, Y) across all assayed individuals in 2D space.   
Three clusters representing the three genotypes, A1A1, A1A2, A2A2 should be 
present for a SNP measured with high accuracy.  Proximity to a cluster determines an 
individual’s genotype [67,68].  Problems genotyping specific SNPs, poor quality 
DNA or low concentration of DNA can mean that genotype clusters are not well 
defined. In this case genotyping algorithms cannot specify individual genotypes with 
certainty and genotypes may be miscalled or set to missing. If the proportion and 
type of genotypes set to missing or miscalled is correlated with the trait of interest 
then false positive and false negative associations can occur [67]. There are several 
precautions that can be taken to minimize the effect of missing or miscalled 
genotypes on obtaining false results. Firstly, individuals for which a substantial 
proportion of SNPs are set to missing and SNPs that do not type in substantial 
proportion of the individuals assayed can be removed. Secondly, SNPs that have 
genotype frequencies that deviate from the expectation in a randomly mating 
population and are not in Hardy-Weinberg Equilibrium can be removed. Thirdly, 
SNPs with a low MAF can be excluded [68]. Following classical protocol, samples 
and SNPs with a call rate below 95% were excluded from downstream analysis [69]. 
The expected genotype frequencies were calculated from the observed allele 
frequencies and compared to the observed genotype frequencies using a chi-squared 
test.  SNPs were removed if significantly out of Hardy-Weinberg Equilibrium with a 
P-value < 0.0001 [69]. SNPs with a MAF < 0.01 were also removed. This protocol 
reduced the number of SNPs available for downstream analysis from 561466 to 
530632. No samples were removed based on the missingness threshold set, leaving 






authors’ [2] working with this dataset had removed poor quality samples prior to 
submission to dbGaP.  
2.2.1.1.2 Genotype Sample Mix-up 
If left undetected accidental mislabelling or swapping of samples during the 
genotyping process will result in misalignment of the genotypes with the phenotypes.  
Sample mix-ups can be identified by comparing the recorded sex to the estimate of 
homozygosity by descent on the X chromosome [68,69]. Homozygosity by descent is 
the excess in the number of SNPs that are monomorphic in a sample relative to the 
number of SNPs that are expected by chance to be monomorphic in the sample [66]. 
Homozygosity by descent for an individual based on the X chromosome can be 
calculated from the observed number of homozygous SNPs and the expected number 
of homozygous SNPs due to chance [66]. The expected number of homozygous 
SNPs due to chance is calculated as the sum of the probability of each SNP being 
homozygous following the expectation under Hardy-Weinberg Equilibrium [66]. 
Human males have one X chromosome and with the exception of variation due to 
genotyping error, genotype calling algorithms should observe that these individuals 
are completely homozygous at SNPs on the X chromosome. In contrast, females 
have two X chromosomes and the observed number of homozygous SNPs on the X 
chromosome is likely to be lower than that observed for males. Based on SNPs on 
the X chromosome females typically have a low homozygosity by descent (~0.2) and 
males typically have a high homozygosity by descent (~0.8) [66]. The recorded and 
predicted homozygosity by descent sex for each of the 148 individuals was 
concordant. This indicated that the genotype data was free from human error relating 
to a male sample being swapped with a female sample and vice-versa.  
2.2.1.1.3 Cryptic Relatedness, Population Structure and Ethnicity 
Cryptic relatedness, population structure and ethnicity can be identified by assessing 
the relationship of each individual with each other individual in the population 






as the proportion of SNPs at which the two individuals have the same alleles 
(identity by state) or as the proportion of the genome that two individuals share from 
a common ancestor (identity by descent). Identity by state is used to infer identity by 
descent [66]. Calculations of allelic sharing for investigating duplication of samples, 
population structure and ethnicity can be conducted using a set of SNPs pruned for 
LD to increase computational efficiency. 
The pairwise estimates of identity by descent can reveal cryptic relatedness. For 
example, in a population sample containing unrelated individuals, identity by descent 
= 1, an estimate which would be obtained if the two individuals being compared 
where MZ twins, is not expected and is likely to be the result of a duplication of one 
sample’s DNA [68,69]. Using r2>0.1 (r=0.31) we pruned sets of SNPs within a 50Kb 
window for LD. We found a total of 35116 SNPs in linkage equilibrium from an 
initial number of 530632 and we found a maximum identity by descent between two 
samples of 0.07319. Since all individuals shared substantially less of their genome 
than third degree relatives (0.125), we did not remove any samples due to cryptic 
relatedness.   
The average proportion of the genome shared identity by state can be used to 
determine if samples look more dissimilar to one another than what is expected if the 
population sample is homogeneous. The matrix of pairwise identity by state 
estimates can be visually interpreted by multidimensional scaling and by plotting the 
first two multidimensional scaling components. This technique can be conducted 
within the population of interest to identify structure. Additionally, this technique can 
be used to examine the ethnicity of samples when samples of known ethnicity, such 
as samples from the HapMap populations are included. In both cases, the distance 
between samples on the plot represents the genetic distance between the samples. We 
used plink [66] to calculate pairwise identity by state and to conduct 
multidimensional scaling with our samples. By plotting the first two 
multidimensional scaling components we identified visually that there was no 






four HapMap populations [41]  (YRI, Yoruba in Ibadan, Nigeria;  JTP and CHB, 
(Japanese in Tokyo and Han Chinese in Beijing; Utah residents with ancestry from 
northern and western Europe, CEU) validated that our samples all clustered with 
HapMap individuals of European ancestry. 
2.2.1.2 DNAm Level Quality Control 
DNAm level measured on the Beta-value scale (see 1.2) at 27,578 DNAm sites and 
sampled from the four brain regions (BRs: CRBL, FCTX, PONS, TCTX) were 
downloaded from the GEO database (http://www.ncbi.nlm.nih.gov/geo/) (Table 5). 
Two samples from the CRBL region were excluded prior to the phenotype quality 
control procedure because these two individuals were not represented in the genotype 
data. All other individuals present in the phenotypic data were present in genotype 
data (Table 5). 
2.2.1.2.1 Detection of DNA Methylation Level Above Background 
Noise 
Samples had been assayed for DNAm level using the Illumina Infinium 
HumanMethylation27 BeadChip (HM27K). The HM27K assay reports a P-value for 
the significance of the detection of the level of DNAm at each DNAm site above the 
background level of noise measured from negative control probes on the array [70]. 
Following others [2], samples were removed if DNAm level at greater than 5% of 
DNAm sites were not detected above background levels of variation (P = 0.01) 
(Table 5). Similarly, DNAm sites were removed if DNAm level at that site was not 
detected above the background level of variation (P=0.01) in greater than 5% of 








Table 5 Samples Available for Analysis after Application of Sequential Quality 
Control Steps 
Each cell in the table gives the number of samples assayed for DNAm level and 
remaining after the sequential quality control steps. The number of samples for each 
brain region is listed separately.  
 CRBL FCTX PONS TCTX 
Downloaded from GEO 121 133 125 127 
No Genotype Data in dbGaP 119 133 125 127 
Detection Above 
Background Variation 
109 132 125 127 
Sample Sex Discrepancy 108 132 125 127 
Cluster Analysis 103 130 121 126 




Table 6 DNAm Sites Available for Analysis after the Sequential Application of 
Quality Control Procedures 
 CRBL FCTX PONS TCTX 
Downloaded 27579 27579 27579 27579 
Detection Above 
Background Variation 
27393 27545 27516 27554 
SNPs Within Assay Probe 20722 20843 20820 20848 


















2.2.1.2.2 Removal of DNAm Sites Assayed by Probes Containing 
SNP 
Only DNAm sites that did not contain a SNP within the assay probe sequence, as 
documented in the manifest file for the Illumina Infinium HumanMethylation450 
BeadChip (HM450K), were retained for analysis (Table 6)  
2.2.1.2.3 Sample Sex Inconsistencies  
Similar to genotype quality control, the process of phenotyping a sample taken from 
an individual is subject to human error that can lead to samples being incorrectly 
labelled. One way of identifying mislabelled samples is to check the recorded sex for 
an individual against the predicted sex for an individual based on the level of DNAm 
of DNAm sites along the X chromosome [71]. Female samples are expected to 
exhibit hemimethylation of the X chromosome in accordance with the mechanism of 
dosage compensation [71]. Male samples are expected to show low DNAm level on 
the X chromosome in comparison to the hemimethylation exhibited by female 
samples.  We assessed the average DNAm level on the X chromosome for each 
sample. The results indicated that the samples clustered into two groups. Indeed, 
samples recorded as being male typically had a lower estimate of average DNAm 
level and higher variance of the mean estimate of DNAm level than samples 
recorded as female (mean for all 4 BR: males = 0.34, females = 0.48, variance for all 
4 BR: males 0.14, females = 0.07). The results indicated that one sample from the 
CRBL region was likely to have been mislabelled and this individual was removed 










Figure 3 Recorded and Phenotypic Estimated Sex for CRBL Samples  
Recorded sex and sex estimated from DNAm level on the X chromosome revealed 
that a sample was potentially mislabelled. One sample reported as male appears to 
have the DNAm level profile of a female. This sample was removed from further 




2.2.1.2.4 Whole Genome Methylation Profiling to Detect Outliers 
We used principal component analysis with autosomal DNAm sites, common to all 
BR, to investigate the phenotypic data for outlying data points. Between 1 and 5 
samples were removed from each BR based on an abnormal DNAm level profile as 









Figure 4 Principal Component Analysis of DNAm Level  
Principal component analyses examining the covariance of DNAm level for all 
autosomal DNAm sites and samples. Within the plots the numbers indicate the 
















































































































































































































































































































2.2.1.3 Gene Expression Level Quality Control 
The level of gene expression measured for genes across the genome and in the 
CRBL, FCTX, PONS and TCTX was available for the samples in the brain dataset 
and downloaded from the GEO database (http://www.ncbi.nlm.nih.gov/geo/).  The 
limma [72], Biobase [73] and arrayQualityMetrics [74] packages for the statistical 
program ‘R’ [75] were used to conduct quality control measures for the mRNA 
expression data. Probes measuring mRNA expression were kept for subsequent 
analysis if they were detected above background noise levels at p < 0.05 in ≥ 95% of 
the samples.  A Kolmogorov-Smirnov test comparing the intensity distribution for 
each sample to that of all samples pooled for each tissue was used to detect and 
subsequently remove sample outliers. A total of 145, 146, 144 and 147 samples from 
the CRBL, FCTX, PONS, and TCTX remained for analysis. The mRNA levels for 
samples were quantile normalized within brain tissue type using limma [72]. 
Additionally, the expression levels of each mRNA probe were adjusted for sex, age, 
time lapse between death and taking the sample (post-mortem interval, PMI), brain 
bank each sample came from (study) and genotyping plate (plate) prior to analyses.  
 
2.2.2 Testing the Effect of Explanatory Variables on 
DNAm Level 
In order to accurately assess the strength of an association between the phenotype 
and genotype data it is necessary to include the effects of variables that can explain a 
significant proportion of the phenotypic variation. As discussed in 2.2.1.3 included in 
the brain dataset were measurements for the 5 variables: sex, age, PMI, plate, and 
study for each individual. Sex and age have been found to correlate with DNAm 
level [59]. Additionally, variation in PMI (ranging from 0 to 28 hours after death), 
plate (7 levels), and study (3 levels) may correlate with inter-individual variation in 






The proportion of the variance explained by a full model, including all 5 explanatory 
variables, was compared to a reduced model including only four of the five 
explanatory variables. To test if the fit of the full model was significantly better than 
the fit of the reduced model we used an F-test, P < 0.05 and the drop1 function in R 
[75]. The results for the inclusion of the effect of sex, age and plate were highly 
enriched for significant associations with DNAm level measured in all four BR 
(results not shown). The results for the inclusion of the variable, study, were highly 
enriched for significant associations in the CRBL (results not shown). The results for 
the inclusion of PMI were moderately enriched for significant associations in the 
FCTX and TCTX (results not show).  Based on these results, and the work of others 
who have analysed this dataset [2], we fit all five variables: sex, age, PMI, plate and 
study in subsequent analyses. The consequence was a loss of 11 degrees of freedom.  
Furthermore, we determined that cause of death was not a significant factor 
influencing variation in DNAm level. A total of 50 different causes of death were 
reduced to the four categorical variables that showed highest representation in the 
dataset (control, multiple injuries, cardiovascular disease and other). The proportion 
of variance in DNAm level explained by cause of death was determined by 
comparison of a full model containing sex, age, PMI, plate, study and cause of death 
and a reduced model that did not contain cause of death. Overall, we did not find an 
enrichment of results where the fit of the full model was significantly better than the 
fit of the null model (results not shown). Therefore, in accordance with previous 
authors’ [2] who have analysed this dataset we did not fit cause of death as a 
covariate in further analyses. 
2.2.3 Transformation of DNAm Level 
The results from fitting a linear model are reasonable descriptive statistics if several 
conditions regarding the dataset were met prior to analysis [76]. Firstly, the 
dependent variable must have a linear relationship with the independent variable, 






variable should be independent and normally distributed, and thirdly the probability 
distribution of the dependent variable for each value of the independent variable 
should have the same standard deviation. In practice, visualization of a plot of the 
residual deviation for each set of data points can be used to check that the third 
assumption is met. However, this is not feasible when one has a large number of 
linear regressions to conduct. Therefore, we used an alternative method to determine 
if our data met the third criteria stated above. We regressed DNAm level on sex, age, 
PMI, study and plate at each DNAm site and we used the Shapiro-wilk test in the 
statistical package R [75] to test if the residual distribution was significantly different 
from a normal distribution. The results suggested that for each brain region 
approximately 80% of the traits did not have normally distributed residuals. 
Therefore, we used a rank transformation to normalize the phenotypic data for each 
DNAm site. After normalization I found that approximately 90% of the DNAm sites 
for each BR had normally distributed residuals as determined by the Shapiro-wilk 
test. The rank transformed Beta-values were used in all analyses in this Chapter 
unless otherwise stated.  
2.2.4 Selection of a Subset of DNA Methylation Sites 
Local to Risk Variants for Disorders and 
Disease of the Brain 
The National Institute of Health full Catalogue of Published Genome-Wide 
Association Studies (http://www.genome.gov/gwastudies/) was downloaded on 
September 30th 2011.  A total of 202 SNPs, representing multiple loci across the 
genome, were listed as being associated with at least one of the following seven brain 
related traits: parkinson’s disease, alzheimer’s disease, bipolar disorder, 
schizophrenia, major depressive disorder, glioma, and neuroblastoma. We identified 







2.2.5 Simulating DNAm Level from the Genotype 
Data 
The phenotype, DNAm level, was simulated for individuals within the brain dataset 
using causal SNPs selected from the genotype data and for a specified heritability. 
We used the GCTA software [77] , which is an earlier version of the REACTA 
software [78] mentioned in 2.2.6. With the --simu-causal-loci command GCTA [77] 
selects effect sizes for each of the causal SNPs from the standard normal distribution. 
Using allele frequencies for these SNPs, calculated from the genotype data, and the 
effect sizes, the total additive genetic variance can be calculated. Specifying a 
heritability for the simulated phenotype facilitates calculation of the environmental 
variance. An environmental deviation for each sample can be obtained from a 
distribution with mean of zero and variance equal to the calculated environmental 
variance. 
2.2.6 Estimating Regional Heritability and 
Prediction of DNAm Level  
Estimation of RH and prediction of DNAm level at an individual DNAm site was 
conducted within a mixed linear model and REML framework using the publically 
available software: REACTA [78]. Below, “total genetic effects” refers to the total 
genetic effects within a region of interest, which except where specified, is +/- 1MB 










2.2.6.1 Estimating Regional Heritability 
Let the following variables be represented: 
𝑦 =  vector of DNAm levels for an individual DNAm site and all samples              
𝑋 =  incidence matrix 
𝐼 =   identity matrix 
𝛽 =  vector of independent effects 
𝑔 =  vector of total genetic effects, one for each sample 
𝜀 =  vector of error terms 
𝑉 =  variance-covariance of 𝑦 
𝐴 = matrix of pairwise genetic relationships for the samples 
𝜎!! =  variance of 𝑔 
𝜎!! =  variance of 𝜀 
 
The variance-covariance in the phenotype, DNAm level, is a function of the 
variance-covariance of the total genetic effects of the samples and the variance-
covariance of an error term (Equation 5) 
Equation 5 
𝐲 = 𝐗𝛃+ 𝐠+ 𝛆;𝐕 = 𝐀𝛔𝐠𝟐 + 𝐈𝛔𝛆𝟐 
The covariance-variance of the total genetic effects of the samples can be related to 
the pairwise genetic relationships between the samples (Equation 6). In our analyses 
the pairwise genetic relationships were calculated from SNP within a region of 
interest (often +/- 1MB of a DNAm site) following a previously defined equation 
[79].   







Restricted maximum likelihood provides the most likely estimate of the variance in 
the genetic effects for specified phenotypic and genotypic data. When the genotypic 
data provided refers to pairwise genetic relationships calculated from SNP within a 
region of interest then the genetic variance relates to the genetic variance within the 
region of interest. Once the variance components have been estimated ℎ!,!!  can be 






The null hypothesis that ℎ!,!!  was not significantly different from zero was tested 
with a Likelihood Ratio Test distributed as 50:50 mixture of Chi-squared 
distributions with 0 and 1 degrees of freedom [80]. If P < 0.05 we rejected the null 
hypothesis and concluded that the DNAm site was heritable. 
2.2.6.2 Prediction of DNAm Level 
Assume the following variables in addition to those specified above: 
 
𝑊 = matrix of the number of reference alleles for each SNP and sample 
𝑁 = total number of SNPs 
𝑢 = vector  of SNP effects 
𝜎!! = variance of SNP effects 
 
Then the mixed model and REML framework (Equation 5) can be utilized to obtain 
individual SNP effects within the genomic region of interest for a given fold of 
samples (Equation 8). In this case the total genetic effect of a sample within the fold 
is a function of the individual SNP effects and the alleles the sample carries at the 
SNPs.  
Equation 8 







Once the effects of SNP within a fold of samples have been estimated they can be 
used to predict the phenotype of samples outwith the fold (Equation 9). The 
predicted phenotype is a product of the SNP effects estimated within the fold and the 





2.3.1 Validation of the Accuracy of Regional 
Heritability Estimates 
We designed simulation experiments to determine if we could accurately detect 
heritability within our dataset that is a homogeneous population sample of up to 129 
unrelated individuals (where sample size depends on BR) of European Ancestry.  
All our models were based on using non-causal array SNPs to calculate the GRM for 
individuals within our dataset. Overall, we examined a total of four different general 
models, the difference between each being the localization of the causal variation and 
the genomic division used for calculation of the GRM. The four general models were 
1) genome-wide causal variations and a genome-wide GRM, 2) causal variations +/- 
1MB region surrounding a DNAm site  (ℎ!!) and a genome-wide GRM (ℎ!!), 3) 
causal variations +/- 1MB region surrounding a DNAm site and a GRM constructed 
from all SNPs outwith the 2MB region containing the causal variations (ℎ!,!"#$%!  
trans) and 4) causal variations +/- 1MB region surrounding a DNAm site  and GRM 
constructed from all non-causal SNPs within the 2MB causal region (ℎ!,!"#!  cis). We 






Following model 1) we simulated 100 phenotypes from 100 causal SNPs randomly 
distributed across the genome and specifying a heritability of 0.2 and 0.9. In the 
majority of cases, the heritability estimated from genome-wide non-causal SNPs did 
not match the simulated heritability of 0.2 or 0.9 (Figure 5). Most often, the 
estimated heritability was an extreme value of less than 0.05 or greater than 0.95 
(Figure 5) and none of the heritability estimates were significant at P < 0.05. 
Following models 2), 3) and 4) we used genotype information from 200 genomic 
regions of 2MB size to simulate the effect of cis acting SNPs on DNAm level. This 
ensured that we captured different LD structures between SNPs within a 2MB region 
and this was important because lower LD between causal and tagging SNP will result 
in an under estimation of the heritability. Each of the 200 simulations can be thought 
of as a replicate experiment and I refer to them subsequently as simulation 
experiments. Additionally, we sought to simulate multiple different biologically 
plausible models that represented how SNPs may affect DNAm level. Others [2] 
have conducted a GWAS with this dataset and they have shown that on average 20 
SNPs within +/- 1MB of a DNAm site associated with level of DNAm at a DNAm 
site. From the aforementioned analysis it is not clear to what extent the SNPs within 
the +/-1MB region that were associated with DNAm level were capturing signal 
from the same causal variant and it is possible that the total number of causal variants 
is less than 20. Therefore, for each of the simulation experiments we used five 
different numbers of causal variants (20, 10, 5, 3, 1). For each simulation experiment 
the 20 causal variants were selected randomly from the genotyped SNPs within the 
2MB region and the lower number of causal variants was always a random subset of 
the next largest number of causal variants. Each of the five sets of causal variants 
was used to generate a phenotype with a known heritability following the protocol 
outlined in 2.2.5. Due to the reported wide range of SNP effects acting in cis to affect 
DNAm level [2] we specified the simulation of phenotypes based on the following 
heritabilities: 0, 0.2, 0.4 and 0.9. The results indicated that on average, for all 
numbers of causal variants, causal genetic effects simulated from SNPs within the 






6). In contrast, genome-wide or trans SNPs do not on average capture the heritability 
simulated within a 2MB region (Figure 6). Moreover, the standard errors of ℎ!,!"#!  are 
substantially smaller than of that from ℎ!,!"#$%! ,  ℎ!! (Figure 6). 
As discussed above, with our sample size only one of the four simulation models that 
we tested accurately captured the effect of the simulated causative variation. 




Figure 5 Genome-wide SNP Effects were not Captured by Genome-wide 
Tagging SNPs 










Figure 6 Heritability Estimated from Simulation Experiments  
Phenotypes were simulated from different numbers of causal SNPs (20, 10, 5, 3 and 
1) located within a 2MB region for a range of heritabilities (0.0, 0.2, 0.4, and 0.9). 
Non-causal SNPs in cis, trans, or genome-wide were used following the method 
described in 2.2.6 to obtain ℎ!,!! . The results from the simulations using the two most 
extreme numbers of causal SNPs are shown and they indicated that in comparison to 
SNPs in cis, SNPs genome-wide or in trans to the causal variation did not accurately 
or precisely capture the genetic effects. This result is reflected by a discrepancy in 
the mean estimated (black dots within boxplot) and simulated heritability and 














































































































2.3.2 Heritability of DNA Methylation Level Due to 
Local Genetic Variation 
Using the RH approach described in 2.2.6 we calculated ℎ!,!!  for +/- 1MB regions 
surrounding the DNAm sites that were autosomal and +/- 1MB of a SNP associated 
with at least one of the seven brain related disorders/diseases listed in 2.2.4. We 
found that at between 9% - 9.7% of the DNAm sites, DNAm level was significantly 
associated with the local genomic region (Table 7). Individual significant local 
genomic regions explained between 6.6% and 97.5% of the phenotypic variation at 
the associated DNAm site and average ℎ!,!!  was 0.27-0.34 (Figure 7, Table 7).  
 
 
Table 7 Regional Heritability Analysis for DNAm level  
 DNAm Sites 
Analyzed (n) 
DNAm Sites (n) 
with significant 
ℎ!,!!  
DNAm Sites (% ) 
with significant 
ℎ!,!!  
Average  ℎ!,!!  for 
Significant 
Associations 
CRBL 3049 294 9.6 0.34 
FCTX 3064 297 9.7 0.27 
PONS 3062 277 9.0 0.28 
TCTX 3065 292 9.5 0.28 















Figure 7 Significant estimates of regional heritability  




2.3.3 Evidence for Genetic Correlation of DNA 
Methylation Level Across Brain Regions 
We have obtained ℎ!,!!  for 3049 DNAm sites common to each of the four BRs. 
However, testing the association of DNAm level measured in each of the four BRs 










































The Number of DNAm Sites with Significant Associations and the 






is because tissue was extracted from the four BRs from a common set of individuals. 
However, assuming four independent experiments one would expect by chance 0.019 
of the DNAm sites to have a significant ℎ!,!!  in all four BRs at P < 0.05 
(3049*0.05*0.05*0.05*0.05). In fact, we found that ℎ!,!!  is significant for 42 of the 
DNAm sites in all four BRs (Figure 8) which is 2210 times larger than expected if 
the measurement of DNAm level in the four BRs was independent. To determine the 
extent of the similarity of the genetic effects across the BRs we investigated the 
correlation of ℎ!,!!  across the DNAm sites for the four BRs, including estimates of 
ℎ!,!!  at all levels of significance (ie. we did not discard non-significant results). The 
overall correlation was between 0.25 and 0.45 depending on the two BRs being 
compared (Table 8). 
 
Figure 8 Heritable DNAm Sites in the Four Brain Regions 
The figure shows the number of DNAm sites with a significant ℎ!,!!  across tissues as 


















Significant Association (p < 0.05) of 







Table 8 Correlations of RH Estimates across Brain Regions for the 3049 DNAm 
Sites Analysed 
 CRBL FCTX PONS TCTX 
CRBL     
FCTX 0.26    
PONS 0.19 0.34   
TCTX 0.23 0.45 0.37  
 
 
2.3.4 DNA Methylation Level can be Accurately 
Predicted From Local Genetic Variation 
DNAm level at 1826 autosomal DNAm sites that were heritable in the TCTX was 
predicted from the local SNPs using the statistical methodology outlined in 2.2.6.1. 
This analysis was conducted using the overlapping set of 314434 SNPs genotyped 
for a control dataset for Parkinson’s disease. The set of overlapping SNPs were used 
to facilitate additional analysis that was then conducted by others. Samples used to 
obtain the SNP effects were not used to predict the phenotype and we conducted five 
fold cross validation, with each fold containing 25 samples. Four of the five folds 
(n=100) were used to estimate the SNP effects and one fold (n=25) was then used to 
obtain a prediction of the phenotype. The correlation of the predicted and observed 
phenotype was computed. We used the residual phenotype on the M-value scale to 
estimate SNP effects; therefore, we compared the predicted phenotype to the residual 
phenotype on the M-value scale. The process was repeated so that a correlation of the 
predicted and observed phenotypes was obtained for each of the five folds. The mean 
accuracy for a DNAm site was calculated as the average of the five correlations, one 
from each fold. To facilitate across trait comparison the mean accuracy was 
normalized by dividing by the theoretical upper limit, which is the square root of 






-0.0012 and 1.115 with a mean of 0.5409 and approximated a normal distribution 
(Shapiro-Wilk normality test; P-value for the deviation from normality = 0.2402). 
Moreover, the accuracy scaled with the theoretical upper limit (Figure 9). We 
calculated the standard error of the sample variance for each DNAm site using the 
conventional variance among means formula [81] using the accuracy obtained within 
each of five folds. We found that the resulting mean accuracy below zero and greater 
than one, for one and three DNAm sites respectively fell within two standard errors 
of the boundary (0 or 1). Therefore, the mean accuracies below zero and greater than 
one were consistent with sampling variation.  Additionally, we found that the number 
of SNPs used to capture the regional effects did not explain a substantial proportion 
of the variance in the estimates of the normalized accuracy (r2 = 0.0580).  
 
 
Figure 9 Accuracy of Five Fold Cross Validations 









2.3.5 Regional Genetic Variation Affects both Fluid 
Intelligence and Local DNA Methylation 
Levels 
Rowe et al. (unpublished at the time of this research) used the RH approach to test 
the association of overlapping genomic regions with measurements of cognitive 
ability. Fluid intelligence (FI) is a measure of the ability to solve novel problems 
through reasoning and it can be thought of as on the spot thinking [82]. Rowe et al. 
(unpublished at the time of this research) found that the genomic region most 
significantly associated with FI spanned Chromosome 5 at 126711782-127335370 
(ℎ!,!! = 0.02, SE = 0.009). We refer to the dataset used for the aforementioned 
analysis as the FI dataset. The FI dataset contained genotypic information and a 
measurement of FI for 1804 samples. Collaborating with Rowe et al. we investigated 
if heritable variation in the level of DNAm or gene expression within Chromosome 5 
126711782-127335370 and measured in brain tissue could affect FI. 
To this end we followed a three-step process. Firstly, we identified a set of 86 SNPs 
common to both the FI dataset and brain dataset and located within Chromosome 5 
126711782-127335370. We used these SNPs to obtain ℎ!,!!  for  
DNAm sites and gene expression probes within Chromosome 5 126711782-
127335370 and measured in the CRBL, FCTX, PONS or TCTX. Subsequently, we 
identified the CPs with a significant ℎ!,!!  because it is only reasonable to predict a 
phenotype from the genotype if evidence suggests that the phenotype is indeed a 
function of the genotype. Secondly, following 2.2.6.2 in the brain dataset the 
individual effects of the 86 SNPs on the heritable CPs were determined. Thirdly, 
following we 2.2.6.2 used the estimated SNP effects to predict the CPs in the FI 
dataset using the FI genotypes.  
 
In the brain dataset, two DNAm sites, cg04431054 and cg15851800 and two mRNA 






Chromosome 5 (Table 9). Cg04431054 and cg15851800 are located 381 basepairs 
apart, 277 basepairs upstream and 104 basepairs downstream of the 5` start of 
PRRC1 that spans chromosome 5 at basepair location 126,853,301-126,890,781 
(which is encoded on the forward strand). ILMN_1685140 is designed to target 





Table 9 Cellular Phenotypes Located in a Genomic Region Associated with 
Fluid Intelligence 
The cellular phenotype (DNAm site or mRNA probe) is listed by the Illumina 
identification and the location is given in the format of chromosome then basepair 
position in genome build 37. 









The estimates, ℎ!,!!  were obtained for cg04431054, cg15851800, ILMN_1652306 
and ILMN_1685140 for measurements of DNAm level from each of the four BRs, 
except for ILMN_1652306, which did not pass the quality control procedure for the 
CRBL.  
 
We found that the region on chromosome 5:126711782-127335370 explained a 






each of the four BR (Table 10). The estimated heritability and standard error of 
cg04431054 measured in the CRBL, FCTX, PONS and TCTX was 0.463 se 0.124, 
0.237 se 0.104, 0.278 se 0.111 and 0.326 se 0.110 respectively (Table 10). However, 
phenotypic variation in cg15851800, ILMN_1652306 or ILMN_1685140 was not 
significantly associated with genetic variation at chromosome 5:126711782-
127335370 (Table 10).  
 
 
Table 10 Heritability of Cellular Phenotypes Located in a Genomic Region 
Associated with Fluid Intelligence 
The ℎ!,!! for each of the DNAm sites and gene expression probes analysed 
Cellular Phenotype Tissue ℎ!,!!  P 
cg04431054 CRBL 0.463 1.370*10-8 
cg15851800 CRBL 0.000 0.500 
cg04431054 FCTX 0.237 1.190*10-5 
cg15851800 FCTX 0.020 0.325 
cg04431054 PONS 0.278 1.270*10 -5 
cg15851800 PONS 0.003 0.477 
cg04431054 TCTX 0.326 1.020*10-8 
cg15851800 TCTX 0.082 0.063 
ILMN_1685140 CRBL 0.025 0.315 
ILMN_1652306 FCTX 0.000 0.500 
ILMN_1685140 FCTX 0.000 0.500 
ILMN_1652306 PONS 0.000 0.500 
ILMN_1685140 PONS 0.046 0.075 
ILMN_1652306 TCTX 0.000 0.500 








Subsequently, we estimated the individual SNP effects on cg04431054 in the four 
BRs and predicted the DNAm level in the FI dataset. The predicted DNAm level for 
the TCTX was significantly associated with FI and explained 0.5% of the variation in 
FI (Table 11). The regression coefficient was positive (0.295, se =0.004) indicating 
that an increase in DNAm level was associated with increase in FI. A significant 
association between predicted DNAm level in the other three BR and FI was not 
observed (Table 11) 
 
 
Table 11 Association of Predicted cg04431054 with Fluid Intelligence. 
Tissue indicates the region of brain in which DNAm at cg04431054 was measured. 
Tp is the significance of the association of predicted DNAm level with FI and r2 is 
the proportion of the variance in FI explained by predicted DNAm level.  
Tissue Tp r2 
CRBL 0.779 0 
FCTX 0.092 0 
PONS 0.861 0 




Using simulation experiments, we have shown that effects of causative variation 
within a 2MB region can be accurately and simultaneously captured using tagging 
variation within the same genomic region. This result was true for different 
heritabilities simulated from different numbers of causative SNPs. The most likely 
explanation for this result is that the tagging variation was in sufficient LD with the 






contrast, in our simulation experiments we found that variation in trans with the 
causative variation, or genome-wide variation could not robustly capture causative 
effects within a 2MB region. The trans SNPs were outwith the 2MB causative region 
and thus it is likely that they were not in LD with the causative variation, which 
results in the inability of the trans variation to capture the causative SNP effects. 
Although genome-wide variation spans the causative 2MB region, the majority of the 
genome-wide variation was outwith the causative 2MB region. In this case it is likely 
that SNPs extraneous to the causative region that were not in LD with the causative 
variation added noise to the estimate of the effects accurately captured within the 
causative region. A similar phenomenon is likely to be occurring when we 
unsuccessfully attempted to capture the effects of 100 causative SNP distributed 
across the genome with genome-wide variation. In this last case, the 100 causative 
SNPs were used to simulate a heritability of either 0.2 or 0.9. A simulated heritability 
of 0.9 allowed for some of the (simulated) causative SNPs to have an effect within 
the range exhibited by discovered trans acting effects on DNAm level (r2 of 0.19-
0.78) [2]. Since we could not detect simulated causative genome-wide effects that 
were similar to (non-simulated) true causative genome-wide effects detected by 
others [2], it was unlikely that we could detect true causative genome-wide effects in 
our dataset. Therefore, in our analyses we fitted only a regional variance component, 
which is unlike some other studies using RH analyses [64,65]. These other studies 
[64,65] have fitted both the effects of regional and genome-wide variation using two 
variance components. Therefore, our estimates for the effect of local genetic 
variation on DNAm level were relative to a null model of no effect of local genetic 
variation on DNAm. In studies fitting both a regional and genome-wide variance 
component [64,65] the regional genetic effects on a trait can be compared against a 
null model of the genome-wide effects. The implication for our study is that we did 
not have an estimate of the background genetic effects on DNAm level to which we 
could compare the estimate of local genetic effects.  
We have shown that genetic variation in risk regions for brain related 






DNAm site in non-diseased brain tissue. Additionally, we have produced estimates 
of the heritability that simultaneously captured the effects of genetic variation +/-
1MB of a DNAm site on DNAm level at the DNAm site. Our results indicated that it 
is possible that genetic variation may lead to disease by first influencing variation in 
DNAm level in a tissue related to disease.  
During the undertaking of this research a paper was published [83] which utilized the 
brain dataset and the methodological framework outlined in 2.2.6 to obtain ℎ!,!!  for 
individual DNAm sites. While this study [83] was similar to our own and fit one 
variance component, it differed in that ℎ!,!!  was obtained for a 50KB window centred 
on a DNAm site. Additionally, DNAm sites genome-wide were analysed rather than 
those selected for location within a risk region for a brain related disorder. Moreover, 
we cannot directly compare the number of significant associations ourselves and the 
authors [83] obtained because we both used different significance thresholds. 
However, generally, both our study and that of Quon et al.[83] were in accordance, 
which highlights the utility of the RH approach to estimate the effects of local 
genetic variation on DNAm level. Despite the difficulties in comparing the exact 
results across our study and that from Quon et al. [83] (as described in the paragraph 
above) several similar trends emerged. Both Quon et al. [83] and ourselves found 
that the percentage of heritable DNAm sites was similar for all four BRs. Quon et al. 
[83] found that 3.0%, 3.1%, 2.9%, and 3.9% of DNAm sites were heritable for the 
CRBL, FCTX, PONS and TCTX respectively while we found that 9.6%, 9.7%, 9.0% 
and 9.5% of DNAm sites were heritable for the CRBL, FCTX, PONS and TCTX 
respectively (Table 7). Additionally, the modal ℎ!,!!  provided by Quon et al. [83] for 
all DNAm sites deemed significantly heritable was ~0.2, which is similar to our 
finding (Figure 7). Quon et al. [83] also examined the correlation between ℎ!,!!  across 
the four BRs. The results the authors [83] obtained were in accordance with our own. 
The TCTX and FCTX were the most highly correlated with respect to ℎ!,!!  and ℎ!,!!  
from the CRBL were least correlated with the other three BRs. There are several 






different for the different BRs. Power can be affected by the sample size and the 
sample size is different for each of the BRs. The standard error of the RH estimate 
will be greater for a smaller sample size and smaller for a larger sample size. In turn 
the magnitude of the correlation between the genetic effects across two BRs could be 
related to the standard error of the RH estimates. Indeed, we found that the two BRs 
with the greatest number of samples had the highest correlation of genetic effects. 
Additionally, the two BRs with the lowest number of samples had the lowest 
correlation of genetic effects. In fact, generally the correlation of genetic effects 
decreased as the number of samples within the two BRs being compared decreased. 
Secondly, the result could be explained by an increase in shared regulatory control of 
the TCTX and FCTX compared to that between the CRBL and the other three BRs. 
For example, genes not expressed in a tissue can be associated with densely packed 
chromatin and extensive DNAm at the promoter region making them inaccessible to 
the transcription machinery [84]. In this case the genes are tightly regulated so that 
they are not expressed and no association between DNAm level at the gene and local 
genetic variation will be observed. However, if the gene is expressed the chromatin 
structure is open to facilitate transcription and in this case local genetic variation has 
an opportunity to affect DNAm level. Given that the majority of SNPs would be 
shared across BRs, an increase in shared open chromatin regions between two BRs 
would lead to an increase in the potential for genetic variation to affect DNAm level 
in both BRs. It is conceivable that the TCTX and FCTX share more open chromatin 
regions than the CRBL does with the other three BRs.   
Finally, we have shown that with 100 unrelated individuals the effects of local SNPs 
on DNAm level can be estimated and used to accurately predict the DNAm level of 
the DNAm site in a separate population sample. Although we conducted our cross 
validations using DNAm level as the phenotype we expect the result to hold for other 
phenotypes that have similar genetic architecture, such as gene expression level. An 
implication of this result is that DNAm level, and possibly other CPs, can be imputed 
into currently available GWAS datasets which contain genotype data and data related 






SNP effects on DNAm level in non-diseased individuals) can be tested for 
association with the disease. A significant association obtained could suggest a 
causal role for the DNAm site in the aetiology of the disease. This is because the 
phenotypic variation in DNAm level at the DNAm site was present before the onset 
of disease. We have used this ideology and shown that phenotypic variation in 
DNAm level at cg04431054 measured in the TCTX was associated with FI [1]. As 
cg04431054 is located 277 basepairs upstream of PRRC1, it is also possible that 
gene expression of PRRC1 in TCTX could affect FI.  
2.5 Contributions 
Konrad Rawlik provided a script to conduct the quality control of the mRNA data 
and provided the information in 2.2.1.3 outlining the procedure.  
Suzanne Rowe and colleagues [1] provided the information that the region on 
chromosome 5 was associated with FI and the FI dataset. 
Gibbs et al. [2], the Division of Aging Biology, the Division of Geriatrics and 
Clinical Gerontology (NIA) were responsible for collection and initial research on 
the brain dataset. The brain dataset was downloaded from the NCBI Data 
Repositories dbGaP (Accession Number: phs000249.v1.p1) and GEO (GSE15745). 












Chapter 3 Investigation of Trans 
Regulation of DNA Methylation 
Level 
3.1 Introduction 
Genetic variation is associated with DNAm level at some DNAm sites across the 
genome [2,54-62,83]. GWASs, have tested the effect of SNPs with DNAm level at 
individual DNAm sites. These studies have revealed a substantial number of 
associations between SNP and a local DNAm site [2,54,55,61].   
In practice, for hypothesis free GWASs, long-range genetic effects on DNAm level 
are particularly challenging to detect. The increased number of association analyses 
needed to test SNPs genome-wide compared to test only SNPs local to a DNAm site 
requires an increased significance threshold. Assuming a given spectrum of SNP 
effects, an increased significance threshold will lead to a reduction in the proportion 
of significant associations. Therefore, in comparison to a cis analysis, a trans 
analysis will suffer from lower power to discover SNP associations.  
Despite the lower power of a trans analysis compared to a cis analysis, GWASs have 
detected some long range effects on DNAm level [2,54,55] (Table 4). In addition, a 
GWAS showed an enrichment of observed trans acting effects on DNAm level 
beyond chance expectation. This result was visible as inflation above the 1:1 line in a 
uniform qqplot of genome-wide SNP effects on DNAm level at individual DNAm 
sites across the genome [55]. Taken together, GWASs provide evidence that some 
SNPs associate with DNAm level in trans.  
There are numerous mechanisms by which genetic variation could affect DNAm 
level in trans. An example is that genetic variation affects the quality of local gene 






This has been observed for mutations within genes that play a major role in 
facilitating DNA methylation, such as DNMTs [85,86] and the enzyme, 
Methylenetetrahydrofolate reductase (MTHFR) [87], which is involved with 
synthesizing methyl donors (Table 12). Genetic variation within a gene that may 
interact with DNMTs has also been associated with changes in global DNAm levels. 
Rs10876043 within DIP2B was associated with the first principal component of the 
autosomal DNAm levels [55]. DIP2B contains a DMAP1 domain, DMAP1 has been 
found to form a complex with DMNT1 and the chromatin-modifying enzyme: 
HDAC (reviewed in [88]). Therefore, it seems plausible that variation in DIP2B 
could affect the enzymatic activity of the DMNT1 complex and global DNAm level. 
Additionally, genetic variation could affect DNAm level in trans in a subtler manner 
than by decreasing the enzymatic function of genes that interact with or are 
themselves responsible for ensuring faithful conservation of DNAm. In this case, 
given the complex interaction between gene expression and epigenetic modifications, 
there are in theory multiple scenarios whereby genetic variation perturbing one 
variable in cis could lead to distal changes in DNAm level. Knowledge of genetic 
variation acting in trans to influence DNAm level is a step towards unravelling 1) 
long-range interactions, 2) the interplay between genetic variation, epigenetic 
modifications and gene expression, and 3) regulatory networks. 
In this study, we tested genetic variation across the genome with DNAm level 
measured in the CRBL. Following on from our previous study, Chapter 2, we used 
the RH approach [64] to test the association of 2MB genomic regions across the 
genome with DNAm level at individual DNAm sites. We conducted this analysis for 
a subset of DNAm sites located in a locus associated with a brain related 
disorder/disease (see 2.2.4). In the majority of cases, when compared to a GWAS, 
the RH approach is thought to be a more powerful approach for detecting genetic 
effects (see 2.1). The increased power of the RH approach is thought to come from 
two main sources. Firstly, the RH approach can capture the combined effect of 






GWAS approach using the RH approach reduces the number of statistical tests. This 
leads to a reduction of the stringency of the multiple testing threshold.  
 
 
Table 12 SNP with Distal and Widespread Effects on DNAm Level 
The table indicates SNP(s) within genes that play a major role in facilitating DNA 
methylation. The SNP(s) within these genes are associated with distal and 
widespread effects on DNAm level. 
Gene  Position of SNP Frequency of 
SNP 



















satellite repeats  
[85] 
DNMT3L  Arginine to 
glutamine 
substitution in 
exon 10 within C-


















methyl donors  
Hypomethylation 










3.2 Materials and Methods 
3.2.1 Defining 2MB Genomic Regions Across the 
Genome for Association with DNAm Level 
We defined 2MB regions across the genome to test for the association with 3049 
DNAm sites that were measured in the CRBL and located within a locus associated 
with a brain related disorder/disease (see 2.2.4). To segment the genome, the length 
of each chromosome was downloaded from the UCSC Genome Browser Database 
[89]. Due to the substantial number of statistical tests to be performed and in order to 
minimize our multiple testing correction threshold, we excluded genomic regions 
where there may have been reduced power to detect an association between the 
genomic region and DNAm level. To this end genomic regions with minimal genetic 
variants were excluded, these regions were those that covered the centromeres or 
contained a low number of SNPs.  Centromeric regions were omitted because these 
regions contain satellite repeats that have not been well characterized in genome 
assemblies; therefore, these regions were unlikely to be represented by many SNPs 
on the array (reviewed in [90]). To define the 2MB regions, each chromosome was 
divided into 2MB regions from the start of the chromosome until the centromere and 
from the centromere until the end of the chromosome. A total of 56 2MB genomic 
regions were removed because they contained 0 SNPs. An additional count of 2, 2, 
and 1 genomic regions were removed because they contained 2, 3 and 6 SNPs 
respectively. This is because given the average extent of LD in the human genome 
[91] it was likely that the sparse SNPs in these regions would insufficiently tag 
casual polymorphism in the 2MB region. This resulted in a total of 1310 genomic 
regions to be tested for the association with DNAm level using the RH method 
outlined in 2.2.6.1. The number of SNPs within the 1310 genomic regions ranged 






3.2.2 Fine Mapping Methylation QTL within a 2MB 
Genomic Region 
The RH approach and a single SNP association approach were used to fine map QTL 
within a 2MB region. To implement the RH approach for fine mapping, the 2MB 
genomic region was divided into smaller window sizes defined by a number of 
SNPs. We used two different window sizes, both 20 and 50 SNPs. The window sizes 
of 20 SNPs and 50SNPs were used for all windows within the 2MB region except the 
final windows, which we allowed to contain greater than the specified number of 
SNPs if necessary. Consecutive windows overlapped by one SNP so that all casual 
variation was located within a window. The RH analysis was conducted as described 
in 2.2.6.1.The single SNP association analysis was carried out in plink v1.06 [66] for 
all SNPs within the 2MB region and on the residuals of the rank transformed (Beta-
value) phenotype.  
3.2.3 Calculation of Lambda for each Genomic 
Region 
The genomic inflation factor is a measure of the average extent to which test 
statistics from a GWAS deviate from the expected null distribution of no association 
between SNPs and a trait (reviewed in [92]). As illustrated by Bell et al. [55] in the 
context of multiple phenotypes, genomic inflation can be used as a measure of the 
enrichment of true positive associations. Similar to the aforementioned concept, for 
the association of each 2MB genomic region with 3049 DNAm sites we measured 
the deviation of the P-values from the distribution expected under the hypothesis of 
no association, the uniform distribution. To calculate lambda, we transformed the P-
values to the –log10 scale and then calculated the expected quantiles from the 
uniform distribution. Subsequently, for each genomic region we applied a linear 
model to the 850 highest (-log10) P-values and calculated the regression slope. We 






distributed as a 50:50 mixture of chi-squared distributions with zero and one degrees 
of freedom [93] , which results in a P value of 0.5 when the LRT test statistic is zero. 
This truncation of observed P-values at 0.5 means they are not uniformly distributed 
between 0 and 1 as expected under the null hypothesis. Therefore, given a number of 
points from which to calculate the expected quantiles of the uniform distribution (n = 
3049), a subset of the data points, the most non-significant P-values, will be more 
significant than the expectation assuming a range from 0-1. We observed that the 
maximum number of P-values at the truncation point (P = 0.5) for a genomic region 
was 2169. Therefore, by choosing to use only the 850 (3049 – 2169 = 880 > 850) 
most significant P-values we do not let the inflation of P-values at the truncation 
point influence the calculation of lambda.  
3.2.4 Permutation Analysis to Set an Empirical 
Significance Threshold  
To determine an empirical distribution of P-values and lambda values under the null 
hypothesis of no association between regional genetic variation and DNAm level, we 
conducted 100 permutations of the phenotype data with respect to the genotype data. 
To parallel our original analyses, we conserved the phenotypic correlations among 
the observed data and the effects of the explanatory variables on the DNAm sites. To 
do this we permuted the DNAm level at all DNAm sites and the measured 
explanatory variables together for a sample. After each permutation each genomic 
region was tested for association with each of the 3049 DNAm sites using the RH 
method as outlined in 2.2.6.1. Subsequently, the empirical threshold for the 
association of a DNAm site with a genomic region was determined by selecting the 
most significant P-value from each permutation. The 95th percentile of these P-values 
was used to specify the significance threshold. In a similar manner, to determine the 
empirical threshold for lambda we used the 95th percentile of the distribution of the 






3.2.5 Investigating Gene Function  
We queried the University of Santa Cruz Table Bowser [89] with defined genome 




Table 13 Information Queried From the UCSC Table Browser 
The table indicates the fields that were queried using the UCSC Table Browser and 
explains how the fields can be interpreted.  
Field  Explanation 
Gene Symbol Gene Name 
Broad Phenotype Phenotype (Disease) associated with genetic variation within the Gene 
Disease Class Category of Broad Phenotype 
Narrow Phenotype Molecular phenotype associated with genetic variation within the Gene 
Publication  Name of report for the association of genetic variation within the Gene and 
Broad or Narrow Phenotype 
Gene Description  Gene name in full 
Kegg Entrez Kegg Pathway ID and Entrez ID for the Gene 
Event ID Reactome event ID 





3.3.1 Trans Association of Genomic Regions with 
DNAm Level 
We found no significant association between DNAm level and a genomic region at a 






P < 1.15*10-8) or at our empirical threshold determined by 100 permutation tests (P < 
1.50*10-8). Despite the lack of statistical significance we explored if there was 
biological evidence to support an association between DNAm level and a genomic 
region in trans. To do this we selected the association most likely not to result from a 
chance correlation, our most significant result, and we investigated if the result 
seemed biologically plausible. The most significant association (P = 5.39*10-6) was 
found between chr8:110100000-112099999 and the DNAm site, cg10002103, on 
chr12:46766730. Cg10002103 is located in the transcription start site of solute 
carrier family 38 member 2 (SLC38A2) which is a gene involved with amino acid 
transport. The genomic region at chr8:110100000-112099999 contained several 
genes (Figure 10).We localized the signal to a 213,665 basepair region at 10460488-
110674152 that contained three genes (Figure 11). We used the UCSC database to 
investigate the function of the three genes (3.2.5). However, we did not find an 
obvious biological role for the interaction of any of the genes with DNAm level at 


















Figure 10 Chromosome 8:110100000-112099999 
The region most significantly associated with DNAm level at a DNAm site 
(cg10002103) in trans using the RH approach. The first track (SNPS) depicts the 
location of SNPs present within our dataset and the second track depicts known 
transcripts (UCSC database). Additional tracks depict the location of common 
variation within the region, SNPs associated with clinical traits, enhancers, the 
histone modification H3K27Ac and transcription factor interactions. There are 
several genes within the region but no obvious connection between regulation of the 
















Figure 11 Fine Mapping Association Signal within Chromosome 8:110100000-
112099999 
The association of genetic variation within chr8:110100000-112099999 with 
cg10002103 at chr12:46766730. The x-axis indicates the location of the genetic 
variation tested and the y-axis the significance of the association. Three analyses are 
shown in different windows, the GWAS fitted the effect of SNPs individually whereas 
RH 20SNPs and RH 50SNPs simultaneously fitted the effects of 20 and 50 SNPs 










Table 14 Genes that Localize with Genetic Variation within Chr8110100000-
112099999 Most Strongly Associated with Cg10002103 
Genes that localize to the region of chromosome 8:110100000-112099999 that had 
the strongest signal for association with cg10002103. The gene information was 
retrieved using the UCSC table browser. There is no obvious biological connection 
between DNAm level at cg10002103 and the three genes based on their description. 
Gene  Transcribed Region Description Broad Phenotype 
PKHD1L1 110374705:110543500 Polycystic kidney and hepatic disease 
1 (autosomal recessive)-like 1 
Tobacco Use 
Disorder 
EBAG9 110551928:110577391 Estrogen receptor binding site 
associated, antigen, 9 
Early-stage breast 
cancers 
SYBU 110586404:110661132 Syntabulin (syntaxin-interacting) 






3.3.2 Inflation of Expected P-values for Association 
of DNAm Sites with a Genomic Region 
Subsequently, we tested for enrichment of associations between DNAm level at 
DNAm sites genome-wide and an individual 2MB genomic region by calculating the 
variable, lambda (see 3.2.3). We hypothesized that a genomic region with a high 
lambda could be regulating DNAm level in trans at a number of DNAm sites across 
the genome. The distribution of observed lambda ranged from 0.69 to 1.5 with a 
mean of 0.99 (Figure 12). However, an empirically determined threshold of P < 0.05 
set by 100 permutation tests revealed that the observed lambda statistics were not 
significantly different from those obtained by chance association between DNAm 








Figure 12 The Observed and Permuted Distribution of Lambda  
The “Observed” window shows the observed distribution (n=1310) of lambda 
values. The highest lambda value from each of the 100 permutations is plotted in the 
window labelled “Permuted”. The dashed line shows the 0.05 threshold at Lambda 
= 1.63 as determined from the 100 permutations. None of the observed values for 





We did not find evidence to support the hypothesis that DNAm level is regulated by 
distal genetic variation. This hypothesis was tested using two different significance 
thresholds, firstly by applying a Bonferroni correction and secondly, by an empirical 
threshold determined by permutation. We used the Bonferroni method to adjust for 
the number of DNAm sites and genomic regions tested; however, we anticipated that 
this threshold would not account for phenotypic correlation among the DNAm sites. 






Bonferroni method that the statistical tests are independent. A Bonferroni threshold 
that assumes more tests were independent than the reality would be conservative. 
DNAm sites could be phenotypically correlated if they were regulated in a similar 
manner and DNAm sites up to 1KB exhibit similar profiles of DNAm level [27]. 
Given that the analysed DNAm sites were chosen based on location within defined 
genomic regions, risk regions for a brain related disorder/disease (see 2.2.4), it 
seemed plausible that some of the DNAm sites could be phenotypically correlated. 
Therefore, we permutated the labels of the phenotypic data maintaining the 
correlation structure among the DNAm sites. The significance threshold set from the 
permutation analyses accounted for the phenotypic correlation among the DNAm 
sites. The fact that the empirical threshold was only marginally more liberal than the 
Bonferroni threshold (P < 1.50*10-8 and P < 1.15*10-8 respectively) suggested that 
the phenotypic correlation among the DNAm sites was minimal and that in the 
majority of cases the statistical tests were independent.  
Our result of no association between DNAm level and genetic variants in trans 
contrasts the significant trans acting associations found by previous authors’ [2] 
using the same dataset and a GWAS approach. A direct comparison between our 
study and that of Gibbs et al. [2] based on the probability of test statistics is 
challenging given the use of  a different statistical methodology and significance 
threshold. Furthermore, we note that we have used only a small subset (~11%) of the 
total number of DNAm sites analysed by Gibbs et al. [2]. The DNAm sites we chose 
to analyse were enriched for location near genetic variation that confers risk to a 
brain related diosorder/disease and as we showed in 2.3.2 for significant cis ℎ!,!! . If 
indeed the subset of DNAm sites we analyzed were regulated by local genetic 
variation then it is not wholly unsurprising that distal effects were small and went 
undetected. This is because the heritability cannot exceed one. Therefore, 
partitioning the heritability into cis and trans acting genetic effects necessitates that 






We did not find any evidence that indicated that a genomic region regulated DNAm 
level at a number of DNAm sites across the genome. Lambda calculated from our 
observed data was distributed around that expected. Initially, this was an encouraging 
result as it suggested that a proportion of the genomic regions exhibited enrichment 
for association with DNAm level. In conjunction, this conformed to our biological 
hypothesis that only a minority and not all genomic regions could act as trans 
regulatory hubs for DNAm level. However, permutation experiments revealed that 
the observed lambda likely resulted from spurious association between DNAm level 
and the genetic variation within a genomic region.  
 
3.5 Contributions 
Gibbs et al. [2], the Division of Aging Biology, the Division of Geriatrics and 
Clinical Gerontology (NIA) were responsible for collection and initial research on 
the brain dataset. The brain dataset was downloaded from the NCBI Data 
Repositories dbGaP (Accession Number: phs000249.v1.p1) and GEO (GSE15745). 













Chapter 4 The Heritability and Patterns of 
DNA Methylation in Normal 
Human Colorectum 
4.1 Introduction 
Studies have shown that DNAm level is linked to gene expression level [30,31]. At 
promoter regions, within a population of individuals average DNAm level and 
average gene expression level of an associated gene were negatively correlated 
across genes [30]. Additionally, DNAm level has been found to associate with sex 
and age [31,59,94] and several environmental factors including early life 
socioeconomic status and stress [31].  Furthermore, results from GWASs and twin 
studies indicate that the genotype can affect level of DNAm [2,54-58] (Table 3, 
Table 4) and that cis acting genetic variation can explain a substantial proportion of 
the phenotypic variation for some DNAm sites [2,54,55].  
 
Recently, studies have indicated that the extent to which genetic variation affects 
variation in DNAm level may differ within tissue depending on the functional 
genomic context of the DNAm sites. In peripheral blood lymphocytes ℎ!"#!  of 
DNAm level for DNAm sites located in high and low CpG density regions of the 
genome was assessed [58]. This study revealed that estimates in regions of high CpG 
density were on average 0.127 or 0.158, whereas in regions of low CpG density 
estimates were greater, on average 0.235 or 0.223, depending on which probe type 
(Infinium I or Infinium II) was used to assay DNAm level. In human brain tissue, RH 
analysis revealed an increased proportion of heritable DNAm sites in regions of the 
genome with low CpG density compared to high CpG density [83]. In addition, a 
decreased proportion of heritable DNAm sites local to genes upregulated in a tissue 






observed [83]. While the aforementioned studies have begun to explore the extent of 
heritability for DNAm sites located in different genomic contexts they have been 
conducted in a minority of tissues and have considered a limited selection of 
functional subgroups for DNAm sites. 
To build on the work of others who have investigated the control of DNAm in 
different genomic contexts, we assayed 196081 DNAm sites with the HM450K in 
healthy colorectum tissue collected from 132 unrelated Colombian subjects who 
attended Colonoscopy examination and with diagnosis of hyperplasic polyp, 
adenoma or carcinoma. We grouped the DNAm sites based on location in relation to 
CpG density, expression status and functional regions of genes. We refer to these 
groups collectively as contextual groups. Within each contextual group we assessed 
the profile of DNAm level calculated across all the 132 samples at individual DNAm 
sites. We estimated the combined effect of local genetic variation +/ 1MB of a 
DNAm site on DNAm level at the DNAm site using the RH approach (see 2.2.6.1). 
We also studied the phenotypic profiles and  ℎ!,!!  for DNAm level of genes expressed 
in epithelial cells obtained from laser capture microdissection (LCM) and whole 
colon biopsy (WCB). In addition we contrasted the distribution of ℎ!,!!  for DNAm 
sites within and outwith known susceptibility loci for Colorectal Cancer (CRC, 
OMIM #114500).  
4.2 Methods 
4.2.1 Ethical Approval 
The study had ethical approval from the Ethics Board of The National Cancer 
Institute of Colombia and from The ethics committee of the General University 






4.2.2 Phenotype QC 
Within each colorectal tissue sample the two intensity values that correspond to the 
number of methylated and unmethylated copies of a DNAm were corrected for any 
variation that arose from non-specific binding. This background correction was 
applied by subtracting the median fluorescence measured by the control probes from 
the intensity values treating intensities measured in the two colour channels 
separately and using the Bioconductor package, ‘lumi’ [95]. Subsequently, samples 
for which the assaying process failed were identified as those with a low average 
intensity value (below 2500) measured in either or both of the colour channels and 
were removed. We examined the percentage of probes that were not detected above 
background levels of variation (P = 0.01) for each sample and found that no samples 
exceeded our threshold of 5% for exclusion. Samples where the recorded sex of the 
individual did not match the sex estimated from the levels of DNAm measured on 
the X chromosome were removed. DNAm probes were removed if they contained a 
SNP within the target sequence or at the site of single base extension or if they were 
cross-reactive [96]. Additionally, probes were removed if they were not detected 
above background levels of variation for greater than 5% of samples (P<0.01). Out of 
144 samples and 486428 autosomal probes this procedure resulted in 132 samples 
and 196081 autosomal DNAm probes left for downstream analysis. Colour bias was 
taken into account by comparing for all samples the within sample distribution of 
total intensities measured by the type I probes in the green channel to those measured 
in the red channel. A quantile normalization adjustment was applied within the 
Bioconductor package, ‘lumi’ [95], so that the intensity values measured in the two 
colour channels followed a similar distribution across and within individuals. We 
also applied a correction to account for technical variation due to the probe design 
type using the BMIQ algorithm [97].  
 
We conducted analyses and reported levels of DNAm using the M-value scale. This 
scale reduces the dependence between the variance and mean of site-specific DNAm 






of the Beta-values and an M-value of 0 equates to a 50% level of DNAm whereas a 
positive and a negative M-value relates to a greater and less than 50% DNAm level 
respectively. 
4.2.3 Genotype QC 
We followed a standard quality control procedure (reviewed in [68]) using Plink [66] 
and genotype data obtained from the Illumina HumanOmniExpress Exome Chip. 
Samples for which greater than 5% of SNPs did not genotype were excluded.  Based 
on the application of three successive filters, SNPs were removed if 1) they failed to 
type in greater than 5% of samples or 2) if they were out of Hardy Weinberg 
Equilibrium (P<0.0001) or 3) if they had a MAF less than 0.01. Additionally, the 
HBD for each sample was calculated from SNPs along the X chromosome and the 
estimate was checked against the recorded sex to identify samples to remove because 
of a discrepancy between the recorded and observed identity. Out of an initial 464 
samples and 944534 SNPs, 451 samples and 682945 remained for downstream 
analysis.  
4.2.4 Testing the Effect of Explanatory Variables on 
DNAm Level 
The explanatory variables sex and age were included in all subsequent analyses 
because they have previously been found to associate with level of DNAm 
[31,59,94]. The 132 samples with quality genotype and phenotype information 
consisted of 65 females and 67 males. The samples ranged in age from 30 to 84 
years, with a mean and median age of 60 and 61 respectively.  
 
We calculated the principal components from the post quality control (autosomal) 
DNAm levels for the 132 samples with genotype and phenotype information. We 
now refer to the principal components of the DNAm levels as eigenprobes and they 
represent a measure of global covariation in DNAm level among the samples. We 






city of recruitment (6 levels), genotyping plate (16 levels) and position on the 
genotyping plate (12 levels), to determine if they could explain a significant 
proportion of the variance in the first 20 eigenprobes. In the majority of cases these 
explanatory variables were not found to significantly correlate with global patterns of 
DNAm level as measured by the eigenprobes (Table 15). This result and the fact that 
fitting these explanatory variables would lead to a substantial loss of degrees of 




























Table 15 Association of Potential Explanatory Variables with Global DNAm 
Level 
The P-values from an ANOVA testing the variance explained by the additional 
variables on global DNAm level measured by the principal components of the DNAm 
level. Location: biological location from where the sample biopsy was taken, 
diagnosis: stage of malignancy, city: city of recruitment, plate: genotyping chip and 
position: position on the genotyping chip. Italic values indicate those tests that were 
significant at the unadjusted level (P < 0.05) and bold values indicate tests 
significant at the level adjusted for the number of tests conducted for a explanatory 
variable (P < 0.0025). 
  Explanatory Variables 
















C1 0.163 0.978 0.451 0.882 0.218 
C2 0.038 0.044 0.277 0.346 0.030 
C3 0.388 0.891 0.568 0.688 0.552 
C4 0.678 0.429 0.231 0.607 <0.001 
C5 0.049 0.215 0.837 0.863 0.053 
C6 <0.001 <0.001 0.100 0.125 0.006 
C7 0.012 0.748 0.483 0.324 0.113 
C8 0.047 0.002 0.810 0.463 0.621 
C9 0.829 0.712 0.014 0.676 0.190 
C10 0.031 0.006 0.706 <0.001 0.857 
C11 0.048 0.067 0.899 0.072 0.731 
C12 0.301 0.764 0.534 0.272 0.268 
C13 0.791 0.815 0.782 0.120 0.377 
C14 0.760 0.475 0.561 0.900 0.043 
C15 0.407 0.191 0.168 0.157 0.173 
C16 0.758 0.668 0.316 0.739 0.692 
C17 0.359 0.940 0.286 0.401 0.011 
C18 0.181 0.985 0.783 0.236 0.507 
C19 0.234 0.299 0.804 0.759 0.817 











We tested if population admixture, quantified by the genotypic principal 
components, had a significant relationship with the variation in global DNAm levels 
as measured by the eigenprobes. The genotypic principal components for 132 
samples and 343838 autosomal SNPs pruned for linkage disequilibrium (one of a 
pair of adjacent SNPs are removed if r2 > 0.5 in a window of 50 SNPs, the window 
being shifted 5bp along and the process repeated; see plink --indep-pairwise) were 
calculated.  We assessed if the proportion of variance in the eigenprobes explained 
by the genotypic PC was significant by comparison of each of three different full 
models (Equation 10) to one reduced model (Equation 11) for each of the first twenty 
eigenprobes. The three full models (Equation 10) differed only in the number of 
genotypic principal components included either 2,10 or 20 (n). In both the full and 





Our analysis revealed that neither of the three formulations of the genotypic PC 
explained a significant proportion of the variation in global DNAm levels (Table 16). 
Additionally, we found that if we included the first two principal components the 
estimates of RH obtained were highly similar to those obtained when the two 
genotype principal components were not included (r = 0.965, slope of the regression 
line = 0.992 for y = RH estimate without PC included and x = RH estimate with PC 




















Table 16 Association of Genotype Principal Components with Variation in 
Global DNAm Level 
Three combinations of genotypic principal components were tested for association 
with each of the first 20 DNAm principal components (eigenprobes). For instance, 
PC1:2 indicates that the first 2 genotype principal components were tested for 
association with each of the first 20 DNAm principal components, denoted by C1 
through C20. The value in each cell is the P-value from the significance test. Values 
in italic indicate those which were significant at the unadjusted threshold (P < 0.05). 
Values in bold indicate a test was significant at a threshold adjusted for the number 
of tests conducted a genotype principal component combination (P < 0.0025). 
  Genotype Principal Components 
















C1 0.185 0.202 0.595 
C2 0.601 0.993 0.940 
C3 0.918 0.605 0.756 
C4 0.014 0.003 0.054 
C5 0.701 0.006 0.001 
C6 0.141 0.071 0.247 
C7 0.485 0.273 0.711 
C8 0.036 0.063 0.064 
C9 0.515 0.878 0.988 
C10 0.864 0.994 0.998 
C11 0.267 0.728 0.929 
C12 0.679 0.965 0.978 
C13 0.645 0.509 0.833 
C14 0.937 0.013 0.023 
C15 0.282 0.003 0.001 
C16 0.278 0.004 0.045 
C17 0.010 <0.001 <0.001 
C18 0.709 0.024 0.045 
C19 0.976 0.211 0.033 








4.2.5 Identification of Genes Expressed in Colon 
Tissue 
Genes expressed in general colon tissue and specifically in colon epithelial cells were 
identified based on the analysis of normal tissue from biopsies of 12 people 
undergoing colonoscopic examination at General University Hospital of Elche 
(Spain). In order to separate epithelial specific expression, tissue samples were sliced 
with alternate slices assigned to the whole tissue and epithelial conditions. In the 
whole tissue condition combined slices for each individual were assayed for gene 
expression. In the epithelial condition we pooled epithelial cells, isolated using Laser 
Capture Microdisection (MMI CellCutPlus), from each slice for each individual and 
mRNA from the slices was amplified prior to being assayed for gene expression. The 
gene expression assay on the 24 samples was performed using the HumanHT-12 
Expression BeadChip. Quality control indicated failure of four samples (one in the 
whole tissue and three in the epithelial condition) which were removed from 
subsequent analysis. We then identified for each condition mRNA probes which 
were detected above background (P<0.01) in more than 80% of samples, i.e., 9 or 
more of 11 samples and 8 or more of 9 samples for the whole tissue and epithelial 
conditions respectively. This yielded 9223 probes in the whole tissue and 4071 
probes in the epithelial conditions.  Probes were mapped to genes using the Illumina 
provided manifest file for the HumanHT-12 Expression BeadChip platform, yielding 
a list of 8114 genes expressed in general colon tissue and 3754 genes expressed in 
epithelium. As expected a majority of genes identified in the epithelial condition 
were also detected in the whole tissue which contains both the epithelial and other 
cells, with only 10 specific to the epithelial condition.  
4.2.6 Location of a DNAm site with Respect to a 
Gene 
A DNAm site was considered to be located within the transcription start site (TSS) of 






as being located within 200bp upstream of the TSS (TSS200) or, within 200-1500bp 
upstream of the TSS (TSS1500) of a gene in our list of expressed genes.  All other 
DNAm sites located within the TSS200 or TSS1500 region of a gene were 
considered as being located within the TSS of a gene not expressed in colon tissue. 
Intragenic DNAm sites were those documented in the HM450K manifest file as 
located within the 5’UTR, 1st exon, gene body or 3’UTR of a gene. Intergenic 
DNAm sites were those not documented as residing within a gene. We applied 
successive filters in the aforementioned order so that each DNAm site fit into one of 
the four mutually exclusive categories.    
4.2.7 Significance Testing of Proportions 
To test if two proportions were significantly different from one another we used the 
prop.test function in R [75]. In brief, this function assumes that the two sample sizes 
are sufficiently large so that the distribution of the first proportion minus the second 
proportion is Gaussian. We applied a two-tailed test because we did not have a prior 
expectation of the relative magnitudes of the two proportions being tested.  
4.3 Results 
4.3.1 Average DNAm Level and Relationship to 
CpG Density, Genic Location and Gene 
Expression  
In the manifest file for the HM450K array each DNAm site is annotated as being 
located either within a CpG island (island), within 2kb upstream or downstream of a 
island (north shore and south shore respectively), within 2-4kb upstream or 
downstream of an island  (north shelf and south shelf respectively) or none of the 
aforementioned categories which we term sea. An island was defined as being 
composed of one or more adjacent sections of the genome each 500bp in length with 






dinucleotides greater than 0.60 [98]. We grouped our 196081 DNAm sites based on 
aforementioned HM450K array annotation (Table 17) 
 
 
Table 17 DNAm Sites Grouped by Physical Distance from Islands 
The number of DNAm sites within each of six contextual groups defined by distance 
from CpG islands. As described in the body of the thesis, north and south shores 
encompassed up to 2KB upstream and downstream of islands respectively. Regions 
2-4KB upstream and downstream of islands were defined respectively as north and 
south shelves [98]. Sea is any DNAm site not annotated as being located within an 
island, shelf or shore in the HM450K manifest file.  
Genomic Context with 














Using DNAm level adjusted for gender and age we found a substantial difference in 
the distribution of average DNAm level across contextual groups of varying CpG 
density (Figure 13). The average DNAm level of DNAm sites in islands tended to be 
much lower than that of DNAm sites located in the sea (mean and median M-value 
was -2.67 and -3.51, and 2.01 and 1.57 for islands and sea, respectively). 
Additionally, our results showed that the distribution of average DNAm level for 
DNAm sites in the north and south shores were similar to one another and more 
similar to the distribution of average DNAm level for DNAm sites in islands rather 
than DNAm sites in the sea (Figure 13). Conversely, the distribution of average 
DNAm level for DNAm sites located in the north and south shelves were similar to 
one another and were more similar to the distribution observed for DNAm sites 






that within shores the mean DNAm level was a function of the distance from the 
edge of the island. Mean DNAm level increased with distance from the edge of the 
island in a non-linear fashion (Figure 14). However, this relationship is not observed 
for DNAm sites located within shelves (Figure 14).  
 
 
Figure 13 Distribution of Mean DNAm level with Respect to CpG Density 
Methylation level was measured on the M-value scale where a DNAm level of 0 can 
be interpreted as a 50% DNAm level. A DNAm level < 0 and a DNAm level greater 
than > 0 can be interpreted as lower and greater than 50% DNAm respectively.  The 
majority of DNAm sites in islands exhibited a low average DNAm level, whereas the 
majority of DNAm sites in low density CG regions  (sea) exhibited a high average 










Figure 14 Mean DNAm level as a Function of Distance from the Edge of the 
Island  
The 4000 BP region upstream (north) and downstream (south) of islands was divided 
into bins of 100 BP. The average of the mean DNAm levels for DNAm sites residing 
within each bin is shown as a white circle enclosed by a line indicating +/- 2 
standard errors of the mean. A shore is up to 2000 BP from an island and a shelf is 





Unless otherwise specified, the following analyses were based on the two most 
extreme cases of CpG density: high CpG density regions (islands) and low CpG 
density regions (sea). We tested if the DNAm level of DNAm sites located in the 
TSS of genes expressed in WCB was different to those located in the TSS of genes 
expressed in cells from the colon epithelium collected using LCM. The genes that 
were expressed in the LCM and the WCB were excluded from the WCB group for 
this analysis. We found that DNAm sites in the TSS of genes expressed in WCB had 
an M-value that was on average 0.16 greater than DNAm sites located in the TSS of 







Subsequently, we grouped DNAm sites located within the sea or an island into four 
mutually exclusive sets based on location a) in a transcription start site (TSS) of a 
gene expressed in WCB b) in a TSS of a gene that is not expressed in WCB c) in 
intragenic DNA, where we do not distinguish between genes expressed or not 
expressed in colon because the methylation level of intragenic DNAm sites has not 
been correlated with the expression of the surrounding gene or d) intergenic DNA 
(Table 18).  
 
 
Table 18 Count of DNAm Sites within Each of Eight Contextual Groups 
Genomic Context Island Sea 
TSS Expressed 13838 2074 
TSS Not Expressed 19051 7603 
Intragenic 31355 30108 
Intergenic 10028 17634 




Additionally, we choose to use the full set of genes expressed and not expressed in 
WCB rather than exclusively in colonic epithelial cells because DNAm level was 
assayed from WCB. We refer to each of the eight contextual groups individually as: 
island TSS expressed (within an island and a TSS of a gene expressed in colon), 
island TSS not expressed (within an island and in a TSS of a gene not expressed in 
colon), island intragenic (within an island and intragenic), island intergenic (within 
an island and intergenic), sea TSS expressed (within the sea and the TSS of a gene 
expressed in colon), sea TSS not expressed (within the sea and the TSS of a gene not 
expressed in colon), sea intragenic (within the sea and intragenic) and sea intergenic 
(within the sea and intergenic). Within each of the eight contextual groups we 






We found a significant difference in the distribution of mean DNAm level between 
island TSS expressed and island TSS not expressed (Kolmogorov-Smirnov test; 
P<2.16*10-16) and between sea TSS expressed and sea TSS not expressed 
(Kolmogorov-Smirnov test; P<2.16*10-16) (Figure 15). We compared the mean of 
the sea TSS expressed to that of the sea TSS not expressed and we compared the 
mean of the island TSS expressed to that of island TSS not expressed. These two 
comparisons were both statistically significant (T-test, P<2.16*10-16, P<2.16*10-16) 
and in both cases being located in the TSS of genes not expressed in colon led to an 
overall greater mean DNAm level. Additionally, we found that the average of the 
distribution of mean DNAm level for DNAm sites located in intragenic and 
intergenic regions was greater than for DNAm sites located in a TSS of a gene 
(Figure 16).  
 
 
Figure 15 Distribution of Mean DNAm level for Eight Contextual Groups 
There are clear differences in distribution of mean DNAm level between DNAm sites 
located in different genomic contexts, in particular between DNAm sites located in 







Figure 16 Moments of the Distributions of Mean DNAm level for Eight 
Contextual Groups  
Mean DNAm level is on average higher at DNAm sites located in the TSS of a gene 
not expressed in WCB than at DNAm sites in the TSS of a gene expressed in WCB. 
Additionally, DNAm sites located intragenically or intergenically had a higher 
Average mean DNAm level than DNAm sites located within the TSS of a gene 





To assess if the phenotypic variation was adequate for downstream RH analysis, we 
investigated the extent to which DNAm level varied across the 132 samples for the 
full set of 196081 DNAm sites that passed our quality control procedure (Figure 17). 
The coefficient of variation (CV) ranged between 0.032 and 14889. Subsequently, 
we conducted exploratory enrichment analysis for the CV both within contextual 






specified 5 different thresholds for the minimum CV (1, 1.5, 2, 2.5 and 3) to 
determine how sensitive our results were to the magnitude of the chosen threshold. 
We found that for each minimum specified CV there was enrichment for DNAm 
sites located in the sea compared to DNAm sites located in an island (Figure 18). 
Specifically and for example, at a minimum CV threshold of one, the proportion of 
DNAm sites located in the sea was 3.19 fold that of the proportion of DNAm sites 
located in an island and the difference in the two proportions was statistically 
significant (P<2.16*10-16). Additionally, at each threshold within the island location 
we found enrichment for DNAm sites located in intragenic and intergenic regions 
when compared to DNAm sites located in the TSS of a gene (Figure 19). This result 
was not found within the sea location (Figure 19). Within the island contextual 
groups and at a minimum CV of one there was a 1.60 fold enrichment of intergenic 
over intragenic DNAm sites (P<2.16*10-16), a 2.63 fold enrichment of intragenic to 
TSS Not Expressed DNAm sites (P<2.16*10-16) and a 1.18 fold enrichment of TSS 
Not Expressed to TSS Expressed DNAm sites (P = 1.50*10-15). Our analysis 
revealed that DNAm sites located in the sea were more variable than DNAm sites 
located in islands; moreover, within islands the DNAm sites within intergenic and 
intragenic regions were more variable than DNAm sites located in TSS regions and 













Figure 17 Distribution of the Coefficient of Variation 
The coefficient of variation was calculated for all DNAm sites used in analysis 
(n=196081). The x-axis is binned in 0.02 increments and is limited to a maximum 
value of 3 for aesthetic purposes. Two percent of DNAm sites have a coefficient of 




Figure 18 Enrichment Analysis for Variability of DNAm level in Islands and 
Sea 
Five different thresholds were specified to determine how sensitive the results were 
to the magnitude of the threshold. The y-axis is the proportion of DNAm sites with a 
coefficient of variation greater or equal to the specified minimum coefficient of 







Figure 19 Enrichment Analysis for Variability of DNAm level with Respect to 
Eight Genomic Contexts  
The proportion (y-axis) of DNAm sites within each genic location and island or sea 





4.3.2 Heritabilities of DNAm Level at Individual 
DNAm Sites 
We found that at 21447 DNAm sites, 10.94% of the 196081 tested, SNPs within 
1MB explained a significant proportion of the variation in DNAm level (nominal P < 
0.05). The percentage of heritable DNAm sites exceeded that expected from a false 
positive rate of 0.05 under the null hypothesis that DNAm level is not associated 
with local genetic variation. For significantly heritable loci, the proportion of the 
phenotypic variance in DNAm level under local genetic control ranged between 0.04 







Figure 20 Estimated Regional Heritability for Heritable DNAm Sites.  
The distribution of local RH estimates for the DNAm sites with a significant RH (P 





We found that the number of SNPs in the local genomic region (Figure 21) explained 
a minute but significant proportion of the variance in RH estimates for the DNAm 
sites with a significant RH (Univariate Linear Regression: R2 = 0.004, slope = 
2.17*10-5, P < 2.2*10-16). For instance, considering the range of the number of SNPs 
within a region (1 to 3037), at the first decile (304 SNPs) and ninth decile (2733 
SNPs) a respective 6.60*10-3 and 5.94*10-2 RH for the DNAm sites found to be 
significantly associated with local genetic variation is expected.   We did not find 
that the variance of DNAm level at each DNAm site, as measured by the CV, was 









Figure 21 SNPs in the Local Genomic Region. 





4.3.3 Heritability of DNAm Level at genes expressed 
in Whole Colorectal Biopsies and Colorectal 
Epithelial 
We investigated the heritability of DNAm level at genes expressed in LCM and in 
WCB excluding those expressed in LCM (Figure 22). The difference between the 
average of the distribution of mean DNAm level for the significantly heritable 
DNAm sites within the two groups was not significant (mean LCM = 0.251, mean 
WCB = 0.255, T-test P =0.638). Additionally, the proportion of significantly 
heritable DNAm sites in the LCM and WCB group was 0.0768 and 0.0770 








Figure 22 Heritabilities of DNAm Level at Genes Expressed in Whole Colorectal 
Biopsies and Colon Epithelial Cells  
DNAm sites were grouped based on the significance of the RH estimate and their 
location with respect to a gene expressed in whole colorectal biopsy or a gene 
expressed in epithelial cells by laser capture microdissection. DNAm were 
significantly heritable if P<0.05. Genes expressed in both the epithelial and whole 






4.3.4 Heritability of DNAm Level in Whole 
Colorectal Biopsies by Genomic Context 
The proportion of sites with a significant heritability was higher in the sea than in 
islands (P < 2.20*10-16, Table 19).  This result was driven by the difference between 
DNAm sites located within the TSS of a gene or in intragenic regions. The 






sea than in the TSS of an island (P < 2.2*10-16); additionally, the proportion of 
heritable DNAm sites is 1.16 times higher for DNAm sites located in the sea 
intragenic than the island intragenic contextual group (P = 7.27*10-10). There was no 
significant difference in the proportion of heritable DNAm sites located in intergenic 
regions when comparing between the sea and island contextual groups (P=0.068).  
 
The proportion of heritable DNAm sites was significantly higher for sea intergenic 
than sea intragenic (P = 3.19*10-10) and was significantly higher for sea TSS not 
expressed than sea intragenic (P = 1.11*10-3). There was no significant difference in 
the proportion of heritable DNAm sites for the remaining comparisons made within 
the sea contextual groups. The proportion of heritable DNAm sites was significantly 
different for all comparisons made within the island contextual groups.  The P-value 
was  < 2.2*10-16 for all comparisons, except the Island TSS Expressed and Island 
TSS Not Expressed comparison where the P-value was = 4.37*10-7 , and the island 
TSS expressed and island intragenic comparison where the P-value was  4.87*10-4. 
Within the island contextual groups the proportion of heritable DNAm sites was as 


















Table 19 Proportion of Heritable DNAm Sites and the Corresponding Mean RH 
Estimate 
Overall there were a higher proportion of heritable DNAm sites (P < 0.05) located 
in the sea compared to islands. Additionally, there were a higher proportion of 
heritable DNAm sites located in intergenic regions compared to regions containing a 
TSS and intragenic regions. The average RH estimates were similar across the 
contextual groups. 
 Island Sea 
 Proportion 
Heritable 
Mean ℎ!,!!  Proportion 
Heritable 
Mean ℎ!,!!  
TSS Expressed 0.070 0.250 0.121 0.263 
TSS Not Expressed 0.085 0.257 0.123 0.271 
Intragenic 0.095 0.260 0.110 0.261 
Intergenic 0.137 0.281 0.129 0.277 




The proportion of heritable DNAm sites for each contextual group followed a similar 
pattern to the mean local genetic variance for each contextual group (Figure 23). 
Across each four sea and island contextual groups the proportion of heritable DNAm 
sites was correlated with the mean local genetic variance (Pearson’s correlation: r = 











Figure 23 Mean Genetic Variance and the Proportion of Heritable DNAm Sites 
for Eight Contextual Groups.  
The x-axis represents the proportion of heritable DNAm sites (P < 0.05) within each 
contextual group and the average genetic variance for each contextual group. The 






The average ℎ!,!!  for significantly heritable DNAm sites located within each of the 
genomic contexts was similar (Table 19). DNAm sites significantly associated with 
local genomic variation and located within an island were on average 0.6% less 
heritable than DNAm sites located in the sea.  
4.3.5 Heritability of DNAm Level in Whole 
Colorectal Biopsies with Respect to Loci 
Associated with Colorectal Cancer 
An extensive number of genetic variants have been found to associate with complex 
disease including CRC [99]. However, in the majority of cases how the identified 






variation could increase risk to disease by mediating changes in DNAm level in 
healthy tissue. If an association between a susceptibility SNP and DNAm level in 
healthy tissue is obtained, one possibility is that the variation in DNAm level 
interacts with additional variables, such as environmental factors, to subsequently 
lead to disease. Therefore, we sought to determine if variation in DNAm level in 
healthy colon tissue was associated with genetic variation that incurs susceptibility to 
CRC. To this end a total of 83 unique autosomal SNPs identified as associating with 
CRC were downloaded from the NHGRI GWAS catalogue [99]. We defined a region 
of +/- 1MB surrounding each SNP associated with CRC as a risk region. A total of 
10469 DNAm sites were located within a defined risk region and due to our 
definition of a risk region the calculation of ℎ!,!!  included the effects at the position 
of the risk SNP. Indeed, we found that 10.6% of DNAm sites located within risk 
regions were heritable (P < 0.05) with an average ℎ!,!!  of 0.262. Outwith a risk 
region, 11.0% of DNAm sites were significantly heritable (P < 0.05) with an average 
ℎ!,!!  of 0.267. The proportion of DNAm sites that were significantly heritable within 
and outwith a risk region was not significantly different (P=0.27) and the average 
heritability of DNAm sites located within and outwith risk regions was similar. In 
conjunction, a recent study [100] found that DNAm levels of two DNAm sites 
measured in healthy colorectal tissue, cg15193198 and cg24112000, were associated 
(FDR < 0.05) with the local CRC risk variant rs4925386 located on chromosome 20 
at 60921044 basepairs. In our study, both cg15193198 and cg24112000 were 
significantly heritable with respective ℎ!,!!  estimates of 0.34 (P = 2.05*10-4) and 0.57 
(P = 4.14*10-12) when including rs4925386 in the calculation of the genetic 
relationships and 0.34 (P = 2.64*10-4) and 0.57 (P = 6.74*10-12) when excluding 
rs4925386. We determined that rs4925386 explained 77% and 53% of the estimate, 
ℎ!,!! , for cg15193198 and cg24112000 respectively and ℎ!,!!  was still significant for 








Table 20 Effects of rs4925386 and Local Genetic Variation on cg15193198 and 
cg24112000 
The estimate for the full model (ℎ!,!!  Full) and reduced model (ℎ!,!!  Reduced) were 
calculated from all SNPs  +/-1MB of the DNAm site excluding rs4925386. The full 
model included fitting the genotypes at rs4925386 as a fixed effect. The effect of 
rs4925386 on DNAm level is reported as the addition of a single copy of the minor 
allele, Adenine.  











cg15193198 0.075 0.211 0.333 2.64 *10-4 -0.423 0.083 




4.4 Discussion  
DNAm sites located in different genomic contexts with respect to CpG density and 
genic location exhibited unique phenotypic profiles in the human colorectum. We 
have shown that average DNAm level is related to CpG density. This result has been 
observed for DNAm level measured at promoters in peripheral blood mononuclear 
cells and fibroblasts [31,101] and concurred with that found by a recent study 
profiling DNAm level in 17 somatic tissues [102]. In addition, we found that 
specifically within shores that there is a shift in average DNAm level from 
predominantly unmethylated to methylated as distance increases from the edge of the 
CpG dense islands. This change in DNAm level is suggestive of a transitional zone at 
the edge of islands captured by the definition of shore. Overall, the lower and less 
variable average DNAm level at individual DNAm sites located in islands compared 
to sea is consistent with the traditional view that CpG dense regions of the genome 
persist due to low methylation and a reduced rate of spontaneous deamination and 






within islands we observed enrichment for DNAm sites located in TSS with low 
coefficient of variation (and conversely enrichment for intergenic and intragenic 
DNAm sites with high coefficient of variation). The low coefficient of variation and 
low level of DNAm for DNAm sites located in CpG dense regions of the genome 
and in TSS supports the idea that these DNAm sites target housekeeping genes 
[101,104]. Housekeeping genes are essential for normal cell maintenance and thus 
expression of these genes may be tightly regulated and this could be reflected by the 
low level and low variation of DNAm level at individual DNAm sites in these 
regions. Additionally, DNAm sites located in the TSS of a gene not expressed in 
WCB were on average more methylated than DNAm sites located in the TSS of a 
gene that was expressed in WCB. This result is suggestive of an overall inverse 
correlation between mean gene expression and mean DNAm level. Finally, our 
examination of the relationship of DNAm level with genic location revealed that 
DNAm level was lower in the TSS than within intergenic or intragenic regions. This 
result concurred with what has been observed in H1 embyronic cells where DNAm 
level has been shown to decrease between the promoter and 5’UTR region before 
increasing through the gene body and into the 3’UTR [26]. The level of DNAm has 
also been shown to be greater in intragenic and intergenic regions compared to 
promoter regions in human brain frontal cortex grey matter [105].  
 
We have assessed, on a genome-wide scale, the local heritability of DNAm level at 
individual DNAm sites in normal WCB using unrelated Colombian individuals. A 
total of 10.94% of DNAm sites in WCB were significantly affected by local genetic 
variation. The mean ℎ!,!!  for the heritable sites was 0.27 but the estimates varied 
substantially with some DNAm sites exhibiting a low heritability and some DNAm 
sites exhibiting heritability close to one. The implication is that DNAm level can be 
inherited through the germ-line. These results were consistent with previous 
estimates of the number of DNAm sites across the genome affected by local genetic 
variation and with the wide range of heritability estimates reported for DNAm [83]. 






heritable DNAm sites located in the sea compared to islands. Overall, our finding 
that heritable DNAm sites were enriched for location outside of islands is in 
accordance with what is observed in human brain tissue [83].We hypothesize that the 
substantial difference in the mean estimates of ℎ!"#!  for DNAm sites located in 
islands and in sea obtained in peripheral blood lymphocytes [58] and outlined in the 
background section of this paper may have resulted from a) the inclusion of all 
DNAm sites rather than just those with a significant heritability estimate b) the use of 
the pedigree to estimate the contribution of the whole genome to phenotypic variance 
and/or c) bias due to un-modelled sources of environmental variation.  Additionally, 
the highest proportions of significantly heritable DNAm sites were located in 
intergenic regions as opposed to within the TSS of a gene or intragenic regions.  The 
estimated heritability is not related to the phenotypic variability of the DNAm site as 
measured by the CV and is not solely a function of the number of the SNPs within 
the genomic region. However, the proportion of heritable DNAm sites was correlated 
with the average estimated genetic variance. Therefore, the lower proportion of 
heritable DNAm sites observed for a contextual group(s) such as islands compared to 
other contextual group(s) such as the sea can in part be explained by a reduction in 
the measured genetic variance. Lower genetic variation could result in lower power 
to capture the true causative loci or it could be indicative of lower causal variation 
due to selective constraints.  
 
DNAm level was slightly higher at the TSS of genes expressed in WCB and not 
LCM compared to those expressed in LCM. This result is consistent with the WCB 
samples being enriched for epithelial cells and a negative correlation between gene 
expression and DNAm level. However, the overall RH of DNAm level at the TSS of 
genes expressed in WCB and not LCM compared to those expressed in LCM was 
similar. One possible explanation for these results is that in healthy colonic tissue the 
genes expressed in the colon epithelium are regulated by DNAm level in a similar 







Finally, we have shown that genetic variants in genomic risk regions for CRC can 
affect DNAm level in healthy colon tissue and that overall DNAm sites within a risk 
region have similar overall RH to DNAm sites outwith an identified risk region. In 
conjunction, we have replicated the previous finding that the CRC risk SNP 
rs4925386 effects DNAm level at cg15193198 and cg24112000.  
We showed that when rs4925386 is excluded the regional genetic variation 
sufficiently captured the causal variation in DNAm level tagged by rs4925386. 
Moreover, rs4925386 alone did not capture all the genetic variance contributing to 
variation of cg24112000 and cg15193198 that is captured by the RH approach. This 
final result highlights the advantage of the RH approach to capture the genetic effects 
on the phenotype, in this case DNAm level.  
 
There are several shortcomings of our study. Firstly, we did not attempt to quantify 
the effects of genetic polymorphism outwith  +/- 1MB of a  DNAm site on variation 
in DNAm level. These long range effects were likely to exist, and studies of larger 
sample size that can overcome the burden of multiple testing are necessary to detect 
their effects.  Secondly, our study has utilized healthy colon tissue from multiple 
locations within the colon and from Colombian subjects attending colonoscopy 
examination and with diagnosis of hyperplasic polyp, adenoma or carcinoma. We 
have shown that diagnosis and location of biopsy had effects on genome wide 
profiles of DNAm level (principal components of DNAm levels); however, the 
reduced sample size would not allow us to estimate heritability for each of the 
diagnoses and biopsy location accurately.  
 
We have identified a subset of DNAm sites genome-wide and measured in healthy 
colon tissue that are influenced by the local genetic variation. Therefore, we have 
contributed to understanding healthy genetically influenced phenotypic variation in 
DNAm level in colon tissue. A number of the DNAm sites which we report as 






genetic susceptibility to CRC. We expect further studies will focus on exploring a 
role for these DNAm sites in disease aetiology.  
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Chapter 5 Across Tissue Comparison of 
Genetic Effects on DNA 
Methylation Level  
5.1 Introduction 
Studies utilizing DNAm level as a quantitative trait have investigated the 
contribution of factors effecting variation in DNAm level. Research assessing the 
genetic basis of inter-individual variation in DNAm level has revealed that 1) the 
genomic heritability and the family-based estimates of heritability are tissue and site-
specific and 2) a substantial proportion of the variation in DNAm level can be 
explained by local genetic factors [2,54-58,83]. In addition, intra-individual variation 
in DNAm level between tissues has been observed. In fact, intra-individual variation 
between tissues appears to be greater that inter-individual variation within a tissue 
and samples clearly cluster by tissue rather than by individual [102,106,107]. 
Moreover, human embryonic stem cells (ES) and ES cell derivatives, primary cells, 
long-term cultured cells and diseased cells can be identified from principal 
component analysis of genome-wide DNAm levels [29]. In conjunction, the 
similarity of DNAm level at DNAm sites across the genome is related to the function 
of the tissues being compared. For example, tissues taken from the same organ 
system typically have more similar DNAm levels across the genome than tissues 
taken from different organ systems [108]. In addition to identifying broad differences 
in the phenotypic profile of tissues, multiple DNAm sites in a region of the genome 
typically less than 500bp in length [29,107,108] or containing up to 50 DNAm 
probes [102] that exhibit a DNAm profile distinctive to a type of tissue (tissue-
specific differentially methylated regions, TS-DMRs) have been identified. 
Moreover, individual DNAm sites that vary across tissues have been identified. For 






that 17.1% of DNAm sites were either constitutively hypermethylated (Beta-value > 
0.9) or hypomethylated (Beta-value < 0.1) across all tissues and samples and that the 
remaining 82.9% of DNAm sites exhibited variability [102]. A second study 
identified that 15.4% of DNAm sites had a difference in DNAm level of at least 0.3 
on the Beta-value scale in at least one of 18 tissues [108]. The difficulties in 
obtaining a tissue sample from many vital human tissues have meant that studies of 
DNAm level tend to be small and to consider a minority of tissues. However, taken 
together, existing research shows that DNAm level at some DNAm sites varies 
across tissues.  
A locus with a different genetic effect across tissues can be thought of as exhibiting a 
genetic interaction with the environment where the tissue represents the environment. 
Genetic by environment (tissue) interactions across tissues have not been well 
characterized for DNAm level. Recently a study [108] found evidence for difference 
in allele-specific DNAm (ASM) across fat, gastric, psoas, small bowel and spleen 
tissue. This study [108] was limited to three samples for each tissue but the results 
suggested that genetic effects may be tissue specific.  
In this study we contrasted local genetic effects on DNAm level between healthy 
colon tissue and tissue taken from four regions of the human brain using two 
population samples of unrelated individuals. One population sample, defined as the 
colon dataset, consisted of 132 Colombian individuals assayed for healthy colon 
tissue (see Chapter 4). The second population sample, the brain dataset, consisted of 
148 individuals of CEU ancestry assayed for DNAm in the cerebellum (CRBL), 
frontal cortex (FCTX), pons (PONS) and temporal cortex (TCTX) (see Chapter 2). 
We aimed to determine if there is evidence that genetic variants have a different 






5.2 Materials and Methods 
5.2.1 Data Quality Control 
Colon data 
We used the processed colon dataset data as outlined in Chapter 4.  
Brain data  
We used the brain dataset processed as outlined in Chapter 2, however, we used the 
full set of DNAm sites that pass the quality control procedure rather than a subset 
located within a risk region for a brain related disorder. 
We used DNAm level measured on the M-value scale in both the colon dataset and 
brain dataset. This scale (M-value), as mentioned in 4.1 is a logit transformation of 
the proportion of probes that are methylated on the microarray that target a DNAm 
site [9]  
5.2.2 Estimation of the Regional Genomic 
Heritability 
The ℎ!,!!  for each DNAm site was estimated using the RH approach as outlined in 
2.2.6.1 
As previously described within the brain dataset we adjusted for the explanatory 
variables sex, age, post mortem interval, study, and assay plate. Within the Colon 
dataset we adjusted for sex, age, and the first two genotype principal components. 
We fitted the first two genotype principal components in the RH of DNAm level in 
colon tissue in this chapter merely because it is conventional to use the genotype 
principal components to adjust for population structure and we have an admixed 
population sample. Although, in 4.2.4 we have shown that we do not expect the 






DNAm level in the colon dataset. Therefore, although we fitted the first two 
genotype principal components in this chapter and not in Chapter 4, we do not expect 
that the adjustment for these two covariates will have substantially affected the 
magnitude of ℎ!,!! . 
5.2.3 Meta Analysis of the Regional Genomic 
Heritability Across Tissues 
To test the hypothesis that genetic variation within a genomic region has a significant 
effect on DNAm level at an individual DNAm site across multiple tissues we used 
Fisher’s method [109] for combining independent P-values. The probability of 
rejecting the null hypothesis that DNAm level is heritable in multiple tissues is 
related to the probability of DNAm level being heritable within each of the 
individual tissues. Assuming that each tissue represents an independent test of the 
heritability of DNAm level at a given DNAm site, the P-value from Fisher’s method 
test statistic is distributed chi-squared with degrees of freedom equal to 2 multiplied 
by the number of P-values being combined. However, if the assumption of 
independent tests does not hold then the logic of Fisher’s method does not apply. 
Repeated sampling from up to four brain tissues from one individual present in the 
brain dataset could result in covariance in DNAm level among multiple brain tissues. 
Therefore, given that the test of heritability of DNAm level may not be independent 
across the brain tissues we do not combine the P-values from all five tissues together. 
Instead, we conducted an analysis using Fisher’s method on the significance of the 
RH result for DNAm sites in colon tissue and one brain tissue at a time. To reiterate, 
we applied Fisher’s method to the four pairs of datasets, colon and CRBL, colon and 
FCTX, colon and PONS, colon and TCTX. In each case, the –log10(P) of the RH 
estimate of the DNAm site measured in the two tissues was used to calculate the 
natural log(P) and Fisher’s method was applied with four degrees of freedom. This 
procedure is a meta-analysis for the RH of DNAm level across tissues assuming that 






5.2.4 Identity of DNAm Sites with Respect to CpG 
Density and Genic Location 
We used the manifest file accompanying the HM450K DNAm array to determine 
location of a DNAm site with respect to CpG density and genic location. A 
description of the information provided in the HM450K manifest file was provided 
in 4.2.6. We determined that out of the 12355 DNAm sites measured in colon and 
brain tissue 3914 mapped to multiple genic locations. As described in the results 
section, we conducted analyses excluding these DNAm sites and without excluding 
these DNAm sites. We did this to determine if DNAm sites that mapped to multiple 
genic locations affected the enrichment analysis that we conducted. We found the 
same trend of enrichment with and without the exclusion of these DNAm sites.  
5.2.5 Testing Regional SNPs for Association with 
Local DNAm Level 
We used the Wald Test implemented in the software Plink [66] to test the effect of 
individual SNPs on DNAm level within a single tissue. DNAm level is regressed on 
the SNP genotype and the Wald test is used to test the null hypothesis that the 
regression coefficient is not significantly different from zero. Rejection of the null 
hypothesis implies that the alternative hypothesis is true and that the SNP has an 
effect on DNAm Level. We specified the significance thresholds we used in the 
results section. 
5.2.6 Determining if Genetic Effects were Different 
Across Tissues  
To determine if SNP effects were different across two tissues we compared the 






Testing this against the standard normal distribution provided an asymptotic P-value 










5.3.1 Regional Genetic Effects on DNAm Level 
Shared Across Colon and Brain Tissue 
A total of 12355 DNAm sites passed quality control procedures in all 5 tissues. 
Within each tissue and for each of the 12355 DNAm sites we took a RH approach 
and partitioned the phenotypic variance into that attributable to local (+/- 1MB) 














Figure 24 Significance of Regional Genomic Heritability for 5 Tissues 
The figure shows the –log10(P) from the cis RH analysis for a total of 12355 DNAm 
sites across the genome and common to the five tissues. The –log10(P) for each of 







The correlation of the significance of ℎ!,!!  (Table 21) ranged between 0.20 and 0.71 
indicating that genetic effects on some DNAm sites may be shared across tissues. 
Additionally, we found that the correlation of the –log10(P) of the estimates of ℎ!,!!  
were much lower between colon and a brain tissue than between two brain tissues 
(Table 21). Therefore, less genetic effects may be shared across colon and a brain 
tissue than across two brain tissues. Shared genetic effects across tissues could reflect 
common biological regulation of DNAm level. It seems plausible that the regulation 
of DNAm level is more similar within tissues of similar function, such as brain 
tissue, than across tissues with different function, such as brain and colon tissue. 
Alternatively, there may appear to be increased sharing of genetic effects across 
brain tissues compared to across brain and colon tissue due to shared technical 
variation within the brain dataset. The shared technical variation within the brain 
dataset could have resulted from using the same set of individuals to obtain a sample 
from each brain tissue or from using similar experimental protocols to obtain a 
measurement of DNAm level.  
 
 
Table 21 Pearson correlation of the significance (-log10(P)) of the regional 
genomic heritability between tissues 
The correlation of the significance of the RH estimates is lower between colon and a 
brain tissue than between two brain tissues 
 CRBL FCTX PONS TCTX COLON 
CRBL      
FCTX 0.45     
PONS 0.45 0.61    
TCTX 0.43 0.71 0.63   







To identify DNAm sites heritable in colon or a brain tissue, or both colon and a brain 
tissue we used Fisher’s method and combined the P-values from the RH analysis for 
the colon and CRBL tissue, colon and FCTX tissue, colon and PONS tissue and 
colon and TCTX tissue. We did not combine the four brain tissues together with 
colon tissue because as stated in section 5.2.3 the assumption of independent tests 
may be violated due to repeated sampling from multiple brain tissues for an 
individual. We found that depending on the two tissues being combined between 11-
12 % of DNAm sites were heritable (Table 22). The average of ℎ!,!!  was comparable 



















Table 22 Genomic Regions Heritable in Colon and a Brain Tissue 
The table shows the results from Fisher’s method conducted on colon and each brain 
tissue separately. A total of 12355 DNAm sites were tested for association with the 
local genetic variation in each of the tissues and the significance was combined 
across colon and each of the brain tissues using Fisher’s method. The table gives the 
count and proportion of DNAm sites significant after application of Fisher’s method 
using an unadjusted for multiple testing threshold and a threshold adjusted for the 
number of traits tested (n=12355). 
  P<=0.05 Adj. P<=0.05 
Colon and CRBL Count (Proportion) 
Regions 
1467 (0.12) 127 (0.01) 
Average RH Estimate  
colon, CRBL 
0.20, 0.23 0.32, 0.51 
Colon and FCTX Count (Proportion) 
Regions 
1460 (0.12) 115 (0.01) 
Average RH Estimate  
colon, FCTX 
0.20, 0.18 0.36, 0.43 
Colon and PONS Count (Proportion) 
Regions 
1380 (0.11) 114 (0.01) 
Average RH Estimate  
colon, PONS 
0.21, 0.18 0.37, 0.45 
Colon and TCTX Count (Proportion) 
Regions 
1459 (0.12) 143 (0.01) 
Average RH Estimate  
colon, TCTX 













Subsequently, we focused on using the colon and FCTX tissue for all downstream 
analyses. We selected the FCTX brain tissue as we have the largest sample size for 
this brain tissue; therefore, heritability estimates may be the most precise for this 
brain tissue.  
Next we investigated the genic location and CpG density at DNAm sites that were 
and were not heritable using ℎ!,!!  from the Fisher’s method analysis with the colon 
and FCTX tissue. At our stringent threshold (corrected for the number of traits 
analysed) we found that the proportion of heritable DNAm sites were depleted within 
CpG islands compared to DNAm sites that were not heritable (P = 1.56*10-11, Figure 
25). Conversely, the proportion of heritable DNAm sites were 1.96 fold enriched for 
location at the edge of CpG Islands (Shores) and 1.06 fold enriched for location in 
areas of low CpG density (Sea) compared to DNAm sites not found to be heritable. 
At a nominal significance (P < 0.05) threshold we found a very similar trend of 
enrichment (results not shown). When we excluded DNAm sites that mapped to 
multiple genic locations and when we used a stringent significance threshold to 
adjust for the number of traits tested, we found that the proportion of heritable 
DNAsites were 1.50 fold enriched 200-1500bp upstream of a TSS (TSS1500) of a 
gene compared to DNAm sites not significant in colon and FCTX tissue (P = 
3.04*10-4) (Figure 26). Again, we found a similar trend of enrichment at a nominal 
significance threshold (P < 0.05) and when we did not exclude DNAm sites that 
mapped to multiple genetic locations (results not shown). Thus, DNAm sites with a 











Figure 25 CpG Density and RH Significance for DNAm Level measured in 
Colon and FCTX Tissue.  
The proportion of DNAm sites significantly (Adj. P < 0.05) or not significantly 
associated with local genetic variation across colon and FCTX tissue with respect to 
CpG Density. Heritable DNAm sites across colon and FCTX tissue are depleted 















Figure 26 Genic Location and RH significance for DNAm level measured in the 
colon and FCTX tissue.  
The proportion of DNAm sites significantly (Adj. P < 0.05) or not significantly 
associated with local genetic variation in colon and FCTX tissue with respect to 
genic location. DNAm sites that mapped to multiple locations were removed. DNAm 
sites that are heritable across colon and FCTX tissue are enriched within 200-1500 





5.3.2 Location, Significance and Magnitude of SNP 
effects within Heritable Regions Across Colon 
and FCTX Tissue 
We have identified genomic regions where genetic variation affected local DNAm 






regions we wanted to narrow down the associated genetic variation to individual 
SNPs. Therefore we assessed the association of each SNP within the regions that 
were heritable (regions were deemed heritable at a significance threshold adjusted for 
the number of DNAm sites tested Adj. P < 0.05, n=115, Table 22) with the 
corresponding DNAm site. Between 43-691 SNPs (mean = 207 median = 200) per 
genomic region were common to both the datasets and were tested for association 
with a DNAm site.  A total of 23828 SNPs were tested in each of the two tissues. In 
the initial analysis below we used the residual DNAm level as the phenotype. We 
found that SNP effects closer to the DNAm site were more significant with a steep 
rise of the –log10(P) starting at approximately 500KB from the DNAm site (Figure 
27, Figure 28). We also observed a decrease in the effect size as distance from the 
DNAm site decreases, particularly within the first 500KB from the DNAm site 

















Figure 27 Significance of SNP Effect and Distance from DNAm site 
SNPs within +/-1MB of a DNAm site with a significant ℎ!,!!  (Adj. P < 0.05) across 
colon and FCTX tissue were tested for association with the DNAm site. The –
log10(P) from the association tests are shown as a function of the distance of the 
SNPs from the DNAm sites. Results from the colon and FCTX tissue are plotted on 
the graph. A negative and positive distance indicates a distance upstream and 
downstream of the DNAm site respectively. SNP effects on DNAm level are higher 
when the SNP is closer to the DNAm site.    
 
 
Figure 28 Average Significance of SNP Effects and Distance from DNAm site  
The average –log10(P) from the SNP association analyses is calculated within bins 
of 10KB from the DNAm site. SNP effects on DNAm level in colon are on average 







Figure 29 SNP Effect and Distance from the DNAm site  
The absolute value of the estimated SNP effects from the SNP association analyses is 
shown as a function of the distance of the SNP from the DNAm site. There is an 
increase in higher effects as the distance between the SNP and the DNAm site 
decreases.   
 
 
Figure 30 Average SNP effects and Distance from the DNAm site  
The average SNP effect is measured within each bin of 10KB from the DNAm site 
and shown as a function of the distance between the SNP and the DNAm site. The 
average SNP effect on DNAm level is consistently different for DNAm level measured 







We observed that the average SNP effect within 10KB bins +/- 1MB of the DNAm 
site, was consistently larger in colon tissue than in brain tissue (Figure 30). The 
systematic difference in the average SNP effect on DNAm level between colon and 
FCTX tissue could reflect a true biological difference of the effect of SNPs in the 
two tissues. For instance, the environmental variance may be lower for DNAm level 
measured in the colon tissue than in the FCTX tissue. An alternative explanation for 
the systematic difference in the average the of SNP effects on DNAm level measured 
in colon and FCTX tissue is that DNAm level is measured on a different scale in the 
two tissues. Although, the measurements of DNAm level were on the M-value scale 
in the colon and brain datasets, DNAm level was measured with a different array in 
the two datasets (HM27K and HM450K). The two arrays differed in the chemistry 
used to obtain a measurement of DNAm level. In conjunction, different quality 
control procedures were conducted to reduce technical variation within the two 
datasets. Therefore, there was a risk that the systematic difference in average SNP 
effects on DNAm level between colon and FCTX tissue resulted from a difference in 
scale of the phenotype across the two tissues. Therefore, we investigated the 
distribution of residual DNAm level  (DNAm level after the adjustment for the 
explanatory variables named in 5.2.2) at the individual DNAm sites analysed 
(n=115) within colon and FCTX tissue. We found that the mean of the distribution of 
mean residual DNAm level was smaller for colon tissue (-0.79) than for FCTX tissue 
(-0.66). Additionally, we found that the mean of the distribution of the standard 
deviation of residual DNAm level was greater for colon tissue (0.54) than for FCTX 
tissue (0.34). The difference in the residual phenotype across the two tissues could be 










Figure 31 Mean Residual DNAm Level in colon and FCTX Tissue 
Distribution of mean residual DNAm level across samples for each DNAm site. The 
average of each distribution is different, smaller for colon than for FCTX tissue. 
 
 
Figure 32 Standard Deviation of Residual DNAm Level in colon and FCTX 
Tissue 
Distribution of the standard deviation of residual DNAm level across samples for 
individual DNAm sites. DNAm level measured in the colon tissue is on average more 







We aimed to compare individual SNP effects on DNAm level measured in colon and 
brain tissue. It did not make sense to compare individual SNP effects across colon 
and the FCTX tissue given the systematic difference in average SNP effects between 
the two tissues. The systematic difference in average SNP effects would likely lead 
to a widespread difference in individual SNP effects across the two tissues. 
Therefore, to minimize the systematic difference we rank normal transformed the 
residual DNAm levels at a DNAm site within each tissue. After rank normal 
transformation residual DNAm level at each DNAm site was distributed with a mean 
of zero and variance of one. 
After rank normal transformation of the residual DNAm level at a DNAm site within 
each tissue we tested the effect of the SNPs on the rank normal transformed DNAm 
levels. We observed that a small systematic difference in the average estimated SNP 
effects in the two tissues remained (Figure 33A). This difference is likely due to a 
systematic difference in the magnitude of the phenotypic variance prior to rank 
transformation. A different phenotypic variance prior to rank normal transformation 
would lead to the estimated effect being rescaled by a different factor.  
So that we could meaningfully compare individual SNP effects on DNAm level 
measured in colon and FCTX tissue we applied a second normalization procedure to 
further reduce the difference in average estimated SNP effect size across the two 
tissues (Figure 33). In this case, we rescaled the SNP effects so that average SNP 
effect in the two tissues was the same. To do this we adjusted the SNP effects in the 
FCTX by a constant factor that was the ratio of the average absolute value of the 
SNP effects in colon to the average absolute value of the SNP effects in the FCTX. 
We tried two alternative procedures for this adjustment and selected the procedure 
that preformed the best, that is the procedure that reduced the difference in average 
estimated SNP effect size across the two tissues the most. In the first case we 
included all the SNP effects and in the second case we included only the effects of 
SNPs located within +/- 500KB of the DNAm site. We used only SNPs located 






surrounding the DNAm site exhibited the largest systematic difference in average 
SNP effect between the two tissues (Figure 33). Moreover, there were substantially 
more significant SNP effects within +/- 500KB of the DNAm site than outside +/-
500KB of the DNAm site (Figure 27); therefore, this region is of particular interest 
for studying a difference in genetic effect across tissues. We found that the 
systematic difference in average SNP effect was reduced the most within +/-500KB 
of the DNAm site when we used the second of the two aforementioned procedures, 
that is when we used only SNP effects within +/-500KB of the DNAm site to rescale 
the SNP effects in the FCTX (Figure 33). Therefore, we used the second procedure 
to rescale the SNP effects and the standard error of the SNP effects in the FCTX (for 
SNPs within the 115 genomic regions significantly heritable across colon and FCTX 
tissue at our adjusted threshold P < 0.05/12355). This rescaling of the SNP effects 
and standard error of the SNP effects in FCTX tissue reduced the systematic 
difference in average SNP effect on DNAm level measured in colon and FCTX 
tissue. Now we could meaningfully make pairwise comparisons of the effects of 















Figure 33 Recalibration of SNP effects 
We rank normal transformed residual DNAm level at each DNAm site and in colon 
and FCTX tissue to ensure DNAm level was distributed equally in the two tissues. 
After rank normal transformation of residual DNAm level in colon and FCTX tissue 
a systematic difference in average SNP effects between the two tissues remained 
(Panel A). To minimize this difference the SNP effects in the FCTX tissue were 
rescaled by a constant factor. We used all SNPs within +/- 1MB (Panel B) or within 
+/- 500KB (Panel C) for the recalibration. The second recalibration procedure 
(Panel C) preformed the best at reducing the systematic difference in average SNP 





5.3.3 Comparison of within Tissue SNP Effects on 
DNAm Level Across Colon and FCTX Tissue 
We aimed to compare the effect of individual SNPs across colon and FCTX tissue. 
For this analysis, we used the SNP effects and the standard error of the SNP effects 






the FCTX tissue on the SNP effects in colon tissue revealed a highly significant (P < 
2*10-16) positive association between the SNP effects (+/- 500KB of the DNAm site) 
in the two tissues (R2 = 0.18). This suggested that some SNP effects were shared 
across the two tissues. Next we wanted to contrast individual SNP effects across the 
two tissues to establish if there was evidence of tissue specific SNP effects. To this 
end, we first selected the SNPs significantly associated with DNAm level in either or 
both of the tissues. Secondly, we tested if the effect of those SNPs was significantly 
different in the two tissues as described in 5.2.6. In doing the first step, we found that 
546 SNPs were significantly associated with DNAm level in at least one of the two 
tissues at a stringent Bonferroni significance threshold that adjusted for the total 
number of SNPs examined within the 115 +/- 1MB regions (P < 0.05/23828). In the 
second step, we tested if the effect of 546 SNPs was significantly different across the 
two tissues using a stringent threshold that adjusted for the total number of tests 
conducted (P < 0.05/546). We found that 17 SNPs had a significantly different effect 
in colon and FCTX tissue (Table 23,Table 24). These SNPs were associated with 
nine DNAm sites that represented eight loci across six chromosomes (Table 23). 
Within each of the eight loci the SNPs were consistently associated with DNAm 
level in either colon or FCTX tissue but not both tissues (Table 24). This means that 
within a tissue and a locus all the SNPs were either, positively, negatively or not 
associated with DNAm level at the local DNAm site. Additionally, at each locus the 
within tissue association of the SNPs with DNAm level was significant only for 







Table 23  Genomic Location of Tissue Specific SNP Effects on DNAm level 
The table shows location of the DNAm site and SNP pairs where the SNP was found 
to exhibitg a significantly (Adj. P < 0.05) different effect across colon and FCTX 
tissue. Eight loci across six chromosomes are represented. The distance between the 
SNP and the DNAm site is also provided with a negative and positive value 
indicating the SNP was upstream and downstream of the DNAm site.  
Locus CHR DNAm Site DNAm Site  SNP SNP BP 
 
DIST (BP) 
      BP       
1 
1 cg14356550 18808102 rs3007733 18800911 -7191 
1 cg14356550 18808102 rs2992753 18808292 190 
1 cg14356550 18808102 rs10907313 18814565 6463 
2 1 cg27535305 53392650 rs11206043 53402552 9902 
3 
1 cg08380539 85039702 rs11163981 84953415 -86287 
1 cg08380539 85039702 rs2945152 85048641 8939 
1 cg08380539 85039702 rs2945145 85062615 22913 
1 cg08380539 85039702 rs2911597 85065769 26067 
1 cg08380539 85039702 rs11164023 85089402 49700 
4 6 cg09548084 8436218 rs12210654 8747817 311599 
5 12 cg25229172 96336121 rs6538691 96353507 17386 
6 14 cg24603941 39703302 rs2038281 39915197 211895 
7 15 cg01789267 45545111 rs1706767 45569099 23988 
8 
18 cg09052983 52495605 rs12457718 52499626 4021 
18 cg22105582 52496070 rs4477812 52357470 -138600 
18 cg22105582 52496070 rs9964078 52384590 -111480 












Table 24 Strength of Effect of Tissue Specific SNP Effects on DNAm level 
Values in bold indicate a significant within tissue SNP effect on DNAm level. SNPs 
within each of the eight loci are either significantly associated with colon or FCTX 
tissue but not both tissues. 
 
DNAm Site SNP	   Effect	  	   SE	   P-­‐value	   Effect	   SE	   P-­‐value	   Z	  Score	   P-­‐value	  
     	   Colon	   Colon	   Colon	   FCTX	   FCTX	   FCTX	   GXE	   GXE	  
1 
cg14356550 rs3007733	   1.12	   0.10	   2.20E-­‐20	   -­‐0.11	   0.12	   3.69E-­‐01	   -­‐7.82	   5.37E-­‐15	  
cg14356550 rs2992753	   1.14	   0.10	   2.33E-­‐21	   -­‐0.11	   0.12	   3.56E-­‐01	   -­‐7.99	   1.38E-­‐15	  
cg14356550 rs10907313	   0.88	   0.15	   3.63E-­‐08	   -­‐0.15	   0.13	   2.48E-­‐01	   -­‐5.21	   1.85E-­‐07	  
2 cg27535305 rs11206043	   0.29	   0.12	   1.40E-­‐02	   1.00	   0.08	   8.10E-­‐26	   5.09	   3.65E-­‐07	  
3 
cg08380539 rs11163981	   0.07	   0.12	   5.40E-­‐01	   0.97	   0.08	   9.76E-­‐24	   6.25	   4.03E-­‐10	  
cg08380539 rs2945152	   0.15	   0.13	   2.43E-­‐01	   1.01	   0.07	   4.62E-­‐27	   5.95	   2.70E-­‐09	  
cg08380539 rs2945145	   0.14	   0.13	   2.81E-­‐01	   1.02	   0.08	   3.63E-­‐25	   5.90	   3.67E-­‐09	  
cg08380539 rs2911597	   0.16	   0.13	   2.04E-­‐01	   1.02	   0.08	   3.63E-­‐25	   5.68	   1.36E-­‐08	  
cg08380539 rs11164023	   0.20	   0.13	   1.32E-­‐01	   1.06	   0.09	   2.08E-­‐20	   5.37	   7.80E-­‐08	  
4 cg09548084 rs12210654	   -­‐0.13	   0.13	   2.91E-­‐01	   -­‐0.93	   0.11	   4.55E-­‐14	   -­‐4.76	   1.96E-­‐06	  
5 cg25229172 rs6538691	   -­‐0.24	   0.12	   5.18E-­‐02	   0.60	   0.11	   2.86E-­‐07	   5.10	   3.41E-­‐07	  
6 cg24603941 rs2038281	   0.29	   0.14	   3.89E-­‐02	   -­‐0.67	   0.10	   6.54E-­‐10	   -­‐5.61	   1.99E-­‐08	  
7 cg01789267 rs1706767	   -­‐0.78	   0.10	   4.40E-­‐12	   0.03	   0.13	   7.87E-­‐01	   4.96	   6.95E-­‐07	  
8 
cg09052983 rs12457718	   0.09	   0.13	   4.92E-­‐01	   0.95	   0.10	   3.49E-­‐16	   5.19	   2.13E-­‐07	  
cg22105582 rs4477812	   -­‐0.15	   0.13	   2.61E-­‐01	   0.82	   0.13	   5.45E-­‐09	   5.26	   1.47E-­‐07	  
cg22105582 rs9964078	   -­‐0.08	   0.13	   5.38E-­‐01	   0.85	   0.13	   2.06E-­‐09	   5.05	   4.48E-­‐07	  




5.3.4 Bioinformatics Investigation of methQTL with 
Tissue Specific Effects 
We used online databases to investigate the function of the eight loci that showed 
statistical evidence of tissue specific genetic effects on DNAm level. We aimed to 
determine if there was a biological reason why the eight loci appeared to be regulated 






the gene closest to the DNAm site and information pertaining to the gene using the 
NCBI Gene database (http://www.ncbi.nlm.nih.gov/gene/) (Table 25,Table 26). 
Using the location of our methQTLs, we also identified the closest published SNP in 
the NHGRI-EMBI Catalgoue of Published Genome-wide Association Studies and 
the associated trait (Table 27) ([99]). Subsequently, we discuss the loci where a 
biological interpretation of the statistical evidence for tissue specific genetic effects 
on DNAm level were most evident, based on the information obtained from querying 
the online databases.  
Within Locus 2 both the DNAm site and associated SNP, rs11206043 were located 
within SCP2. SCP2 is a lipid transfer protein (Table 25). Individuals deficient in 
SCP2 may be categorized as having the neurological condition: 
Leukoencephalopathy with Dystonia and Motor Neuropathy (OMIM #613724) 
(Table 25). Additionally, A SNP 180KB downstream of rs11206043 has been found 
to associate with the neurological condition: Hippocampal Atrophy (Table 27). We 
found that the addition of the minor allele of rs11206043 significantly increased 
DNAm level at SCP2 in non-diseased FCTX tissue but not in colon tissue (Table 24). 
Assuming that disease arises from variation in DNAm level measured in a tissue 
relevant to disease, our result support the idea that this locus is involved in the 
aetiology of brain related traits. Additionally, rs11206043 has been found to 
associate with gene expression of SCP2 in Lymphoblastoid cells; however, strength 
of this association was only suggestive as it was below the standard genome-wide 
association study significance threshold (Table 26). However, the aforementioned 
finding suggests that the influence of rs11206043 on cellular phenotypes may not be 










Table 25 Genes Local to DNAm Sites with Tissue Specific QTL 
The gene processes inferred from Gene Ontology [111] is given in column 3, for 
instance if multiple related processes were found for a gene the over arching process 
was reported.  Relationship between the gene and a trait of clinical importance as 
listed in the NCBI Genetic Testing Registry [112] or inferred from publications is 
listed in column 4. 
Loci Gene 
Symbol 
Gene Name Gene Process Gene and Trait 
Relationships 
1 KLHDC7A Kelch domain 
containing 7A 
Protein ubiquitination - 






Deficiency of SCP2 is 
Leukoencephalopathy 
with dystonia and 
motor neuropathy  




Catabolic Processes  
SNP in CTBS linked to 
multiple myeloma  









expressed in colon 
cells [113] and have a 
function in cancer 
proliferation [114]  














process and Histidine 
catabolic process 
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8 RAB27B Member RAS 
oncogene family 
Melansome and protein 
transport 
Signal Transduction, 
Positive regulation of 
Exocytosis 
Expression of 
RAB27B is marker for 
gastrointestinal stromal 
tumors [115] and 







Table 26 Published eQTL Local to Our Tissue Specific methQTL 
Published eQTL results were found within 5 of the 8 tissue specific methQTL. In 
addition to being a methQTL in our study, one SNP (bold), was found to have a 
marginally significant effect on gene expression within the same locus and in 
Lymphoblastoid cells. 
       




P-value Tissue Ref 
1 rs12144656 1:18792299 1:18807424 2.26*10-6 Liver [117] 
2 rs11206043 1:53402552 1:53392948 4.10*10-5 Lymphoblastoid 
Cells 
[118] 





















 Table 27 Significant GWAS Results Local to SNP Associated with Tissue 
Specific DNAm Level 
Distance between the GWAS SNP and the closest SNP associated with tissue specific 
DNAm level in our study is shown. A negative and positive distance indicates the 
GWAS hit was upstream and downstream of our SNP, respectively.   
 GWAS Hit 
Locus Distance (BP) SNP ID Trait P-value Ref 
1 - 5656 rs3007729 Diabetic Retinopathy 5*10-6 [119] 
2 +179118 rs3820201 Hippocampal Atrophy 1*10-6 [120] 
3 -84454 rs604708 IgG Glyosylation 8*10-6 [121] 
4 +250994 rs2064197 Glucose Homeostasis Traits 7*10-6 [122] 
5 -82079 rs1036429 Pulmonary Function 1*10-7 [123] 





































In locus 4, rs12210654 was associated with level of cg09548084 in colon but not 
brain tissue (Table 24). Cg09548084 is located within SLC35B3, which is 
preferentially expressed in colon tissue (Table 25). Our result can be explained by 
assuming that DNAm level is linked to gene expression and chromatin structure and 
that only genetic variation can affect DNAm level and gene expression when the 
chromatin structure is open. For example, open chromatin facilities gene expression 
and can provide an opportunity for genetic variation to perturb level of gene 
expression. In contrast, closed chromatin inhibits the molecules necessary for 
transcription and translation to access the DNA, thus genetic variation in these 
regions may not influence the level of local gene expression. Given these 
circumstances, an expressed gene would more likely be affected by genetic variation 
than a gene that is switched off. Low or no expression of SLC35B3 in tissues other 
than colon could indicate that this gene is switched off in these tissues. In 
comparison, expression of SLC35B3 in colon tissue follows from an open chromatin 
structure that is susceptible to genetic variation altering DNAm level at the locus.  
 
5.4 Discussion 
5.4.1 Regional Heritability Across Colon and A 
Brain Tissue 
Based on the RH analysis of each of the five tissues individually, (see 2.3.2 and 
4.3.2) we found that more DNAm sites were heritable across colon and a brain tissue 
than expected if the heritability of DNAm level at a DNAm site is independent 
across tissues. For instance, we find that  ~10% of DNAm sites have a significant RH 
in colon tissue and in each of the four brain tissues; therefore, by chance we might 
expect DNAm level at 1% of DNAm sites to be significantly heritable in both colon 
and any one of the brain tissues when in fact DNAm level at the DNAm site is not 






combined the significance of the RH estimates across colon and a brain tissue we 
found that between 11-12% of DNAm sites tested were heritable. This result is likely 
to, in part, reflect the procedure used to determine DNAm sites significantly affected 
by local genetic variation across colon and a brain tissue. Fisher’s method will 
identify DNAm sites with significant RH in both tissues, some DNAm sites with a 
significant RH in one tissue and a small RH in the second tissue and possibly some 
DNAm sites with a small RH in both tissues. The small effect may not have been 
identified in RH analysis on the tissue alone. Therefore, by using Fisher’s method we 
have increased the power to detect effects across tissues compared to if we selected 
DNAm sites with a significant RH in each of the two tissues independently.  
Previously, we have shown that CpG dense regions of the genome contain less 
genetic variation than that observed for the remainder of the genome (see 4.3.1). 
Additionally, we have shown that in colon tissue DNAm sites located in CpG dense 
regions of the genome are less likely to be heritable (see 4.3.1). Given these two 
previous findings, it is not surprising that loci with significant ℎ!,!!  across colon and 
FCTX tissue were depleted for location within CpG dense regions of the genome 
compared to regions of low CpG density. However, given our previous finding in 
colon tissue that DNAm sites located within the TSS of a gene were less likely to be 
heritable than intragenic and intergenic DNAm sites it was surprising that DNAm 
sites with significant ℎ!,!!  across colon and FCTX tissue were enriched for location 
within the TSS of a gene. One possible explanation is that genetic effects on DNAm 
sites located within TSS are smaller than the genetic effects on DNAm sites located 
in intragenic and intergenic regions. In conjunction, the genetic effects on DNAm 
sites in intragenic and intergenic regions are more tissue specific than the genetic 
effects on DNAm sites located with TSS. In this case, when combining information 
across tissues the genetic effects on DNAm sites located in TSS become significant 
where as the tissue specific genetic effects on DNAm sites located in intragenic and 






5.4.2 SNP Effects on DNAm Level Measured in 
Colon and FCTX Tissue 
We have shown that that there is an inverse relationship between the distance of a 
SNP from a DNAm site and both the strength of association and the corresponding 
effect size. This relationship has been observed for DNAm level measured in brain 
tissue [2] and in studies of gene expression level. Our results indicated that the 
strength of association and effect size of a SNP declined rapidly within 500KB of the 
DNAm site. In 2.3.1 and 2.4 we have respectively shown and discussed that when 
estimating the RH including extraneous SNPs that do not tag the causal variation can 
lower the power to detect the causal variation. The results from our SNP association 
analyses suggest that in our colon and brain datasets to optimally capture local 
genetic effects using the RH approach a maximum window size of +/- 500KB 
surrounding the DNAm site would be appropriate. To extend this insight to 
additional datasets one would need to consider the extent of LD within the dataset 
and the number of SNPs per proposed region. On average there was 207 SNPs in the 
2MB regions we used. Therefore, a maximum window size in a human dataset, or 
dataset with similar average LD, may have a considerably lower number of SNPs. 
Indeed, others’ that have conducted RH analysis on the brain dataset have found that 
a window size of 50KB centred on the DNAm site provided the highest count of 
significant RH estimates [83]. In the aforementioned study [83] the 50KB region 
contained between 0 and 40 SNPs with a mode of 6. Thus, reducing the region size 
from 2MB and the number of SNPs would likely increase the power to detect 
heritable genomic regions. In turn, this may uncover additional genomic regions 
where the combined genetic effects are not currently significant enough to surpass 
our cut-off threshold.  
We found a systematic difference between the SNP effects estimated from DNAm 
level measured in colon and FCTX tissue. This difference could reflect a true 
biological difference between the regulation of DNAm level in the two tissues. For 






DNAm level measured in colon tissue than in FCTX tissue which could mean that 
overall the environment plays a decreased role in regulating DNAm level in the 
colon tissue compared to the FCTX tissue. However, a different phenotypic 
measurement scale in the two tissues could also lead to a systematic difference in 
SNP effects between the two tissues. In both datasets, DNAm level at a DNAm site 
was measured as the logit transformation of the proportion of methylated 
oligonucleotides (M-value scale) ([9]). Despite using the M-value measurement scale 
for DNAm level we observed a difference in the standard deviation of the residual 
phenotype between the two tissues. On average, the standard deviation of the 
residual phenotype was greater for DNAm level measured in the colon tissue 
compared to in the FCTX tissue. There are several reasons why this result could 
occur. Firstly, it is possible that DNAm level at a DNAm site is more variable in 
colon tissue than in FCTX tissue. Secondly, there may be a different extent of 
random noise in the measurement of DNAm level between the two datasets. Thirdly, 
DNAm level could be measured on a different scale in the two datasets. Different 
arrays were used to measure DNAm level in the two datasets, in the brain dataset the 
HM27K array was used and in the colon dataset the HM450K array was used. 
Similar to the HM27K the use of the HM450K involves bisulfite treatment and 
amplification of genomic DNA, leading to the conversion of an unmethylated 
cytosine to thymine. The proportion of targets containing a thymine to those 
containing a cytosine is quantified from the intensity measures of fluorescently 
labelled nucleotides added to the array. Adenine and thymine are labelled with a red 
fluorescent molecule and guanine and cytosine are labelled with a green fluorescent 
molecule [98]. However, the HM450K differs from the HM27K in that it employs 
two different probe designs to assess methylation level. Each DNAm site on the 
HM450K array is assayed by either the Infinium I design, the design used on the 
HM27K array or the Infinium II design. The majority (90%) of DNAm sites assayed 
on the HM27K array by the Infinium I design are assayed by the Infinium II design 
on the HM450K array [98]. The Infinium II design differs from the Infinium I design 






and the location where the fluorescent nucleotide anneals to the target DNA. The 
Infinium I design uses two probe types to assay DNAm level at a DNAm site, one 
probe to bind to the unmethylayed target and one probe to bind to the methylated 
target. The extent of target binding to the two probes is measured in the same colour 
channel, either red or green. The colour channel used depends on the nucleotide base 
in the probe that is next to the DNAm site being assayed. In contrast the Infinium II 
design uses one probe to assay both the methylated and unmethylated target by single 
base extension complementary to the interrogated cytosine [98]. This design results 
in the incorporation of an adenine complementary to a methylated cytosine and a 
guanine complementary to an unmethylated cytosine; therefore, resulting in the use 
of two colour channels to measure the proportion of methylation at a single DNAm 
site. An additional difference between the Infinium I and Infinium II design is that 
unlike the Infinium I design the Infinium II design can incorporate up to three 
degenerate R bases without compromising the ability of the target to anneal to the 
probe. Therefore, in contrast to the Infinium I, the Infinium II design does not 
assume that DNAm sites within the probe target are of the same phase (methylated or 
unmethylated) to the DNAm site being assayed. However, a limitation of the 
Infinium II probe design being able to incorporate degenerate R bases is that the 
probes are restricted to assaying DNAm level in lower CpG density regions of the 
genome than the Infiunium I design. For instance, there is an enrichment for Infinium 
II probes over Infinium I probes in CpG shores and regions distant to CpG islands, 
but not within CpG islands, reflecting this constraint of the Infinium II design [129]. 
Incorporation of two probes designs, (Infinium I and Infinium II) leads to additional 
quality control steps for the data from the HM450k array (colon dataset) compared to 
the data obtained from the HM27K array (brain dataset). For instance, the use of two 
colour channels to measure DNAm level at a single DNAm site with the Infinium II 
design means that it is necessary to account for colour bias (we used quantile 
normalization see 4.2.2) [130,131]. Additionally, the distribution of beta values 
produced by probes of the Infinium I and II design are different to one another 






and was corrected for when using data from the HM450K array (we used the BMIQ 
algorithm [97] see 4.2.2). The differences in how the arrays obtained the 
measurement of DNAm level and consequentially different quality control 
procedures for the two arrays could result in DNAm level being measured on a 
different scale across the two arrays. The correlation between DNAm level at DNAm 
sites assayed by the two arrays (25,978 Infinium I on HM27K and 25,978 Infinium I 
and Infinium II on HM450K) is high (r=0.98) [98]. However DNAm level assayed 
by these two arrays does not appear to be on average equal (the regression coefficient 
is not provided in the reference but observation of the graph indicates that for the 
most part the values do not lie on the 1:1 line) [98]. At most of the DNAm sites, 
DNAm level appears to be higher when measured on the 450K array compared to the 
27K array [98]. In the preceding analysis [98] only one sample was assayed so the 
difference in the variance of DNAm level at a DNAm site across the two arrays was 
not reported.  However, the difference in mean could reflect a difference in 
measurement scale across the two arrays. Our samples have been measured on either 
of the two arrays and we have no overlap of samples measured on both arrays. 
Therefore, it is challenging to determine if the difference in phenotypic standard 
deviation and average estimated SNP effect across the two datasets represents a true 
biological difference in the regulation of DNAm level or if it results from the use of a 
different scale of measurement across the two arrays. The risk that measurement of 
DNAm level was scaled differently in the two tissues led us to rank normal transform 
the residual phenotypes. We did this because scale of measurement could affect the 
estimate of the SNP effects and we wanted to meaningfully compare the individual 
SNP effects across the two tissues.  
This transformation of the residual phenotypes reduced the systematic difference in 
average estimated SNP effects between colon and FCTX tissue. The small systematic 
difference that remained after rank normal transformation could be explained as a 
real biological difference between the two datasets or by a systematic difference in 
the magnitude of noise between the two arrays. Rank normal transformation first 






standardized residuals so that they are normally distributed and have a mean of zero 
and variance of 1. If the SNP effect on DNAm level is the same in two tissues but the 
mean level of noise is not, then the residual DNAm level and the SNP effect will be 
rescaled by a different factor. The result is that the effect in the two tissues will 
appear to be different after rank normal transformation. We minimized the 
systematic difference in average SNP effect across the two tissues that may have 
occurred due to a different level of noise in the two datasets by rescaling the SNP 
effects in the FCTX tissue. This allowed us to directly compare the magnitude of the 
SNP effects across the two tissues and identify tissue specific genetic effects.  
In addition, for identifying SNP with a different effect across the two datasets we 
analysed SNP within genomic regions found to have a significant ℎ!,!!  across colon 
and FCTX tissue at our Bonferroni threshold adjusted for the number of traits 
analysed. Compared to the use of a nominal threshold, the use of a stringent 
threshold increased our confidence that the significant regions represented true 
positive associations of genetic variation with DNAm level. In turn, we used a 
conservative Bonferroni adjusted threshold to determine individual SNPs within the 
genomic regions that were associated with DNAm level.  Overall, this meant that we 
could be confident that the within tissue associations of SNP with DNAm level were 
true positive associations and not false positive associations. Therefore, when we 
contrasted the estimated SNP effects across the two tissues we were likely not 
contrasting the effect of SNPs on DNAm level that resulted from chance (ie. false 
positive associations). When we compared the SNP effects across colon and FCTX 
we also used a conservative Bonferroni threshold to identify SNPs with a different 
effect in the two tissues. This meant that we could be confident that our result; 17 
SNPs have a different genetic effect in the two datasets, reflected the true biological 
situation.  
SNPs with a different genetic effect in different tissues can be thought of as 
exhibiting a genetic by environment interaction where the tissue is the environment. 






mean that different biological processes are regulating DNAm level at the DNAm 
site. Assume the following biological model where a SNP affects transcription factor 
(TF) binding and gene expression level that in turn has an inverse affect on DNAm 
level. In this case, the SNP affects DNAm level in all tissues in which the gene is 
transcribed. However, the abundance of circulating TF in a tissue could also affect 
the extent to which the gene is transcribed and consequentially DNAm level. A 
genetic by environment interaction could occur if the SNP affects DNAm level in the 
tissue proportionally to the amount of TF abundance (and TF abundance is different 
in the two tissues). Similarly, a SNP that affects DNAm level in a tissue 
proportionally to the amount of DNMT or methyl donors present in the tissue would 
have a different effect size across the tissues if abundance of the DNMT or methyl 
donors were different. Even a different direction of a SNP effect across tissues does 
not necessitate that the associated DNAm site be regulated differently in the tissues. 
For instance, if a SNP leads to variation in DNAm level in two tissues and in one 
tissue a mechanism takes effect so as to stabilize DNAm level, whereas in a second 
tissue this mechanism does not take effect, then a difference in the direction of SNP 
effect could be seen across the two tissues. The aforementioned examples could be 
viewed as genetic by environment interactions driven by tissue specific stochastic 
variation where the core underlying biological process regulating DNAm level 
remains similar across tissues. However, it is also possible that SNP effects on 
DNAm level differ across tissues due to different processes regulating DNAm level 
in the tissues. For instance, in different tissues different proteins may bind to the 
DNA to regulate DNAm level. Different proteins may be affected by a SNP to a 
varying degree and this would lead to an overall different estimated SNP effect on 
DNAm level across the tissues.  
The 17 SNPs that we found to have a different effect in colon and brain tissue 
represented 8 loci. We queried online data repositories to establish a biological 
explanation for the tissue specific genetic effects on DNAm level; however, this 
proved to be challenging given the sparse knowledge of the function of genes in 






our results. We expect increased research assessing the relationship between genetic 
variations, cellular phenotypes and diseases/traits to enhance the functional 
annotation of the genome. This is turn will help biological interpretation of future 
studies similar to our own which has investigated tissue specific genetic effects on 
DNAm level.  
We have identified SNP that have a different effect in colon tissue collected from 
Colombian individuals and FCTX tissue obtained from individuals genetically 
similar to the HapMap CEU population (as determined by cluster analysis, see 
2.2.1.1.3). Therefore, in our analyses tissue is confounded with population. This 
means that we cannot be sure that a genetic by environment interaction results from a 
difference in SNP effect across tissues (colon and FCTX) and it may result from a 
difference across populations (south and north American). Nevertheless, our 
procedure has revealed that genetic by environment interactions for DNAm level do 
exist and we expect larger scale studies of this nature will follow. 
5.5 Contributions 
The colon dataset was collected and prepared by Gustavo Hernandez-Sanchez, Maria 
Carolina Sanabria and Martha Serrano-Lopez, Jose Luis Soto, Adela Castillejo, 
Cristina Alenda and Eva Hernandez-Illan 
Gibbs et al. [2], the Division of Aging Biology, the Division of Geriatrics and 
Clinical Gerontology (NIA) were responsible for collection and initial research on 
the brain dataset. The brain dataset was downloaded from the NCBI Data 
Repositories dbGaP (Accession Number: phs000249.v1.p1) and GEO (GSE15745). 






Chapter 6 Final Discussion and 
Conclusion 
6.1 Findings 
Overall, our RH study suggests that variation in DNAm level at some DNAm sites is 
at least partially controlled by local nuclear genetic variation (Table 28). For 
instance, even at a conservative Bonferroni threshold (P < 2.4*10-7) that adjusted for 
the total number of cis association tests conducted across all five tissues, DNAm 
level was heritable at a number of DNAm sites within each tissue (Table 28).  
 
 
Table 28 Number of Associations between DNAm Level and the Local Genomic 
Region at Different Significance Thresholds.  
Each column heading indicates the Bonferroni adjustment conducted and the 
significance threshold. The number within each cell is the count of DNAm sites 
significant at the specified threshold. 
Tissue Nominal  
 
P < 0.05 
Traits within Tissue 
 
CRBL P < 1.64*10-05 
FCTX P < 1.63*10-05 
PONS P < 1.63*10-05 
TCTX P < 1.63*10-05 
Colon P < 2.5*10-07 
Traits within Tissue Set  
 
Brain P < 4.1*10-06 





P < 2.4*10-07 
CRBL 294 22 15 8 
FCTX 297 33 23 16 
PONS 277 23 19 12 
TCTX 292 32 28 22 








In conjunction, we used the RH framework and found that DNAm level could be 
predicted from the local sequence variants with an accuracy that scaled with the 
estimated ℎ!,!! . Furthermore, the RH approach was able to capture additional effects 
of cis acting genetic variation beyond that detected by the CRC risk SNP, rs4925386. 
In contrast to the cis effects detected, using our study design we found no evidence 
that suggested that DNAm level was associated with regional genetic variants in 
trans.  
We examined the local ℎ!,!!  of DNAm sites located within and outwith a disease 
susceptibility region and measured in a relevant tissue and found that the two sets 
exhibited a similar overall pattern of estimated ℎ!,!! . 
Additionally the propensity for DNAm level to be associated with the local sequence 
variation differed with respect to CpG dinucleotide density and genic location. Most 
notably, DNAm sites located in CpG dense regions of the genome were less likely to 
be heritable than DNAm sites located in CpG sparse regions of the genome. 
Additionally, within both CpG dense and CpG sparse regions of the genome 
intergenic DNAm sites were more likely to be heritable than intragenic DNAm sites.  
Finally, we found evidence that genetic effects on DNAm level differed between 
DNAm level measured in colon tissue from South American individuals and DNAm 
level measured in FCTX tissue from North American individuals.  
6.2 Implications 
6.2.1 Regional Heritability is a Useful Approach for 
Estimating Genetic Effects on Cellular 
Phenotypes such as DNAm Level. 
The successful application of the RH method to DNAm level using a small sample of 






other cellular phenotypes. There are several characteristics of the phenotypic and 
genotypic data and RH approach which provide power for ℎ!,!!  . Firstly, while 
unrelated individuals share a small proportion of their whole genome in common, 
regionally, the proportion shared between two individuals can vary substantially in 
the population (and from genomic region to genomic region). Secondly, 
simultaneously testing all SNPs within a genomic region compared to testing SNPs 
individually for association with a trait allows for small effects to be combined to a 
measureable estimate. Moreover, the use of regions rather than single SNPs can 
reduce the number of statistical tests conducted and allow for a less stringent 
significance threshold. Thirdly, genetic effects on DNAm level are relatively large in 
comparison to those observed for ultimate phenotypes (UPs) and they are enriched 
locally to the DNAm site. Given this last point, we expect the RH method will be of 
utility in estimating the genomic contribution to cellular phenotypes (CPs) with a 
similar overall genetic architecture to DNAm level, such as level of gene expression. 
Moreover, the observation that risk SNP contributed to a proportion of the local 
ℎ!,!!   for DNAm level in healthy tissue has implications for predictive genetic models. 
This result highlighted that in comparison to use of single SNP, the RH approach can 
pick up additional genetic effects in a relevant healthy tissue which may mediate 
susceptibility to an UP. Therefore, genetic models that aim to predict an UP or 
DNAm level could benefit from using regional genetic variation rather than single 
SNP.  
6.2.2 Genetic Variation and DNAm Level at an 
Associated DNAm site can be used to 
Determine if DNAm level Causes Disease 
One implication of DNAm level being heritable is that genetic variation associated 
with DNAm level can be used to determine if DNAm level causes disease using the 






and a disease, such as that which may be obtained from EWAS, can arise from 
several scenarios. For instance, changes in DNAm level may cause changes in 
disease status or vice-versa. Additionally, the change in DNAm level and disease 
status could independently be caused by an additional factor (confounding). An 
assumption of Mendelian randomization is that the SNP is not correlated with 
unmeasured factors associated with an exposure (DNAm level) and an outcome 
(disease). Therefore, if the SNP is associated with the exposure (DNAm level) it can 
be used as a proxy for the exposure (DNAm level), which negates the effects of the 
confounding variable(s). A second assumption of Mendelian randomization is that 
the SNP is independent of the outcome (disease) given the exposure (DNAm level) 
[136]. Given these assumptions, then an association between the SNP and the 
outcome (disease) indicates that the exposure (DNAm level) causes disease. Our 
research has indicated that cis rather than trans acting genetic effects on DNAm level 
predominate. The substantial cis acting associations uncovered reveal that cis acting 
genetic variation is a promising pool of genetic variation to use in Mendelian 
randomization experiments.  
Mendelian randomization studies are of particular utility for identifying targets for 
therapy. Unlike studies that uncover association between DNAm level and disease 
but provide no insight into the direction of causality, MR can identify potential 
exposures that cause disease. Understanding the cause and effect relationship 
between DNAm level and disease is of interest to the medical community because 











Figure 34 Mendelian Randomization Framework  
A SNP associated with DNAm level can be used to determine the causal relationship 
between DNAm level and disease status. It is assumed that the SNP is not associated 
with the confounding factors, that is it associated with DNAm level and that the only 
association with disease is through DNAm level. In this case, association of the SNP 
with disease status suggests that change in disease status is caused by change in 





6.2.3 Methods for Increasing the Power to Detect 
Genetic Effects on Ultimate Phenotypes 
Our research has implications when considering QTL to prioritize for association 
with an UP. The location of a DNAm site with respect to susceptibility regions was 
independent of the likelihood of DNAm level being heritable and the heritability 
estimate (see 4.3.5). Therefore, using QTL associated with DNAm level (methQTL) 
to prioritize genomic regions for association with an UP would not provide 
enrichment for significant associations beyond that which would be obtained from a 






strategy for reducing the significance threshold as a means for increasing the power 
to detect the effects of genetic variation in an association study. Interestingly, this 
finding contrasts that found in studies of gene expression. GWAS results at P <10-5 
were enriched for eQTLs in blood [137] and schizophrenia susceptibility SNPs were 
enriched for eQTLs in human brain [138]. Additional studies [52,139] have indicated 
that susceptibility SNPs are enriched for eQTLs and they have used eQTL results to 
prioritize sub significant QTL from GWAS for replication. One explanation for the 
difference in enrichment of eQTLs compared to methQTLs in susceptibility QTL 
could be related to the functional consequence of QTL. For instance, QTL may more 
often influence an UP by acting directly on level of gene expression rather than on 
level of DNAm. Further studies could provide evidence for this hypothesis and 
validate our finding that QTLs (for UPs) are not enriched for methQTLs. Our study 
has focused on using regional genetic variation local to DNAm sites within and 
outwith susceptibility loci, where a susceptibility locus is defined as +/- 1MB of 
susceptibility SNP. The aforementioned eQTL research has been conducted using a 
single SNP approach. Enrichment analysis using the RH method with gene 
expression level and the single SNP approach with methylation level could help 
resolve if the difference is an artefact of the use of different experimental design. 
6.2.4 DNAm Level does not Always Need to be 
Assayed to be used in an Analysis  
An implication of accurate prediction of DNAm level in healthy tissue is that it is not 
always necessary for DNAm level to be directly assayed. DNAm level could be 
accurately predicted in the currently abundant large GWAS datasets. Predicted 
DNAm level could then be tested for association with an UP. This would provide a 
set of DNAm sites putatively associated with the UP in healthy tissue for replication 
at a reduced significance threshold. Moreover, because the predicted DNAm level is 
based on genetic effects estimated in healthy tissue relevant to disease an association 
between predicted DNAm level and a disease will reflect variation in DNAm level 






highly suggestive evidence for variation in DNAm level causing disease. However, 
in order to predict DNAm level in a disparate dataset the regional SNP effects must 
first be estimated. We have shown that a small number of samples can be used to 
obtain accurate estimates for SNPs effects within a 2MB region and local to a 
DNAm site. While local SNP effects on DNAm level are thought to be tissue 
specific, provided sufficient power, the effects need only be estimated once within 
each tissue to facilitate prediction of DNAm level into a large number of datasets. 
Therefore, it would be of utility to the research community to store regional SNP 
effects on DNAm level in the public domain. The data repository, GRASP [140], 
currently contains results from association of SNP with CPs. However, this database 
is not optimally designed to hold regional SNP effects and overall it contains limited 
information regarding methQTL.  For instance only one single SNP methQTL study 
conducted in one tissue is represented in GRASP [140] and the direction of the effect 
of SNP on DNAm level is not noted. A database containing the location and size of 
the region analysed, ℎ!,!! , tissue, population and effect of SNPs within the genomic 
region would be of benefit to the research community. 
6.2.5 DNAm Sites in Different Genomic Contexts 
may have Different Functional Roles 
Finding that the local RH of DNAm Level is related to the location of the DNAm site 
with respect to defined genomic contexts has implications for understanding the 
function of the human genome. Functional elements of the genome can be 
determined by several different scientific approaches and each approach will 
necessitate a slightly different interpretation of what it means for an element to be 
‘functional’ (reviewed in [141]). Firstly, evolutionary methods that measure the 
extent of neutral or positive selection can define functional elements in the genome. 
Assays that measure biochemical activity at regions of the genome provide a second 
measure of functionality. Thirdly, genetic variation can be defined as functional if it 






on functional genetic variation based on this third definition. For instance, our RH 
analyses determined that genetic variation can have a functional effect on DNAm 
level for DNAm sites located in the eight genomic contexts we studied (see Chapter 
4 in particular 4.3.4). However, we also showed that the probability of genetic 
variation having a functional effect on DNAm level is related to the genomic context 
of the DNAm site (see 4.3.4). The propensity of a genomic context to be functional 
may be related to the biological role of DNAm level at DNAm sites located within 
the genomic context. In this view, DNAm level is related to fitness (by affecting an 
UP) and to a different extent within different genomic contexts. In conjunction, the 
lower probability of DNAm level being heritable reflects lower genetic variation due 
to negative selection acting to purge SNP with effects that decrease fitness.  
6.3 Further Research 
Broadly, further research will focus on using healthy tissue to understand the genetic 
and environmental component of DNAm level, the molecular role of DNAm level 
and how these factors and variation in DNAm level relate to disease and trait 
aetiology.  
6.3.1 Estimating Genetic Effects on DNAm Level 
To date, studies exploring the genetic architecture of DNAm level have concentrated 
on the analysis of cis acting genetic variation. This is primarily due to the 
determination that a substantial proportion of the phenotypic variation in DNAm 
level can be explained by local genetic variation and that these effects are relatively 
easy to quantify. In contrast, less attention has been paid to understanding the 
contribution of trans acting genetic variation on DNAm level. This is likely a 
consequence of needing to adopt a more stringent significance threshold to test 
genetic variation genome-wide compared to when testing local genetic variation. 
With a given number of samples, adopting a more stringent significance threshold 
leads to decreased power to detect genetic effects and an increased minimum 






trans and cis acting genetic variation, then the proportion of trans acting effects 
detected will be smaller than the proportion of cis effects detected. Indeed, this is 
what we have observed in our studies (see 2.3.2, Chapter 3 and 4.3.2) and what 
others’ [2,54,55,61] who have assessed the effects of both cis and trans acting 
variation on DNAm level have shown. 
Currently, research assaying DNAm level has typically been limited to using a small 
set of samples. This is because the ability to quantify DNAm level at individual sites 
genome-wide is relatively new and samples from many tissues are challenging to 
obtain and can take years to accumulate. As studies get larger in sample size, 
providing the multiple testing threshold does not dramatically change, we expect 
there to be an increase in the number of trans acting variants discovered both with 
the single SNP and RH approach. Moreover, within the RH framework a larger 
sample size would facilitate the fitting of a second variance component to estimate 
the total effect of trans acting variation on DNAm level.  
However, there is scope for studies of small sample size to investigate trans acting 
effects on DNAm level; although based on our work and the publish literature we 
suggest developing a novel approach.  For instance, we would consider using the RH 
approach with different window sizes. Little information regarding the genetic 
architecture of trans acting variation makes it challenging to determine the optimal 
window size for analysis. For instance and as previously discussed, unlike a single 
SNP approach the RH approach can capture the combined effect of multiple small 
effect variants acting within a region. However, inclusion of extraneous genetic 
variants can induce noise and reduce the power of the RH approach. In conjunction, 
in the case of one or few causal genetic variants acting on a phenotype, the power of 
the RH approach may be decreased in comparison to a single SNP approach. 
Therefore, based on the underlying genetic architecture of the causal variation the 
size of the genomic region tested will affect the power to detect an association. An 
additional approach that could be undertaken either within the RH framework or the 






the effect of a subset of genetic variation that is a priori thought to affect DNAm 
level in trans. If one hypothesizes that 1) genetic variation that affects gene 
expression will also affect DNAm level at the gene and 2) genes that are co-
expressed will be to some extent affected by the same genetic variation, then gene 
networks could be used to prioritize genetic variation. For instance, genes involved 
with a process related to the tissue in which DNAm level is measured could be used 
to select genomic regions of interest. Within these regions, genetic variation could be 
tested for association with DNAm level. Finally, if one assumes only the first of the 
two hypotheses above then genetic variation found to have a trans effect on gene 
expression level could be prioritized for association with DNAm level measured in 
the same tissue. This last point necessitates that trans effects on gene expression 
level have been tested and reported in the tissue of interest. In the case of our brain 
dataset this has occurred; therefore, it would be relatively straightforward for us to 
conduct the outlined experiment in human brain tissue.  
Our finding that in most cases DNAm level is not solely determined by genetic 
variation raises the question of what environmental factors influence variation in 
DNAm level. Often datasets are limited in the number of environmental factors that 
are measured, measuring only those with a probable effect or those that are simple to 
measure. This makes examination of putative environmental effects in the primary 
study challenging. One environmental factor not analysed in our study of the colon 
dataset presented in Chapter 4 is the location of biopsy with respect to what is 
clinically defined as proximal and distal colon. There are several differences between 
the proximal and distal colon (reviewed in [142]); therefore, they could be thought of 
as different cellular environments. We hypothesize that these two environments lead 
to variation in DNAm level. Following the investigation of the RH of DNAm level in 
colon tissue presented in Chapter 4, proximal and distal colon has been classified and 
is being analysed for association with DNAm level by Konrad Rawlik.  
In addition, further studies that investigate if genetic effects on DNAm level differ 






on our work (see Chapter 5) and that of others’ [2] we would suggest focusing on 
investigating the effects of SNPs within +/- 500KB of a DNAm site on the DNAm 
level. To conduct the meta-analysis, one could use summary statistics from within 
tissue association analyses or one could follow a new method for meta-analysing 
correlated traits [143].  This new method [143] could be used to meta-analyse 
DNAm level measured in the brain dataset and our colon dataset, using the 
measurements from the four brain regions simultaneously.  
6.3.2 Understanding the Molecular Role of DNAm 
Level 
We have shown that the genetic variation local to a DNAm site could explain a 
proportion of the phenotypic variation in DNAm level. This result leads naturally to 
the question of the molecular role of DNAm level in cellular processes and how this 
role is perturbed by genetic variation. For instance, does genetic variation alter 
DNAm level directly or does it first alter other CPs such as gene expression that 
consequentially leads to a change in DNAm level? Ideally, to investigate these 
questions the more types of CPs measured (gene expression, different chromatin 
marks) the better and preferably in the same individuals. Consider the underlying 
assumption that DNAm level will phenotypically co-vary with a CP that it works in 
concert with to regulate cellular processes. In this case, genetic variation that affects 
DNAm level will also affect the CP with which DNAm level co-varies. Therefore, 
examining genetic effects on DNAm level and co-varying CPs could provide an 
indication of the molecular role of DNAm level. An example of a particular study 
design that could be used is a bivariate or multivariate analysis with the RH 
approach. If the dataset is not of adequate power to facilitate the use of a multivariate 
analysis then one could conduct separate genetic association analysis for each CP 
and examine the correlation of the resulting P-values. While these preceding two 
approaches may provide an indication of CPs that interact, they do not inform on the 






[144] could help resolve causal pathways.  These lines of research could be explored 
now in the brain dataset using gene expression level and DNAm level.  
An important consideration is a ‘dynamic’ role of DNAm level where DNAm level 
functions differently with respect to other CPs under certain circumstances, such as 
location of the DNAm site in the genome. Indeed, we showed a different propensity 
for DNAm level to be heritable across different genomic contexts. It would be 
interesting to determine if the probability of other CPs being heritable, such as gene 
expression level, varies accordingly. A difference in the extent of genetic co-variance 
in different contextual groups could be indicative of a different molecular role for 
DNAm level across those groups. However, the extent of genetic variation could 
affect the power to detect genetic effects and also the estimate of genetic co-
variation. Overlaying information of evolutionary conservation and positive selection 
would help determine if estimates of the genetic effects were influenced by the extent 
of genetic variation. Moreover, understanding the evolution of the DNA sequence 
with respect to the heritability of DNAm level (and the genetic co-variance of 
DNAm level and CPs) could provide valuable insight into the functional role of 
DNAm level.  
6.3.3 Determining if DNAm Level is Causal for 
Disease 
Our study (see 4.3.2) has provided a list of DNAm sites where DNAm level 
measured in healthy colon tissue is associated with local genetic variation.  There are 
several different methods that could be used to try and discern which, if any, of these 
heritable DNAm sites are causal for disease of the colon such as CRC. Firstly, as 
described in 2.2.6.2 the cis acting SNP effects on DNAm level could be estimated. 
Subsequently, the estimated SNP effects could be used in a disparate dataset 
containing genotypic and case control status for CRC to predict DNAm level. 
Predicted DNAm level could be tested for association with disease outcome to 






used to identify the SNP within the local region most strongly associated with 
DNAm level. The SNP could then be used in a one step mendelian randomization 
process in a dataset containing genotypic information, measurements of DNAm level 
and CRC status.  Thirdly, longitudinal data could provide an indication of changes in 
DNAm level occurring prior to disease onset. This last study is clearly challenging to 
undertake. It would take years to acquire the required data or it would necessitate that 
the relevant tissue have been measured and the disease status recorded in a pre-
existing longitudinal study. However, the preceding first two lines of 
experimentation are quite easily facilitated and could be conducted using our colon 
dataset. This is because in the colon dataset we have used only a subset of the 
samples for which we have extracted tissue.  
6.4 Final Words 
Understanding the genetic basis of disease is fundamental to advancement in 
personalized medicine. Currently, many human diseases are proving challenging to 
predict from the genotype alone. Understanding how phenotypic variation in DNAm 
level relates to genetic variation and disease susceptibility is a promising avenue of 
research to progress personalized medicine. For instance, DNAm level correlated 
with disease and under genetic control could be used to suggest individuals to target 
for prospective treatment. In addition, DNAm level which causes disease can itself 
be used as a target for therapy. With the extensive datasets and computational 
resources now available, this era is likely to bring many pivotal discoveries in human 
genetics.  
6.5 Contributions 
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Introduction
Loss of cognitive function is one of the most feared aspects of
growing old. Intelligence and the rate of age related cognitive
change vary widely in healthy individuals and have been
associated with health status, longevity and quality of life
[1,2,3,4,5,6]. As the general population ages, cognitive health is
of paramount importance, and understanding the underlying
mechanisms of general intelligence and age-related decline has
wide-ranging social and economic implications. Although patho-
logical cognitive decline has been studied in diseases such as
Alzheimer’s [7], available phenotypic measures for lifetime
changes in cognitive abilities of healthy individuals are rare. An
important part of the variation in human general intelligence and
in non-pathological, age-associated cognitive decline [8,9] can be
attributed to heritable genetic variation. Identifying the genes and
loci that contribute to the estimated genetic variance would offer
new biological insight, with opportunities to develop tailored
interventions and to inform policy makers.
Here we analyse the genetic contributions to complex variation
in three measures of intelligence: (i) crystallised intelligence; (ii)
fluid general intelligence; and (iii) lifetime change in intelligence.
We use three Scottish birth cohorts whose intelligence was
measured in childhood (age 11 years) and again in late adulthood
(age 65 to 79 years). Crystallised intelligence (gc) is typically
assessed using vocabulary and knowledge-based tests, and tends to








remain stable with age. Fluid intelligence (gf) is assessed using tests
that require on-the-spot thinking — often with abstract materials
and under time pressure — and tends to peak in early adulthood
and decline thereafter [10,11]. Here, cognitive change was
measured as fluid intelligence in old age adjusted for intelligence
measured at age 11 as described in Deary et al. [9], who showed,
using the same data, that the lower bound estimate for the
proportion of variation in lifetime change of intelligence explained
by genetic factors was 0.24.
To date, as is seen in many complex traits, and despite
moderate-to-high heritability estimates, genomic studies have
yielded little knowledge of the underlying genetic factors
affecting cognitive traits. Although studies for other complex
traits have been successful at garnering the few common genetic
variants that explain a sizeable amount of variation, genome
wide association studies (GWAS) have generally failed to
capture a large proportion of the genetic variation in complex
traits [12,13,14]. A recent GWAS for crystallised and fluid
intelligence did not result in any replicable genome-wide
significant association despite moderately high heritability
estimates of 0.4 (s.e. 0.11) and 0.51(s.e. 0.11) for gc and gf
respectively for the population under study [8]. To address this
gap, we have applied a recently proposed analytical approach
[15] that captures the combined effect of multiple genetic
variants at a region of the genome, thereby identifying some of
the heritability missing when applying standard ‘one at a time’
SNP analyses [16,17]. This approach has the potential to
overcome stringent multiple testing penalties and has been
shown to be more powerful than the ‘one at a time’ SNP
approach in simulated and real data [15]. We hypothesise that
combinations of common and rare variants, that are not in
complete LD with common tagging SNPs, may account for a
substantial part of the missing heritability and that these will be
best captured by estimating the genetic variation from an entire
‘region’ or geographically co-located set of SNPs. The trade-off
comes between capturing as much variation as possible, whilst
having the resolution to locate causal effects. Here we divide the
genome in two ways (regionally and functionally): firstly, into
overlapping regions of 101 SNPs; and secondly by chromosome,
separating SNPs that lie within genes and SNPs that map
outside a 5 kb boundary of genes. We examine the genetic
variation explained by each region or chromosome for
crystallised and fluid intelligence and for the lifetime change
in fluid intelligence, and we compare that to the most significant




Ethical approval for all the projects was obtained from the
Lothian Research Ethics Committee. Data were gathered
from three longitudinal studies of relatively healthy older
individuals with detailed cognitive phenotypes: the Lothian
Birth Cohorts of 1921 (LBC1921, N = 550) and 1936
(LBC1936, N = 1091), and the Aberdeen Birth Cohort of
1936 (ABC1936, N = 548). The years 1921 and 1936 refer to
the participant’s year of birth. Participants took a validated
intelligence test at a mean age of 11 years: the Moray House
Test No. 12 (MHT), which is a test of general intelligence
[18,19] and detailed follow-up assessments at a mean age (sd)
of 79.1 (0.6), 69.5 (0.8) and 64.6 (0.9) for LBC1921, LBC1936
and ABC1936, respectively. Cognitive test scores from age 11
and old age were available.
Construction of phenotypes
Selection of individuals, ethical consent, and full details of the
assessments have been described in previous studies
[8,9,18,19,20,21]. In brief, for each cohort, cognitive phenotypes
of fluid-type and crystallized-type intelligence were constructed
[19,20]. The final measure of lifetime cognitive change was
constructed by adjusting fluid intelligence in old age for prior
cognitive ability providing a quantitative measure of cognitive
change from age 11 to old age. Phenotypes were adjusted within
cohort for age and standardised within gender, and are further
defined in Appendix 1.
Genotypic data
Following informed consent, venesected whole blood was
collected for DNA extraction. A total of 599,011 single nucleotide
polymorphisms (SNPs) were genotyped using the Illumina610-
Quadv1 chip as described previously [8]. Quality control (QC)
procedures were performed per SNP and per sample. Individuals
were excluded from further analysis if genetic and reported gender
did not agree. Samples with a call rate #0.95, and those showing
evidence of non-European descent by multidimensional scaling
analysis, were also removed. SNPs were included in the analyses if
they met the following conditions: call rate $0.98, minor allele
frequency $0.01, and Hardy-Weinberg equilibrium test with
p$0.001. To avoid bias from hidden family structure, if a pair of
individuals shared more than 2.5% of the genome in common, one
individual was omitted from the analysis. After QC, 1804
individuals (ABC1936, N = 376; LBC1921, N = 484; LBC1936,
N = 944), and 547,750 autosomal SNPs were included in the
analysis.
Estimation of regional and functional genetic
contribution
In a population of unrelated individuals, SNP genotypes can be
used to estimate shared co-ancestry or identity by state between
individuals with rare SNPs weighted more heavily. Under certain
assumptions it can be shown that a region that is shown to be
identical by state will also be identical by descent [22]. The n6n
genomic relationship matrix (GRM) of relatedness at a population
level between n individuals gives the covariance structure for the
phenotype based on the premise that the more related two
individuals are, or the greater the amount of the genome they
share in common, the greater the expectation of phenotypic
similarity.
Using theory adapted from standard variance components or
pedigree based linkage analysis [23,24,25] and further developed
for genomic prediction [26,27,28], a GRM containing information
from the genotypes of m SNPs can be used to solve a linear mixed
model [Model 1] and partition the phenotypic variance into
estimates of the genetic and environmental variance [15,29]. To
avoid confusion with the well-known family-based estimates of
heritability [30] we define the amount of phenotypic variance
captured by the genotypes of unrelated individuals as population-
sense heritability (h2ps). The linear mixed model (LMM) is:
Y~XbzIuze ðModel 1Þ
Where Y is an n61 vector of phenotypes for n individuals; Xn621 is
the incidence matrix relating the regression coefficients for 20
principal components and gender to the n individuals; b is a 2161
vector of fixed effects; u is a n61 vector of the additive genomic
random effects where u,N(0,Gs2u), G is an n6n genomic
relationship matrix estimated from the SNP genotypes and s2u
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is the genetic variance captured by the SNPs used to estimate the
relationships among the n individuals; I is an n6n identity matrix;
and e is an n61 vector of individual residual effects. The variance
of Y is var (Y) = Gs2u+Is2e. G is calculated following Van Raden
(2008) [28]. In short, an n6m matrix, W, is constructed where m is





with xij being 0, 1 or 2 for the three
possible SNP genotypes for the j-th SNP of the i-th individual and
pj being the allele frequency of the j-th SNP. G is calculated as
WW’/m.
An extension of this to a bivariate analysis [Model 2] was used




Where 1 and 2 refer to trait 1 and trait 2, u1 and u2 are n61
vectors of additive genomic random effects. G is the genomic
relationship matrix between all individuals as described above.
The additive genetic covariance of Y1 and Y2 - cov(u1,
u2) =s
2
u12 and the environmental covariance cov (e1, e2) is
s2e12. The additive genetic correlation of Y1 and Y2 is s
2
u12/













. A full derivation of the
estimation of the genetic covariance is given in [31].
Regional population-sense heritability
Yang et al. [32] implement the linear mixed model [Model 1] in
the software package GCTA and have shown that the method can
be used to partition the genetic variation across chromosomes and
functional regions of the genome such as genes [15].
By combining information on multiple SNPs within a genomic
region we aim to capture a substantial part of the heritability
missed by traditional ‘one SNP at a time’ approaches. Identifying
those regions of the genome that capture most variation is an
efficient way of selecting candidate regions for high throughput
sequencing that could complement whole-exome sequencing
experiments until whole genome sequencing is feasible for large
numbers of samples. Here, autosomal SNPs were ranked by
genomic location and divided into regions spanning 101 consec-
utive SNPs. Regions were overlapping to allow for the possibility
that genetic variation is distributed among two or more windows,
with a shared region between two consecutive regions spanning 50
SNPs, resulting in 10,908 overlapping regions from 547,750 SNPs.
Each region was fitted individually in the linear mixed model
[Model 3].
Y~XbzIuRze ðModel 3Þ
Where R is the genomic region. uR is a vector of n additive
genomic random effects from the region, n is the number of
individuals and I is the identity matrix as described above.
Var(Y )~GRs2uRzIs
2
e ; where GR is a GRM derived only from
SNPs within the defined region.
Functional population-sense heritability
Genes are the most important functional units of the genome. In
order to investigate their contribution to variation in cognition we
partitioned, for each of the autosomes, the genetic variance
captured by SNPs located inside and outside genes. SNPs mapping
to each autosome were separated into those that mapped within
5 kb of the transcription start and end sites of a gene (i.e. within
genes) and those that mapped outside these limits. Genome build
37 was used to identify genes and gene limits. A linear mixed
model was used to fit forty-four variance components simulta-
neously, capturing SNPs within genes and SNPs outside genes on







Iuoutc ze ðModel 4Þ
Where uc
in is the vector of additive genomic random effects which
for each chromosome is solved using a GRM derived from SNPs
which lie within genes or within a 5 kb boundary of a gene on that
chromosome c; uc
out is a vector of additive genomic random
effects solved using a GRM derived from SNPs which lie outside
genes on that chromosome c.
For comparison we grouped SNPs by chromosome and the
population-sense heritability was estimated for individual chro-
mosomes [Model 5]. This approach was used previously in a meta-
analysis of five cohorts including those described here for adult





Where uc is the vector of additive genomic random effects on
chromosome c solved for each chromosome using a GRM derived
from SNPs which lie on that chromosome c.
Model fitting
Initially all SNPs were fitted in the model to estimate the genetic
variance and overall heritability for the three cognitive traits in the
population. Bivariate analyses to estimate covariances amongst the
three cognitive measures were performed using ASReml 2
software [33]. To avoid confounding of genetic variation of the
trait and potential variation due to population stratification,
eigenvectors were estimated from the genetic relationship matrix
and the first 20 principal components were fitted as covariates in
the linear mixed model. Sex was also fitted into the model.
Analyses were subsequently carried out fitting the regions defined
above to estimate regional and functional population-sense
heritability.
GCTA/ACTA [34] solves the LMM and obtains estimates of
genetic and residual variances by restricted maximum likelihood
(REML) using the average information (AI) algorithm.
Test statistics were obtained using a standard likelihood ratio
test (LRT) statistic calculated as twice the difference between the
log likelihoods of the full model and a null or reduced model that
did not fit a genetic component. For a single test, the expectation
of the LRT for testing one extra variance component is a 50:50
mixture of a point mass of 0 and a chi square distribution with 1df
[35]. This is so because under the null hypothesis the true value of
the variance components is on the boundary of the parameter
space defined by the alternative hypothesis.
Results from the 10,908 regions were ranked by likelihood ratio
test statistic. The top ten non –overlapping or approximately 0.1%
of regions were fitted back into a linear model with an eleventh
‘polygenic’ variance component comprising all the available
autosomal SNPs. This model was tested against a null model
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containing only the polygenic variance component under the
expectation that the likelihood ratio test is distributed as a chi-
square with ten degrees of freedom. We repeated the analyses
without the ‘polygenic’ variance component and obtained virtually
the same results.
Finally, the contribution of the identified top ten regions for
each of the traits were analysed for putative pleiotropic effects
across cognitive phenotypes.
Permutation analysis
To date there is little evidence for the empirical distribution of a
suitable threshold for the LRT statistic when testing multiple
genomic regions. Rowe et al. [36] showed that for variance
components based QTL mapping methods, the test statistic and
the variance explained can be hugely inflated if multiple testing
and the underlying genetic architecture are not properly
accounted for. Given that over 10 000 tests were performed,
many of which were highly correlated due to the overlap of
regions, and the novelty of the approach, we derived the empirical
distribution of the test statistic using ACTA [34] to perform 100
permutations for each of the traits resulting in empirical thresholds
for individual tests ranging from 17.6 for gf to 18.8 for gc for a type
1 error rate of 5%. As 100 permutations is not sufficient to ensure
a stable estimate of the threshold, but testing 10,908 regions for
three traits hundreds of times is computationally intensive, we
repeated the analyses using non-overlapping windows and carried
out a further 500 permutations. A permutation involved randomly
permuting the phenotypic and genotypic data and testing 5454
alternate or non-over-lapping regions on the permuted data set.
For each set of permuted data; i) regional population-sense
heritabilities were estimated for all regions (each spanning 101
SNPs) and ii) The top ten regions ranked by LRT test statistic from
each permutation were simultaneously fitted into a linear model to
determine their combined contribution. These were fitted with
and without a ‘polygenic’ component. This gave the empirical
distribution of the test statistic under the null hypothesis for fitting
a single region and for when the ten top ranking regions are fitted
simultaneously.
‘One SNP at a time’ genome-wide association analysis
The software package PLINK [37] was used to carry out single
SNP association tests to assess whether the SNPs of greatest
significance were associated with the regions from [4] that
explained the greatest amount of genetic variation.
Results
Variance captured by all autosomal SNPs or population-
sense heritability
For simplicity we define the proportion of phenotypic variance
captured by SNP genotypes in unrelated individuals as population-
sense heritability (h2ps) to distinguish it from the often used narrow
and broad sense heritability [29]. Heritabilities, phenotypic and
genetic correlations are given in Table 1. Population-sense
heritability estimates for cognitive traits ranged from 0.19 (s.e.
0.2) to 0.37 (s.e. 0.19). Estimates for crystallised intelligence are
similar to those from the larger previous study [8]. Fluid
intelligence estimates differ slightly due to differences in sample
size, study design and population demographics. Fluid intelligence
was highly genetically correlated to both cognitive change
rA = 0.95 (s.e. 0.25), and to crystallised intelligence rA = 0.66 (s.e.
0.34) (i.e. the amount of correlation emerging from pleiotropy is
high). There was little genetic correlation between crystallised
intelligence and cognitive change rA = 0.008 (s.e. 0.53).
Regional population-sense heritability
The distributions of regional population-sense heritability
estimates for the three traits are similar. Most regions explain
variance close to zero with 1.7 to 2.5% explaining greater than 1%
of variation, 0.07 to 0.18% explaining greater than 2%, and only
0.02% explaining greater than 3%.
The likelihood ratio test statistic for the regional heritability scan
across the genome and the most significant hits from the genome
wide association analyses (2log10P-value.2.7) are given in
Figure 1. Table 2 gives details of the top ten regions for each
trait ranked by LRT and appendix 2 gives the known genes for
each of these regions and pathway analysis. The top ten single
SNP associations for the three traits were all within regions with
h2ps.1% (Table S1 in File S1). The correlation between the
greatest 2log10 (P-value) for SNP association in each region and
2log10 P-value from the LRT test for each region was 0.52
(Figure 2). When regions were ranked by LRT a region on
chromosome 6 ranking 3rd and 4th for cognitive change and fluid
intelligence respectively also contained the top SNP in the GWAS
for cognitive change. For fluid intelligence, the top ranking region
on chromosome 5 spanned the third ranking single SNP
association (P,3.41E-06). This region on chromosome 5 associ-
ated with fluid intelligence was the only region for all three traits to
exceed genome-wide significance at the P,0.10 threshold. When
the top ten regions (Table 2) from each trait were fitted together in
a LMM they explained 13% (Pperm = 0.58), 15% (Pperm = 0.11)
and 18% (Pperm = 0.43) of the phenotypic variation for crystallised
intelligence, fluid intelligence, and cognitive change respectively.
Table 3 shows regions that explained greater than 1% of
phenotypic variation in more than 1 trait including regions on
chromosome 9 and 11 that potentially have pleiotropic effects on
all three traits.
Regions were defined by number of SNPs; hence there was
variation in physical length of regions across the genome, with the
average region spanning 534 kb. No relationship was found
between the physical length of a region and its significance or the
amount of additive genetic variation explained (Figure S1 in File
S1).
Permutation analyses
To estimate empirical thresholds, phenotypic data for each of
the three traits were permuted 500 times to attain an estimate of
the null distribution when genotype and phenotype were randomly
assorted. We performed 5,454 REML analyses across the genome
for each of the permuted data sets resulting in over 8.2 million
single tests. The results were ranked by log likelihood and
compared to a null model using an LRT. The resulting genome-
wide significance thresholds for the LRT (P,0.05) were 17.2 for
crystallised intelligence, 17.5 for fluid intelligence and 17.08 for
cognitive change Figure 3 shows that the distributions of the test
statistic for the three traits were very similar and that they were
highly inflated when compared to the expectation of the null
distribution for a single test. Thresholds were close to those for the
10,908 tests but less conservative than a Bonferroni correction for
5,454 independent tests which would result in a 5% threshold of
19.7. Table 4 shows that the genome-wide threshold values were
stable after 300 permutations indicating that 500 permutations was
sufficient to estimate 5 and 10% genome-wide thresholds.
The distributions from the permutation analysis (Figure 3) show
that by chance in 5% of cases the variance explained by a region
exceeded 3.8, 3.8 and 4.0% for gc, gf and cognitive change
respectively.
For each permutation the top ten regions were identified, i.e.
those with the greatest likelihoods and fitted simultaneously into a
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LMM. An LRT was calculated as twice the difference between the
log likelihood of a model fitting ten regions and a null model
without a genetic effect, and we did not fit a polygenic model when
testing the top ten regions. The 95th percentile was used to
estimate a 5% genome-wide threshold for significance of the LRT
between a model fitting the top ten regions of the genome; and a
null model. The polygenic component was omitted as the original
genetic structure was removed by the permutation of genotypes
and phenotypes. The 5% genome-wide threshold was P,3.3E-24
for crystallised intelligence, P,1.42E-24 for fluid intelligence and
P,1.03 E-24.
Functional population-sense heritability
Figure 4 shows estimates of population-sense heritability for
each of the 22 autosomes, and for h2ps estimates using information
from SNPs inside genes and estimates using information from
SNPs outside genes for each chromosome and trait. For
crystallised intelligence heritability estimates from SNPs on
autosomes 3, 5, 11, 15 and 19 were significantly different from
zero. When divided further chromosomes 9, 15 and 19 had
significant estimates for h2ps within genes. For fluid intelligence,
estimates of h2ps on chromosomes 3, 9 and 10 were significant,
explaining 6, 5, and 8% phenotypic variance, respectively.
Table 1. Population-sense heritability (diagonal), phenotypic (upper diagonal) and genetic (lower diagonal) correlations for
measures of general intelligence and cognitive decline estimated from relationship matrices based on 547,750 SNP genotypes.
Trait Crystallised Intelligence Fluid Intelligence Cognitive change
Crystallised intelligence (n = 1791) 0.36 (0.19) 0.59 (0.01) 0.22 (0.02)
Fluid intelligence (n = 1706) 0.66 (0.34) 0.19(0.20) 0.78 (0.009)
Cognitive change (n = 1602) 0.0084(0.53) 0.95 (0.25) 0.26(0.22)
Heritabilities on diagonal, genetic correlations below diagonal, phenotypic correlations above diagonal and standard errors given in brackets.
doi:10.1371/journal.pone.0081189.t001
Figure 1. Plot of likelihood ratio test for phenotypic variance explained by each of 10,908 regions (groups of 101 consecutive
SNPS) (bars) and 2log10 P-values.2.7 for single SNP association (circles). Dashed line is 1% nominal significance threshold for LRT for
individual regions, dotted line is 5% genome-wide significance threshold for individual regions obtained by permutation analysis. A crystallised
intelligence n = 1791, B fluid intelligence n = 1706 , and C cognitive change n = 1602.
doi:10.1371/journal.pone.0081189.g001
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Autosomal h2ps within genes was significant for chromosomes 9,
14 and 15 and outside genes for chromosomes 3, 16 and 22. For
cognitive change chromosomes 4 and 10 had significant estimates
of h2ps with chromosome 6 significant for h
2
ps outside genes.
Genetic variation of the traits differed across autosomes and for
SNPs within or outside genes. SNPs within genes explained 48, 64
and 38% of the total genetic variation for gc, gf and cognitive
change respectively. There was no correlation between estimates
of autosomal heritability and the number of SNPs used to estimate
each genetic relationship matrix (Table S2 in File S1). Distribu-
tions of allele frequencies for SNPs inside and outside genes did
not differ P,0.99).
Brain-related intermediate traits
The top region associated with gf was genome-wide signifi-
cant at the 10%, however, even if the locus was truly associated
with gf we were not expecting a high level of statistical support
due to the small sample size of the study. In order to gather
further independent evidence that could support or reject the
association of the locus with gf we assembled previously
published data of brain-measured intermediate phenotypes
[38]. Within the chromosome 5 region we found two DNAm
sites, cg04431054 and cg15851800 and two mRNA probes
ILMN_1652306 and ILMN_1685140. DNAm sites cg04431054
and cg15851800 are located 381 base-pairs apart, cg04431054
is 277 base-pairs upstream of PRRC1, and cg15851800 is 104
base-pairs downstream of the transcription start site of PRRC1,
which spans chromosome 5 at base-pair location 126,853,301–
126,890,781. ILMN_1685140 targets transcripts of PRRC1
(Proline-Rich Coiled-Coil 1) and ILMN_1652306 transcripts of
MEGF10, a receptor for amyloid beta uptake, located between
position 126,626,523 and 126,801,429. All four intermediate
phenotypes were measured on tissue from the Cerebellum
(CRBL), Frontal Cortex (FCTX), the Pons (PONS) and the
Temporal Cortex (TCTX). ILMN_1652306 did not pass our
quality control procedure for the CRBL and thus was excluded
from further analyses. Regional genetic relationships were
estimated from 86 available SNPs located within the top 101
SNPs region associated with gf. h
2
ps was estimated with ACTA
[34].
The 86 SNPs located on chromosome 5 between 126711782–
127335370 base-pairs explain a significant (P,0.0001) proportion
of the phenotypic variation of cg04431054 for each of the four
brain tissues (Table 5). h2ps of cg04431054 measured in the CRBL,
FCTX, PONS and TCTX brain regions was 0.46, 0.24, 0.28 and
0.33, respectively.
So far, we have shown that the 623 kb region of chromosome 5
associated with gf is associated with cg04431054 levels in the
CRBL, FCTX, PONS and TCTX brain regions. However, we
have not yet shown a direct link between cg04431054 levels and gf.
To do that, we estimate the effect of the 86 SNPs on the brain
phenotypes and construct a genetic score [39] for each individual
with gf phenotypes. A significant regression of genetic score for
cg04431054 with gf would indicate a link between the levels of
Figure 2. Comparison of significance of region and top SNP within region. Scatter plot of 2log10 P-values for single SNP association of
greatest significance in region and significance of LRT test for variance explained by entire region (each region contains 101 SNPs). Correlation
coefficient is 0.52.
doi:10.1371/journal.pone.0081189.g002
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cg04431054 and gf. Only one of the four brain regions (TCTX)
showed a significant association with gf (P = 0.004), and explained
0.5% of the phenotypic variance. The regression coefficient was
positive (0.295, se = 0.004) indicating a positive correlation
between methylation levels and gf. Hence, our analyses of brain-
related intermediate phenotypes provides supporting evidence of
the region being truly associated with gf, uncovers the likely target
region of the brain associated with gf and identifies PRRC1 as a
candidate gene for gf.
Discussion
We implemented a recently proposed method of genome
scanning by expanding single SNP analysis to the estimation of
genetic variance explained by regions spanning 101 co-located
SNPs. After deriving empirical thresholds by permutation analysis
we show that stringent thresholds close to that of a bonferroni
correction are necessary for evaluating the likelihood ratio test
statistic and that the distribution of multiple tests is highly inflated

















10 84493034 84943238 0.01 0.008 0.011b 0.007 14.08 4.4 0.009
5 153024650 153532086 0.02 0.01 0.017 0.009 12.07 2.45 0.003
10 84323605 84670475 0.02 0.012 - - 11.85 3.78 0.008
13 57449351 58113705 0.01 0.008 0.01 0.006 10.48 4.45 0.008
9 78430995 78767837 0.01 0.008 0.008 0.006 10.08 3.56 0.008
10 17430161 17790975 0.01 0.008 0.015 0.008 9.95 4.79 0.008
11 102565882 102978790 0.02 0.01 0.015 0.008 9.72 2.43 0.005
14 20640453 21072443 0.03 0.014 0.02 0.012 9.57 2.42 0.004
6 51858157 52238923 0.01 0.008 0.007 0.006 9.55 2.46 0.005
2 84702898 85301342 0.01 0.008 0.013 0.008 9.49 1.59 0.003
13 100772901 101089435 0.02 0.009 0.014 0.008 8.78 2.97 0.002
Fluid Intelligence
5 126711782 127335370 0.02 0.009 0.013 0.008 16.00 5.47 0.013
6 39140691 39378453 0.03 0.013 0.016 0.012 14.10 3.74 0.009
13 65117143 65633593 0.02 0.01 0.015 0.01 14.07 4.15 0.009
6 740414 1013400 0.02 0.009 0.013 0.008 12.36 4.74 0.011
6 39236400 39493104 0.04 0.018 - - 12.34 3.52 0.008
11 102565882 102978790 0.02 0.009 0.015 0.008 11.55 4.42 0.010
9 78430995 78767837 0.01 0.009 0.01 0.007 11.07 3.25 0.007
11 102824059 103220693 0.01 0.007 - - 10.91 3.34 0.007
3 101162780 101999012 0.02 0.011 0.02 0.011 10.55 5.04 0.012
5 33703559 34034521 0.02 0.012 0.016 0.01 9.44 0 0.005
2 151358558 151655394 0.02 0.01 0.012 0.008 9.37 3.43 0.008
5 127010643 127650653 0.01 0.009 0.015 0.008 9.33 0.91 0.007
Cognitive Change
4 53606097 54158143 0.02 0.009 0.01 0.008 10.44 4.4 0.011
15 90960003 91404141 0.02 0.011 0.017 0.011 10.15 4.83 0.012
6 740414 1013400 0.02 0.009 0.014 0.009 10.08 5.57 0.014
4 62441864 63300488 0.03 0.014 0.024 0.012 9.50 2.57 0.006
6 891665 1138987 0.02 0.009 - - 8.77 1.56 0.003
6 12418779 12930959 0.02 0.009 0.014 0.009 8.70 4.02 0.010
2 237734083 238123037 0.02 0.011 0.016 0.006 8.30 3.6 0.009
13 98189341 98677491 0.04 0.022 0.035 0.018 8.12 2.59 0.006
14 64270578 64666246 0.02 0.011 0.016 0.01 8.10 2.77 0.006
6 88043140 88678348 0.01 0.007 0.008 0.007 8.08 3.37 0.008
4 148617678 149254898 0.02 0.01 0.023 0.013 7.92 2.71 0.006
aheritability of region when full model fitting 11 variance components first ten independent (i.e. non overlapping) regions and rest of genome.
bOnly the best supported of multiple overlapping regions was fitted.
doi:10.1371/journal.pone.0081189.t002
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when compared to the null distribution for a single test. This is also
true for estimates of heritability (h2ps). Table 2 shows that within
the top ten regions ranked by LRT, only a region on chromosome
6 for fluid intelligence and a region on chromosome 13 for
cognitive change explained a greater proportion of the genetic
variance (h2ps) than 95% of the ranked permutation analyses.
Despite this the LRT for the comparison of the linear models did
not achieve genome wide significance for either of these regions.
We did find a genome wide significant region (P,0.10) for the
LRT statistic on chromosome 5 associated with fluid intelligence.
The region spans the CTXN3 gene (cortexin 3) (Figure 5), a brain
(including foetal brain) and kidney specific integral membrane
protein, highly enriched in cortex and located on 5q23. This gene
has been previously identified as a candidate for schizophrenia and
measures of cognitive change [40]. In the GWAS, the third highest
ranking SNP rs790837 (P,1026) is located at position 127004506,
10 kb away from this gene.
The CTXN3-SLC12A2 region is a strong candidate region and
has been linked to brain function and schizophrenia in multiple
studies [41,42,43]. The relationship between pre-morbid measures
of intelligence and the risk of schizophrenia is also documented as
greater than with many other psychoses [44,45]. Although the
overlapping region containing SLC12A2 ranked within the top ten
regions with an LRT of 9.33 (Table 2), here the region containing
cortexin 3 (LRT = 16) was the only region to achieve genome wide
significance (P,0.10). Nonetheless, the strongest evidence suggests
that variation of methylation levels at the promoter region of
PRRC1 are mediating variation if gf. The function of the Golgi-
associated PRRC1 gene in the brain is unknown and will require
follow-up functional studies.
The population-sense heritabilities for fluid intelligence are
lower than those previously reported possibly due to an older
demographic. Family based (narrow-sense) estimates of heritability
for IQ related traits have been shown to decline somewhat with
age [46]. This, in part, will be due to an increase in environmental
variance.
Autosomal heritability
In general the estimates of genomic heritability for chromo-
somes reflected the analysis of smaller regions in that the regions
with the highest test statistics are located on chromosomes
explaining the greatest variance. The sum of heritability estimates
for individual chromosomes was inflated by 20–50% compared to
estimating the heritability for the entire genome. When heritabil-
ities were estimated from SNPs inside and outside genes (i.e. fitting
44 variance components) heritability for fluid intelligence was
doubled when compared to fitting the 22 autosomes (Table S3 in
Table 3. Pleiotropic regions affecting multiple traits.
Chr region start (bp) region end (bp) h2 Crystallised s.e. h2 Fluid s.e. h2 Cog change s.e.
6 740414 1013400 0.00 0.01 0.02 0.01 0.01 0.01
14 64270578 64666246 0.00 0.00 0.02 0.01 0.02 0.01
9 78430995 78767837 0.01 0.01 0.01 0.01 0.02 0.00
10 17430161 17790975 0.01 0.01 0.02 0.00 0.00 0.01
11 102565882 102978790 0.02 0.01 0.02 0.01 0.01 0.01
11 102824059 103220693 0.02 0.01 0.02 0.01 0.01 0.01
doi:10.1371/journal.pone.0081189.t003
Figure 3. Distribution of the likelihood ratio test and variance explained under the null hypothesis. Comparison of the distribution of
likelihood ratio test and variance explained for 5454 regions spanning 101 SNPs for fluid intelligence, crystallised intelligence and cognitive change.
Lower set of distributions for each plot are from the real data, upper set are the 5% genome-wide significance threshold from each of 500 permuted
data sets i.e. empirical null distribution.
doi:10.1371/journal.pone.0081189.g003
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File S1). This could be due to fitting so many correlated variance
components simultaneously; however, estimates for crystallised
intelligence remained stable. It is also possible that this is due to
the lack of independence of SNPs within chromosomes inflating
estimates, although fitting all 44 variance components simulta-
neously should account for this. It is probable that more
information from a greater number of individuals would enable
more precise estimates of covariances and therefore more accurate
estimation and partition of variance components. It is also possible
that crystallised intelligence is a more polygenic trait with some
genetic variance contributed from most chromosomes whereas
fluid intelligence and cognitive change show variation around
many autosomal estimates which are truly zero.
Pleiotropy
Only 2.5% of regions show an h2ps greater than 1%. Despite
this there is much overlap between the three traits with top regions
affecting multiple traits (Table 3). This suggests that the three traits
are likely to be affected by the same genes and biological pathways.
However, the direction of the effects in these regions will tend to
be different for traits such as cognitive change and crystallised
intelligence that show a genetic correlation close to zero (Table 1).
A single region might also contain linked QTL alleles or regulatory
factors in coupling or cis.
It is also feasible that regional significance is biased by other
factors making a region more or less likely to explain variation in
one or multiple traits. We found no relationship between physical
length of region and test statistic. Yang et al. [29] proposed that
the genetic variation explained by a region was proportional to the
total length of genes. We did not find this in the current study. The
unadjusted r2 values for the relationship between heritability of
autosomes and total length of known genes on each chromosome
was 0.14, 0.02, and 0.01 for crystallised intelligence, fluid
intelligence, and cognitive change with corresponding p-values
of 0.07, 0.54, and 0.65. It is possible that this is dependent on the
heritability and the genetic architecture of the trait, i.e. the more
Table 4. Genome wide thresholds for the Likelihood Ratio
Test (LRT) derived from N permutations.




N P,0.05 P,0.10 P,0.05 P,0.10 P,0.05 P,0.10
100 19.0 16.5 19.4 16.3 18.0 16.6
200 17.8 15.8 18.1 16.3 17.6 16.5
300 17.5 15.8 17.6 16 17.0 16.1
400 17.4 15.8 17.1 15.8 17.3 16.3
500 17.5 15.8 17.1 15.9 17.2 16.2
doi:10.1371/journal.pone.0081189.t004
Figure 4. Distribution of population sense-heritability inside and outside genes. Distribution of heritability estimated from all SNPs, SNPs
inside genes and SNPs outside genes by chromosome for crystallised intelligence, fluid intelligence and cognitive decline.
doi:10.1371/journal.pone.0081189.g004
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polygenic the trait the higher the correlation between the amount
of heritable genetic material on each chromosome and the
estimate of heritability. This is reflected in Yang et al.’s report
where, although height and BMI were highly correlated with the
length of genes, there was variation amongst traits with an r2 value
of only 0.02 for von Willebrand factor.
Distributions of the regional heritability test statistic (2log10 P-
value) were compared across traits and gender using a Kolmo-
gorov-Smirnov test. Cognitive change differed from fluid and
crystallised intelligence (P,2.2E-16 and P,5.0E-11, respectively).
Differences between crystallised and fluid intelligence were less
marked (P,0.01). Interestingly, we found some evidence that the
distribution of heritability across the genome for cognitive change
differs in males and females. Genetic variation was higher in
females and the Kolmogorov-Smirnov test of the distributions of
heritabilities for the 10,908 regions in males (n = 871) and females
(n = 933) was suggestive at P-value of 0.06, although the test does
not account for the correlation of the regions and is likely to be
inflated. A previous study showed higher variation within males for
a measure of general intelligence [47]. It is possible that the
increased environmental variance attributable to old age happens
sooner in males than females.
It is not clear from this study whether there is utility in a method
which expands single SNP analyses to encompass genomic regions
Table 5. Population-sense regional heritability for each brain-measured intermediate phenotype within the top gf associated
region on chromosome 5.
Regional heritability of brain-measured intermediate traits
Intermediate Phenotype Tissue h2ps SE P
cg04431054 CRBL 0.463 0.124 1.370E-08
cg15851800 CRBL 0.000 0.075 0.500
cg04431054 FCTX 0.237 0.104 1.190E-05
cg15851800 FCTX 0.020 0.050 0.325
cg04431054 PONS 0.278 0.111 1.270E-05
cg15851800 PONS 0.003 0.046 0.477
cg04431054 TCTX 0.326 0.110 1.020E-08
cg15851800 TCTX 0.082 0.078 0.063
ILMN_1685140 CRBL 0.025 0.053 0.315
ILMN_1652306 FCTX 0.000 0.049 0.500
ILMN_1685140 FCTX 0.000 0.041 0.500
ILMN_1652306 PONS 0.000 0.033 0.500
ILMN_1685140 PONS 0.046 0.051 0.075
ILMN_1652306 TCTX 0.000 0.079 0.500
ILMN_1685140 TCTX 0.000 0.045 0.500
Tissue: brain region, h2ps: estimated regional population-sense heritability, SE: estimated standard error of the regional population-sense heritability. P:p-value from the
LRT test testing the significance of the genetic variance component.
doi:10.1371/journal.pone.0081189.t005
Figure 5. Region on chromosome 5 significantly associated with fluid intelligence. Annotation from Ensembl genome browser.
doi:10.1371/journal.pone.0081189.g005
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and that it is able to capture complex local genetic architectures.
We acknowledge the limitations of our analysis. Statistical power
and accuracy of estimation of variance components is most
certainly an issue. Fluid intelligence and cognitive change are
important traits and to date lifetime measurements are rare. This
limits our ability to increase the sample size. We have shown that
the heritability of a region or autosome is not merely a function of
its length or the number of genes contained therein. It will be
desirable to test the methodology with much larger data sets. It
would be interesting to assess whether the regions of greatest
significance are enriched for psychiatric genes in comparison to
randomly selected regions. Gene set enrichment analyses devel-
oped for microarray analysis could be a useful tool for this.
Conclusions
Using a recently proposed population-based linkage scan of the
genome we have conducted a search for regions significantly
associated with measures of cognition and age related cognitive
change. Permutation analysis shows that test statistics and variance
explained by a single window were highly inflated when compared
to the assumption of a chi square distribution for a single test. We
found a significant region on chromosome 5 associated with fluid
intelligence explaining 2% of phenotypic variation.
Although single SNP and regional analysis have similar profiles,
the ranking of the top regions differ. The regions with the highest
test statistic although not genome-wide significant did affect
multiple traits and encompass biologically plausible and interesting
putative candidate genes. These regions indicate areas of the
genome where re-sequencing efforts could be focused to disen-
tangle the fine scale contribution of linked genes and pathways.
Although our methodology would benefit from larger sample sizes
and increased power, the results give new insights into the study of
general intelligence and the underlying mechanisms of cognitive
change.
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